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ABSTRACT
Populations of neural stem cells (NSCs) residing in different locations of the central 
nervous system (CNS) are predicted to have similar gene expression profiles, which 
identify them as stem cells. The best in vitro model to study NSCs is the neurosphere 
-  a spherical colony generated from a single NSC. Currently, there is a lack of 
markers to characterise NSCs and distinguish them from lineage-committed 
progenitor cells. One promising candidate is Sox2, which is a member of the Sox 
family of transcription factors and is expressed within the CNS. Sox2^geol+ mice carry 
a p-galactosidase/ neomycin fusion gene in the Sox2 locus. Homozygous Sox2^eo 
mutants exhibit peri-implantation lethality since Sox2 is essential for the maintenance 
of the pluripotent epiblast cells in the embryo. I have established that the neurosphere- 
generating cellular component, throughout the developing CNS, resides within the 
Sox2 expressing population. Through neomycin selection, neurosphere cultures 
derived from Sox2^geo/+ mice have been enriched for NSCs and have been used to 
characterise NSCs.
Differences in the gene expression profiles of cells expressing and not expressing 
Sox2 have been carried out through microarray experiments. To investigate the 
possible function of Sox2 in NSCs I have depleted SOX2 by RNA interference, 
followed by microarray analysis, to identify potential targets of Sox2 that may further 
affect the proliferation or differentiation of stem cells. The influence of the niche 
surrounding stem cells within the neurosphere has been addressed through a series of 
culture experiments comparing NSC-enriched to non-enriched neurospheres.
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In order to elucidate the genes responsible for the identity of stem cells, enriched NSC 
cultures have been compared to their tissue of origin through microarray analysis. 
These studies have revealed genes expressed at significantly elevated levels within the 
stem cell cultures compared to the tissue samples - a predominantly differentiating 
population. Pair-wise comparisons between neurospheres generated from the spinal 
cord (11.5 dpc, 14.5 dpc) and dorsal telencephalon (14.5 dpc) were used to refine 
candidate genes and provide an insight into the spatial and temporal properties of 
NSCs. Several candidate NSC markers, including transcription factors and 
extracellular matrix molecules common to all populations, have been identified.
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CHAPTER 1
Introduction
1.1 Principles of Stem Cells
A stem cell is a cell that can divide to generate one daughter cell with stem cell 
properties and another daughter cell that produces differentiated descendants. Some 
stem cell types are unipotent, giving rise to a single type of differentiated cell, such 
as spermatogonial stem cells, where ultimate descendants are sperm, while others can 
give rise to many, such as bone marrow stem cells. Transit amplifying progenitor 
cells are more committed than true stem cells and while they may divide, they do not 
strictly self-renew as they progress down one or more pathways of differentiation. 
However, it is not always easy to distinguish between these two cell types. To make 
a definition of stem cells more practical, the range of cell types produced by a 
progenitor has to be considered alongside self-renewal, where the original potential 
also needs to be maintained. Also, in theory, in conditions that promote self-renewal, 
single stem cells should be able to give rise to populations of equivalent cells that can 
be serially passaged for an extended number of divisions. This would reflect the 
continued presence of stem cells in vivo, often throughout the life of the adult animal, 
but conditions to allow this to happen in vitro are only known for a few stem cell 
types. True stem cells may be totipotent i.e. have the ability to generate all the cell 
types within the organism. Such cells may exist in plants and in some animal species, 
but almost certainly not in mammals where the only truly totipotent cells are the 
fertilized egg and blastomeres of early cleavage stage embryos, which do not self- 
renew on division. A more common usage of the stem cell definition includes cells of 
more restricted potential, such as the vast array of cell types of multipotent character
17
that proliferate after gastrulation in the embryo and can give rise to all differentiated 
cells in their lineage. Although it is arguable whether most of these are truly stem 
cells in vivo, since their properties evolve as the embryo becomes more complex. 
Once the potential of a cell becomes restricted, and typically begins to express 
markers associated with more differentiated progeny, it can be referred to as a 
precursor or a committed progenitor. These cell types may retain the capacity to 
divide giving rise to cells of more than one type (although this capacity is more 
restricted in this lineage) or they may terminally and irreversibly differentiate.
If stem cells divide symmetrically to give rise to two identical daughter stem cells, 
this will result in an exponential increase of cell numbers. Such divisions are more 
common in the embryo as they are associated with growth. In the adult, stem 
cells/progenitors will normally undergo asymmetric divisions, giving rise to a 
multipotent daughter cell and one cell that will commit or is already committed to 
differentiate. This type of division maintains cell numbers in the adult fairly constant 
since the numbers of new cells that are generated are similar to the numbers of 
differentiating or dying cells. It is likely that there are feedback mechanisms whereby 
the differentiating cells regulate division of the stem cells. See section 1.1.4 for 
further discussion.
1.1.1 Stem cells in the early mouse embryo
Embryonic Stem (ES) cells can be isolated from the inner cell mass of blastocyst 
stage embryos within the narrbw time frame of about 3.5 to 4.5 dpc in the mouse. In 
terms of differentiation capacity, they behave as the in vitro equivalent of the early 
epiblast. They are therefore able to give rise to all cell types of the embryo and the
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adult mouse and to some extraembryonic cell types, but not to trophectoderm
derivatives. While they can give extraembryonic visceral endoderm in vitro, they do
so very inefficiently in vivo after re-introduction into preimplantation embryos. They
are therefore pluripotent rather than totipotent- although the latter term is often used
erroneously. ES cells were first isolated from the inner cell mass of murine
blastocysts in 1981 (Evans and Kaufman 1981; Martin 1981), following pioneering
observations that pluripotent cells can be derived from teratocarcinomas generated
from embryos transferred to extrauterine sites. Stem cell-like cells derived from
teratocarcinomas were termed embryonal carcinoma (EC) cells and have properties
similar to ES cells but they are often aneuploid. Some EC cells can contribute to
normal embryonic development in chimeras after their introduction into normal host 
*
embryos at the blastocyst stage, however their contribution is often sporadic and less 
extensive than that of ES cells (Gardner 1968). With very rare exceptions, they have 
been unable to contribute to the germ cell lineage (Papaioannou and Rossant 1983). 
On the other hand, ES cells have the ability to contribute readily to all cell types of 
the developing embryo including the germ line. Their pluripotency has been 
demonstrated further through the generation of completely ES-cell derived normal 
mice through the production of ES cell-tetraploid embryo aggregation chimeras, 
where the tetraploid component is excluded from the embryo proper but will form 
functional extraembryonic cell types (Nagy et al. 1993). More recently, ES cells have 
been derived from human blastocysts (Thompson et al. 1998) and from some 
primates, but there has been no success in their isolation from cows, sheep or rats. 
Mouse, but not human, ES cells in culture require leukaemia inhibitory factor (LIF), 
which promotes self-renewal, either as an additive to the medium or supplied by 
fibroblasts acting as feeder cells. They are both usually sustained in supplemented
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foetal calf serum but in mouse ES cell culture, bone morphogenic protein 4 (BMP4) 
has been identified as being the factor within the serum that is sufficient to maintain 
ES cells together with LIF (Ying and Smith 2003). ES cells can differentiate into a 
wide range of cell types in culture. This will happen spontaneously, especially when 
they are not passaged and have formed large clumps of cells. Although their 
differentiation is disorganised, it tends to follow routes taken by normal early embryo 
differentiation. Thus, the first differentiated cell type to be identified in culture is 
extraembryonic endoderm. ES cells as well as EC cells have the ability to form 
aggregates in non-adherent culture conditions, and these are known as embryoid 
bodies. Cells cultured in this way readily differentiate and, to some extent, can be 
directed by external factors to differentiate into specific cell lineages e.g. retinoic 
acid favours differentiation into neural cell types. It is also possible to use very 
defined conditions, whereby the withdrawal of LIF and BMP can lead to the majority 
of the cells following a neural pathway. This is not strictly a default pathway as it 
involves autocrine signalling via FGFs made by ES cells (Ying et al. 2003).
From fertilisation until the 8-cell stage, all the blastomeres divide symmetrically and 
all progeny are totipotent. This remains a property of the ICM in the blastocyst (4.0 
dpc). The ICM gives rise to extraembryonic endoderm, epiblast, which remains 
pluripotent until gastrulation (the process that leads to the establishment of the 
primitive germ layers), ectoderm, mesoderm and endoderm, as well as to primordial 
germ cells. Although cells of the ICM lose their ability to form trophoblast cells in 
vivo and are pluripotent, in a few abnormal situations, cultured ICM cells have been 
shown to generate trophoderm cells, for example after the loss of Oct4 (Nichols et al. 
1998) or Sox2 (Avilion et al. 2003). The outer cells of the blastocyst are the first cells
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to undergo lineage commitment, where their fate becomes restricted to that of the 
trophectoderm lineage. The trophoblast cells in contact with the ICM are known as 
polar trophectoderm and they are induced to divide in a relatively undifferentiated 
state, remaining diploid, and giving rise to extraembryonic ectoderm, whereas the 
mural trophectoderm cells undergo endoreduplication and differentiate as giant cells. 
The extraembryonic ectoderm gives rise to the chorionic ectoderm, which is 
essentially a population of stem cells able to give rise to all the differentiated 
trophectoderm derivatives of the placenta. In culture, trophoblast cells can be 
maintained as undifferentiated trophoblast stem (TS) cells in the presence of 
fibroblast feeders and FGF4. TS cells can also be isolated from blastocysts, 
extraembryonic ectoderm at 6.0-7.0 dpc and from chorionic ectoderm at 7.5 dpc. TS 
cells can differentiate into all cell types of the trophectoderm lineage including 
trophoblast giant cells, when either FGF4 or the feeder cells are removed (Tanaka et 
al. 1998). More recently, it has been possible to culture a third type of stem cell from 
the late blastocyst. These are called XEN cells and are able to give rise to 
extraembryonic endoderm cell types in vitro, or in chimeras (Kunath et al. 2005). 
After gastrulation, the generation of ectoderm, endoderm and mesoderm results in a 
restriction of potential in each layer, but many of their component cells retain 
multipotent properties as they can generate all the cell types required for specific 
structures. Ectoderm gives rise to skin, dermal appendages, brain and neural tissues; 
endoderm gives rise to the gastrointestinal tract and internal glandular organs (such 
as liver, lung) and mesoderm gives rise to connective tissue, muscle, bone and blood 
vessels (Arey 1974).
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As gastrulation proceeds, the majority of the cells in the embryo commit to a 
restricted fate. By 7.25 dpc approximately 30-50 cells that reside outside the embryo 
proper, and which are derived from the epiblast, become committed as primordial 
germ cells (PGCs) (Ohinata et al. 2005). These cells are excluded from somatic 
specification and restriction. Although not pluripotent as such, they are fated to make 
either sperm or oocytes, which are both highly specialised cell types. However, they 
retain some properties reminiscent of early epiblast. Notably, they express certain 
marker genes (Sox2, Oct4) and their potential can be realised by fertilisation. 
Furthermore, in vitro, they can give rise to embryonic germ (EG) cells, which are 
very similar to ES cells (Matsui et al. 1992). PCGs proliferate and re-enter the 
embryo from the extraembryonic mesoderm, migrating through the hindgut and 
dorsal mesentery to arrive at the gonadal primordium, the genital ridge, by 11.5 dpc. 
PGCs proliferate until shortly after gonadal sex determination, where in the female 
they enter meiosis between 13 and 15 dpc (McLaren 1984), and in the male they 
undergo mitotic arrest between 13 and 14 dpc and become primitive spermatogonia. 
These do not resume mitosis until 3 days postnatally (Nebel et al. 1961), giving rise 
to spermatogonial stem cells. These are true, unipotential stem cells, which on 
division give rise to transit amplifying spermatogonial cell types which then progress 
into spermatocytes, spermatids and sperm. PGCs isolated throughout gestation until 
after their arrival in the genital ridge, can be cultured as EG cells from both male and 
female embryos (Matsui et al. 1992; Resnick et al. 1992). As with ES cells, their 
long-term culture requires the presence of LIF, as well as the mitogen basic 
fibroblast growth factor (bFGF) and Steel factor (SF), the c-kit ligand. Most EG cell 
lines contribute to chimeras in a similar way to ES cells and can also give germ line 
transmission (Labosky et al. 1994; Stewart et al. 1994). PGCs from 10.5 dpc
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embryos have been used to obtain full-term foetuses by nuclear transfer (Miki et al. 
2005). Although they share many similar characteristics with ES cells in culture, they 
display considerable differences in imprinting of specific genes. This reflects the 
normal erasure of genomic imprinting.
Figure 1.1 Cartoon outlining the in in vivo totipotent (yellow) and pluripotent 
(orange) lineages in the early mouse embryo. Adapted from Papaioannou and 
Hadjantonakis, Stem Cells Handbook (2004). The PGCs are labelled pluripotent 
here, only because of their ability to generate EG cells in vitro.
Totipotent Lineage 
Pluripotent Lineage
1-cell 2-cell 4-cell 8-cell
O ^
64-cell
Fertilization 1.5 dpc 2.0 dpc 2.5 dpc 3.5 dpc 4.5 dpc 8.5 dpc 10.0 dpc
1.1.2 Stem cells in the late embryo and in the adult
As development progresses, the plasticity of stem cells tends to become more and 
more restricted. This results in populations of specialised stem cells and progenitors 
that in vivo give rise to a restricted range of differentiated cell types. One example is 
mesenchymal stem cells (MSCs), which are the adult progenitors of the 
mesenchymal cells found in bone marrow, skin, muscle and adipose tissue. They are 
also referred to as bone marrow stromal cells and can indirectly give rise to two 
multipotent progenitors: multipotent haematopoietic stem cells (HSCs) and stromal 
progenitors, which can give rise to fibroblasts, adipocytes, smooth muscle,
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chondrocytes and osteoblasts. MSCs have also been isolated from adult human 
dental pulp, primary teeth and periodontal ligament. All dental MSC populations can 
be cultured in vitro and have the ability to regenerate human dental tissues when 
transplanted into mice (Shi et al. 2005). The therapeutic potential of MSCs also 
extends to the possibility for manipulation to treat cartilage disorders. They have the 
potential to become cartilage both in vivo and in vitro and it has been recently 
demonstrated that insulin-like growth factor I has chondrogenic effects on MSCs 
(Spagnoli et al. 2005). However, more surprisingly, and against the rules of normal 
embryonic development, MSCs have been induced to differentiate into mature 
functional neurons in vitro, then transplanted into animal models of ischaemic brain 
injury and Parkinson’s disease where it is claimed they successfully integrate 
(Dezawa et al. 2005). When in direct contact with neonatal cardiomyocytes, MSCs 
have also been reported to transdifferentiate into cardiomyocytes (Goodell et al. 
2001).
HSCs are thought to give rise to two multipotent progeny, the hemocytoblast that 
enters the blood cell pathway, and the lymphoid stem cell that enters the lymphocytic 
pathway, giving rise to T-lymphocytes and B-lymphocytes. HSCs arise after 
gastrulation 7.5 dpc), but when isolated from such an early stage embryo they do not 
have the same properties as those isolated from the adult. Cells resembling adult 
HSCs can first be isolated from the aorta-gonad-mesonephros (AGM) region of the 
embiyo at 10.5 dpc. It has been reported that single adult HSCs can reconstitute the 
haematopoietic system in mice (as well as to contribute to endoderm-derived 
tissues) (Krause et al. 2001). HSCs have also been reported to give rise to muscle 
(Ferrari et al. 1989; Jackson et al. 1999; Goodell et al. 2001) and brain (Bjomson et
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al. 1999; Brazelton et al. 2000). The generation of liver from HSCs may have 
therapeutic potential (Peterson et al. 1999), as bone marrow-derived hepatocyte 
transplantation in mouse models of hereditary tyrosinemia type 1 results in complete 
metabolic correction.
In humans, bone marrow transplants from healthy, matching donors are used to 
replenish the adult stem cell population after chemotherapy for the treatment of 
leukaemia and various blood disorders. Cancer chemotherapy may utilise 
combinations of several chemotherapeutic agents as well as radiation therapy. Some 
treatments require very high doses that also ablate HSCs (myeloablation) to levels 
from which they cannot successfully regenerate in the remaining lifespan. Another 
approach is to remove bone marrow from patients prior to chemotherapy, and to use 
a fluorescence activated cell sorter (FACS) to purify HSCs using specific stem cell 
marker antibodies. This, has been reported to deplete contaminating cancer cells by
100,000 fold (Manz et al. 2004) and the HSCs can be returned to the patient after the 
completion of the treatment. This manipulation of HSCs in therapy has been reported 
in three clinical trials for breast cancer, non-Hodgkin’s lymphoma and multiple 
myeloma treatments (Michallet et al. 2000; Negrin et al. 2000; Vose JM 2001).
The epithelium of the skin epidermis is composed of the interfollicular epidermis, 
which surrounds hair follicles, sebaceous glands and sweat glands. A layer of 
proliferating stem cells attached to the underlying basal lamina maintains skin 
homeostasis. These detach from the basal lamina and terminally differentiate until 
they are eventually lost from the surface of the skin (Watt 2002). Hair follicles host 
at least two stem and progenitor cell populations, which reside in the external outer
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root sheath known as the bulge. These stem cell populations are in contact with the 
basal lamina and are therefore known as the basal stem cells of the bulge. Cells with 
progenitor properties have also been isolated from the suprabasal bulge and 
sebaceous glands, although these are thought to be progenitor cells that have 
migrated from the basal bulge to populate other areas. The stem cells of the 
interfollicular epidermis can contribute to all keratinocyte derivatives: hair follicles, 
interfollicular epidermis and sebaceous glands when grafted in vivo and demonstrate 
self-renewal in vitro (Blanpain et al. 2004). The success incurred through grafts of 
bulge stem cells in mice may provide sources of treatment for human patients such as 
post-operational skin cancer patients and bums victims.
The retina is derived from the optic sulci, which form from the anterior neural plate 
when this evaginates in the region of the presumptive diencephalon. Retinal 
progenitor cells (RPCs) are responsible for the generation of all retinal cell types and 
during retinogenesis, their potential is influenced by environmental cues such as 
EGF, SHH, LIF, and CNF (Fischer and Reh 2003, Wang et al. 2005). In the late 
embryonic retina, RPCs can be cultured as CNS stem cells to reveal that the 
progenitor pool consists of mainly differentiating or commited progenitors and a 
small amount of proliferating stem cells, similar to other regions of the developing 
CNS (Tropepe, 2000). In the retina of amphibians and fish, a specialized proliferative 
zone called the ciliary marginal zone (CMZ) harbours the stem cells of the retina 
(CMZ stem cells), which remain active throughout life. In higher vertebrates, 
proliferative activity has been observed in late embryonic and early postnatal stages. 
However the adult retina of mammals does not exhibit a capacity for in vivo 
regeneration. Retinal progenitor cells (RPCs) have recently been isolated in vitro
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from the pigmented ciliary margin (PCM) of adult mice (Tropepe 2000). These form 
neurosphere-like colonies in culture and are both neurogenic and gliogenic and are 
able to give rise to the majority of retinal cell types (Taranova et al. 2006). The 
successful re-introduction of these cells in host retinas has not yet been 
demonstrated. The role of RPCs in the adult mammalian retina has not been 
determined so far. Progenitors in the post-natal rat retina have been shown to respond 
through proliferation in vivo to growth factors such as FGF2 (Zhao et al. 2005). Their 
identification supports the idea that tissue-specific stem cells in non-proliferative 
regions of the adult may be inhibited from proliferating by environmental cues.
1.1.3 Brief overview o f stem cell markers
To date, no factor has been identified that can exclusively mark all stem cell 
populations in the mouse and it is very unlikely that this will ever be the case. 
Several stem cell populations may have markers in common, but these may also be 
expressed in lineage-restricted progenitors of other populations, or other non­
proliferative cell types.
Table 1.1 Summary of commonly used markers for the identification of various 
murine stem cell lineages. ______________________________________________
Stem Cell Type Markers Expressed
ES Sox2, Oct3/4, Nanog
Hemangioblast 
(HSC & EPC progenitor)
Flk-1, Sic, Tie-1, Tie-2, CD34, Tal-1, Hex, c-kit
EPC Flk-1, Sic, Tie-1, Tie-2, CD34, CD133
HSC CD34, Seal, c-kit
Basal Bulge CD34, alpha6-integrin, betal-integrin, Sca-1, K14, K19, K15, K5
Hepatocyte OV-6, c-met
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1.1.4 A requirement for a niche
Extrinsic factors can affect cells in multiple ways. They can induce differentiation, 
proliferation, migration or death. Cell-cell contact and diffusible factors are 
responsible for conducting correct patterning throughout development alongside 
intrinsic cues. The microenvironment around cells or, as it also known, the niche, has 
been shown to play a crucial role in the homeostasis of several stem cell populations 
and their descendants. If not controlled, stem cells could overpopulate tissues leading 
to a high number of proliferative progeny, risking the introduction of mutations that 
can lead to tumor formation. If the rate of differentiation becomes greater than the 
rate of self-renewal, the stem cell population may eventually become depleted. The 
concept of the existence of a stem cell niche was first proposed for hematopoietic 
stem cells by Schofield (Schofield 1978). Niches have been proposed for numerous 
tissues since then, and some of the best defined are within the testis, hematopoietic 
system, gut epithelium and epidermis.
If a stem cell divides symmetrically such that both daughter cells retain contact with 
the niche then each will remain a stem cell. This also happens in culture if stem cells 
are grown in conditions that favour self-renewal. If they divide symmetrically but 
move away from their niche, then both will differentiate. Alternatively, a stem cell 
can divide asymmetrically to give rise to progeny with different fates. This can occur 
through two mechanisms: (i) the cell can contain determinants already localised in an 
asymmetric fashion, such that the two daughter cells will have different fates; or (ii) 
the plane of division can locate one of the progeny in a position remote from the 
niche, where different extrinsic cues result in an altered fate to that of its sister cell 
that has remained in contact. In the hypothetical stem cell niche, signals from the
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surrounding microenvironment promote the stem cell state. Once removed from their 
niche, stem cells may lose their potential, as is the case with HSCs. Hence, stem cell 
numbers are limited by the size, availability and location of one or multiple niches. 
In proposed stem cell niche systems, the stem cells are in contact with other cells, 
such as supporting cells, and basement membranes. These seem important to contain 
stem cells within the niche, specify polarity and provide cues that promote 
proliferation and inhibit differentiation. However, the differentiated progeny of the 
stem cells also contribute to the niche, as they will feed back signals to the stem cells 
(directly or indirectly via supporting cells) to control their rate of division and 
perhaps also the plane of division.
Figure 1.2 Cartoon outlining the theoretical effects of the niche in the fate of progeny 
based on the plane of division. If a stem cell (yellow) in contact with the niche (blue) 
divides symmetrically, then both progeny will remain stem cells (A). If a stem cell in 
contact with the niche divides asymmetrically, then the daughter cell still in contact 
with the niche will remain a stem cell and the daughter cell that loses contact with 
the niche will differentiate (orange, (B)). In the absence of a niche, both progeny of a 
stem cell will differentiate irrespective of the plane of division (C). The effect of 
differentiated progeny surrounding stem cells must be taken into account as they may 
influence aspects such as the plane and timing of division (D).
1.2 Neural stem cells
The mammalian CNS is composed mainly of astrocytes, oligodendrocytes and 
neurons. The latter are the main functional unit of the CNS, but astrocytes and 
oligodendrocytes provide critical support and modulate their activity. During 
embryonic development, the ability to generate new neurons (neurogenesis) declines, 
which led to the idea that the adult CNS is mitotically quiescent, and unable to repair 
tissues that have been damaged due to disease or injury. The multipotent stem cell of 
the CNS, the neural stem cell, was once thought to reside only in neurogenic regions 
of the embryo and in the early postnatal period. Although in vivo studies generally 
supported this theory, there were exceptions that identified a proliferative zone of the 
adult brain, the forebrain subependyma (Altman 1962). This was believed to be 
species-specific. Work on rodents revealed that during adolescence, when 
neurogenesis has largely subsided, limited regions of the brain, such as the 
hippocampus, remain neurogenic (Bayer 1980). Further significant evidence that 
neurogenesis persists in adult vertebrates came from studies in songbirds, where the 
two telencephalic song control nuclei of adult male canaries were found to 
significantly enlarge during spring when the birds have to demonstrate stable singing 
and acquire a new repertoire. These findings were attributed to a cycling increase in 
neurogenesis and the number of synapses according to mating season (Nottebohm 
1981).
Apparently uncommitted cell types responsible for the generation of new neurons 
were first isolated and serially cultured from the dorsal telencephalon of mouse 
embryos. These were shown to have stem cell properties and had both neurogenic 
and gliogenic potential (Temple 1989). From the adult mouse, NSCs were also 
isolated from the two principal neurogenic regions: the subventricular zone (SVZ)
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and the dentate gyrus of the hippocampus (Reynolds and Weiss 1992; Lois and 
Alvarez-Buylla 1993). However other regions of the CNS not known to be 
neurogenic, have also been identified as sites in which NSCs reside and from where 
they can be isolated, such as the embryonic spinal cord (McKay 1997; Rao 1999; 
Gage 2000) and the adult striatum and septum (Palmer et al. 1995). NSCs isolated 
from these regions have neurogenic potential in vitro. Even more surprisingly, cells 
exhibiting similar properties in culture to NSC have been isolated from neural crest, 
a peripheral nervous system derivative (Stemple and Anderson 1992).
Figure 1.3 Cartoon outlining areas from which NSCs can be isolated in the brain 
(yellow). In the adult mouse brain (A) Proliferation is highest in the SVZ and the 
SGZ (blue). In the embryo, represented here by a transverse section through one 
hemisphere of the 14.5 dpc forebrain (B), NSC-rich regions line the lateral ventricles.
Knowledge of expression of markers common to NSCs and their in vivo morphology 
are limited, hence their isolation cannot depend on these. Instead, the culture 
conditions used encourage the survival of proliferating cells from a pool of 
progenitors and differentiated cells, which are normally found in the CNS tissue. The 
surviving cells include NSCs, which can be identified through functional features 
such as their proliferation capacity and self-renewal, their multipotentiality, which
A B
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can be sustained over long time periods, and by the generation of a large number of 
progeny, most probably through one or more transiently amplifying populations of 
progenitors.
Being able to distinguish between stem cell and transit amplifying progenitors would 
be a step toward understanding what attributes make neural stem cells unique. This 
knowledge could be exploited to manipulate the proliferation and differentiation of 
NSCs in vitro or in vivo, to establish strategies for therapies for damage of CNS 
tissue from disease or injury.
Stem cells are often quiescent, i.e. they rarely divide, but when they do they give rise 
to a transit amplifying progenitor cell type. In most culture systems, a distinction is 
rarely made between the transit amplifying progenitors and the true stem cells. NSCs 
require the presence of mitogens to stimulate their proliferation both in vivo and in 
vitro (Richards et al. 1992; Kilpatrick and Bartlett 1993; Gritti et al. 1996; Gritti et 
al. 1999), and differentiate in their absence. Various studies have used culture 
medium containing epidermal growth factor (EGF), which seems to be sufficient for 
the long-term sustainability of NSC-derived colonies (Reynolds et al. 1992; 
Reynolds and Weiss 1992; Reynolds and Weiss 1996). Others have used basic 
fibroblast growth factor (bFGF) without EGF in the same way, generating cultures 
with a higher fraction of proliferating cells (Palmer et al. 1995; Gritti et al. 1996; 
Qian et al. 1997). However when the two growth factors are provided in 
combination, they appear to have a synergistic effect on neural stem cells resulting in 
higher numbers of rapidly proliferating cells (Vescovi et al. 1993; Weiss et al. 1996; 
Ciccolini and Svendsen 1998). Studies in 14.0 dpc murine striatal cultures indicate
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that the initial responsiveness of NSCs is only to bFGF, but that upon culture with 
bFGF they then become responsive to EGF. Consistent with this, NSCs of the 
mammalian embryonic CNS acquire bFGF receptors earlier in development, and 
only subsequently express EGF receptors. In high concentrations, bFGF can promote 
in vitro neurogenesis of typically non-neurogenic regions (Palmer et al. 1995; 
Shihabuddin et al. 1997; Palmer et al. 1999). The bFGF concentration has also been 
reported to regulate the switch between neuronal, oligodendroglial and glial fates, 
mimicking the in vivo order of the generation of neurons, then glia (Qian et al. 1997).
Several markers of NSCs have been proposed mainly from in vitro studies, as 
outlined in Table 1.2. As is the case for other stem cell populations, it is unlikely that 
a single marker will be sufficient for the identification of the true stem cell type or 
types of the CNS. Moreover, many of these markers are not exclusive to NSCs as 
they are expressed at other sites, within or outside the CNS. Several groups have 
therefore proposed combinations of expressed markers, or even the lack of 
expression of some genes, aiming to distinguish the stem cells from more committed 
progenitors.
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Table 1.2 Table summarising markers for the identification of NSCs that have been 
proposed to date (‘+* denotes expressed, denotes note expressed and To’ denotes 
expressed at low levels).
Marker Organism Reference
LeX/Ssea-l+ Mouse (Capela and Temple 2000)
Nestin+ Mouse (Kawaguchi 2001)
Sox2+ Mouse (Zappone et al. 2000; Cai et 
al. 2002)
CD133+5E12+CD34'CD45"CD24'/1° Human fetal (Uchida 2000)
Prominin 1 /CD 13 3+ Mouse (Lee et al. 2005)
Mcm2+ Mouse (NSC 
subpopulation)
(Maslov et al. 2004)
Nestin+PNA'/l0CD24‘ Mouse (adult 
periventricular region)
(Rietze 2001)
1.2.1 Neural Stem Cell niches in the mouse
In the developing CNS, the predominant cell type identified as a neural stem cell is 
the radial glial cell (Malatesta et al. 2000; Alvarez-Buylla et al. 2001; Campbell and 
Gotz 2002; Doetsch 2003; Kriegstein and Gotz 2003; Merkle et al. 2004). Radial glia 
within the ventricular zone line the lateral ventricles and proliferate to generate glial 
and neural derivatives. Their processes, along which differentiating progenitors 
migrate, extend up to the pial surface of the cortex, enabling the formation of 
organised layers where the last cells to be generated occupy positions furthest from 
the ventricular layer. The proliferating NSCs of the adult brain have been identified 
as radial glial-derived astrocytes, residing in the subventricular zone (SVZ) of the 
lateral ventricles and the subgranular zone (SGZ) of the hippocampal dentate gyrus. 
By lineage tracing they have been shown to give rise to neurons, glia,
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oligodendrocytes as well as to ependymal cells (Merkle et al. 2004). Astrocytes in 
the brain express Gfap and S-100J3. Cells proposed to be NSCs in the SVZ uniquely 
express Gfap suggesting that they comprise a distinguishable stem cell subpopulation 
(Ma et al. 2005). Astrocytes from the dentate gyrus, apart from providing structural 
support, have also been shown to contribute to the niche through producing factors 
that promote proliferation and neurogenesis in vitro (Song et al. 2002). It is likely 
that at different developmental stages, cells within the niche will respond in distinct 
ways to particular extrinsic cues or have unique requirements.
Also contributing to the niche are the basal lamina and endothelial cells of adjacent 
blood vessels. It has been proposed that, the NSC population within the SVZ, which 
has a glial phenotype, is in contact with the basement membrane (Doetsch et al. 
2002; Mercier et al. 2003). In the SGZ it has been shown that proliferation is highest 
around associated blood vessels (Palmer et al. 2000). The extracellular matrix has 
also been shown to provide signals that can affect NSC proliferation, differentiation 
and migration. In the adult, the basal lamina is in close association with the neural 
stem cells in the SVZ in the space between the stem cells and blood vessels and this 
may also be the case in the dentate gyrus (Alvarez-Buylla and Lim 2004). As 
surrounding blood vessels enter the parenchyma, the associated basal lamina 
invaginates from the pial surface towards the ventricles. The basal lamina is rich in 
laminin 1 and collagen and maintains extensive contact with radial glial cells 
throughout development.
Endothelial cells of the blood vessels produce vascular endothelial growth factor 
(VEGF), which when infused into the adult brain, induces proliferation of neurogenic
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precursors. In vitro, endothelial cells produce soluble factors that promote 
proliferation and neurogenesis in embryonic NSCs, as demonstrated through co­
culture experiments (Shen et al. 2004).
Figure 1.4 Cartoon outlining NSC niches for the adult brain that have been proposed 
in the literature by others. Possible architecture of the proposed adult NSC niches in 
the mouse SVZ and SGZ (Adapted from (Alvarez-Buylla and Lim 2004)). In the 
SGZ, astrocytic NSCs with projections extending toward the pial surface generate 
progenitor cells, which mature into granule cells that integrate into the granule cell 
layer. Progenitor cells may have the ability to migrate along the stem cell scaffold. In 
the SVZ, the astrocytic NSCs are in close contact with their transit-amplifying 
progeny and neuroblasts, generated from the transit-amplifying cells, which migrate 
along the RMS differentiating into olfactory bulb intemeurons. Some astrocytes 
extend projections to contact the ventricle and display a single cilium. Ependymal 
cells in the ventricular zone produce factors critical for the niche. In both niches, a 
strong association with the basal lamina and associated vasculature is proposed.
Granule
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Subventricular Zone Niche
Astrocyte
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LeX (also referred to as Ssea-1 or CD 15) is a carbohydrate moiety that is expressed 
in adult astrocytes that behave as stem cells in vitro (Capela and Temple 2002). It is 
also expressed in blood vessel endothelial cells in the brain. In the early embryo it is 
thought to be associated with blastocyst adhesion. It is likely that it has a role in the 
niche to promote adhesion of NSCs and transit-amplifying progenitors.
Mitogens such as EGF and FGF have proliferative effects on NSCs and transit- 
amplifying progenitors in vitro and in vivo. EGF is not endogenously expressed in 
the adult SVZ, but its function may be replaced by TGFa, which can also activate 
the EGF receptor. In addition, activation of Notch signalling in the SVZ inhibits 
neuronal differentiation and may lead to greater numbers of stem cells (Chambers et 
al. 2001). SVZ astFocytes express both FGFs and Notch ligands suggesting that they 
regulate their own fate to some extent. Morphogens such as SHH promote 
proliferation of NSCs in vitro and a partial dependence on Shh signalling for this 
proliferation has been demonstrated in vivo (Machold et al. 2003; Ahn and Joyner 
2005). Early on, BMPs promote differentiation to non-neural cell types, whereas 
BMP signaling in the embryonic cortex promotes gliogenesis and differentiation into 
astrocytes. BMPs are thought to induce the expression of Id genes, which inhibit 
neurogenesis. In the adult SVZ, the stem or progenitor cells express both BMPs and 
their receptors which may promote an astrocytic stem cell fate through the same 
mechanisms, but ependymal cells secrete the BMP antagonist Noggin, which will 
then permit neurogenesis (Lim 2000). Astrocytes also express Vg7, which promotes 
neurogenesis in the adult hippocampus (Ueki et al. 2003).
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It remains unclear if the role of the NSC niche is simply to inhibit differentiation or 
whether it has a more complex role to actively promote both proliferation and 
induction into neuronal lineages. However, some evidence suggests that the latter 
may be the case. Studies reveal that astrocytes not residing within niche regions of 
the adult CNS have neurogenic potential when transplanted into appropriate 
domains, but this is not evident within their original location (Lie et al. 2004; Emsley 
et al. 2005). When SGZ progenitors are transplanted into the RMS, where normally 
only SVZ neuroblast progenitors migrate towards the olfactory bulb and 
differentiate, they behave in a similar way to the endogenous cell population and 
generate tyrosine hydroxylase expressing intemeurons.
1.3 Sox2 as a marker of stem cell populations
One gene that is widely expressed in stem cell generating regions and specific stem 
cell populations is Sox2. Its expression is necessary for the ES cell state and the 
maintenance of pluripotency, alongside Nanog and Oct3/4 (Avilion et al. 2003; 
Chambers et al. 2003; Mitsui et al. 2003) Through co-operation with Oct3/4, Sox2 
has been shown to regulate Nanog (Kuroda et al. 2005; Rodda et al. 2005; Wu da and 
Yao 2005). It has been demonstrated that Sox2 is expressed in several stem cell- 
generating regions of the CNS. A subset of Sox2 expressing cells from such regions 
has been shown to be capable of forming neurospheres in culture (Zappone et al. 
2000; Cai et al. 2002). Neural precursors derived from embryonic stem (ES) cells 
have been isolated through selecting for Sox2 expression (Li et al. 1998). This 
evidence suggests Sox2 may play a role in neural stem cell initiation and 
maintenance as well as in the properties of the stem cell. In the early post- 
gastrulation embryo, Sox2 is expressed in the neuroepithelium throughout the CNS
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(Li et al. 1998). At later stages of the developing embryo, Sox2 is expressed in the 
forebrain (dorsal telencephalon), midbrain, hindbrain, spinal cord, in the olfactory 
epithelium, in the lens and otic placodes. It is also expressed in some cell types 
outside the CNS known to contain stem cells, such as the bulge region of the hair 
follicles and gut endoderm. The expression of Sox2, in many regions where stem 
cells are found, renders it a good candidate as a stem cell marker.
1,4 Sox genes
The SOX (SRY-related HMG box) family encodes transcription factors related 
primarily by homology within their high-mobility group (HMG) box DNA binding 
motif including specific signature amino acids (Gubbay et al. 1990). The high 
mobility group (HMG) domain sequence ranges in different proteins between 70-80 
amino acids (79 amino acids long in SOX proteins). Proteins containing an HMG 
box belong to the HMG superfamily. This superfamily includes two families- the 
TCF/SOX/MATA family where the members have single HMG domains, and the 
HMG/UBF family that contains members with multiple domains (Soullier et al. 
1999) including non-histone chromosomal proteins HMG1 and HMG2, UBF; a 
nucleolar RNA polymerase I transcription factor and mtTF; a mitochondrial 
transcription factor. Members of the second family are found throughout eukaryotic 
species and are widely expressed. They have no particular sequence specificity but 
have an affinity for bent or structured DNA. In contrast, members of the 
TCF/SOX/MATA family are mainly tissue-specific transcription factors recognising 
specific DNA sequences. MATA proteins are found in yeast and TCF/SOX in 
animals. SOX proteins bind a heptameric consensus motif that has been characterised 
as: 5,-(A/T)(A/T)CAA(A/T)G-3\ They bind to the minor groove of DNA (Laudet et
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al. 1993), unlike most other transcription factors, which bind the major groove. 
When SOX proteins bind, they induce a 70-80° bend in the DNA, a property that is 
essential for their role in regulating gene expression (Scaffidi and Bianchi 2001). 
Vertebrate SOX genes can be classified into distinct groups, based on sequence 
comparisons of their HMG domains, as well as non-box sequences (Laudet et al. 
1993; Wright et al. 1993; Soullier et al. 1999; Wegner 1999; Bowles et al. 2000; 
Schepers et al. 2002). In the mouse, there are 20 Sox genes classified into 8 groups 
(A to G, including B1 and B2) (Bowles et al. 2000). The majority of SOX proteins 
have HMG domains with at least 50% identity to the HMG domain of SRY (Bowles 
et al. 2000). Mouse SOX2 has 50% HMG sequence identity with that of SRY 
(Collignon et al. 1996), but some of the most recently classified members such as hu- 
SOX30 only have 48% homology with SRY (Osaki et al. 1999). Many of the Sox 
genes found in vertebrates are thought to have arisen by genome duplication 
(Soullier et al. 1999; Wegner 1999; Bowles et al. 2000). This is probably true of the 
closely related genes Soxl, Sox2 and Sox3, which are classified in the SOX B1 
subgroup (Kamachi et al. 2000), but the duplication must be ancient, because each 
gene maps to a different chromosome (8, 3 and X, respectively).
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Figure 1.5 An unrooted phylogeny for the mouse SOX proteins. Adapted from 
Bowles et al (2000), where it was computed based on SOX HMG amino acid 
sequences by distanced based phylogenetic analysis. Different colours are used to 
identify individual groups. Most recent members SOX 16, SOX 12 and SOX30 have 
not been included in this diagram as there is insufficient information available on 
them.
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The ability of SOX proteins to act as transcription factors depends on their interaction 
and co-operative activity with other transcription factors. SOX2 is expressed in the 
ICM and epiblast of murine blastocysts and then later in the forming neuroepithelium. 
Its expression pattern in the early embryo overlaps with that of OCT3/4- a POU 
transcription factor (encoded by the Pou5fl locus and is also referred to as Oct3 and 
Oct4). SOX2 binds the Fgf4 enhancer in exon 3 of the gene, separated by only 3bp 
from the POU binding site were OCT3/4 binds. The two factors act in synergy to 
regulate Fgf4, which is required for early embryogenesis (Ambrosetti et al. 1997). 
OCT3/4 also acts together with SOX2 to regulate Sppl (osteopontin) (Botquin et al.
1998). OCT3/4 activates transcription of osteopontin when it binds the enhancer 
alone, whereas SOX2 binding results in transcriptional repression. The pair also 
regulate UTF1 (Nishiinoto et al. 1999), Fbxl5 (Tokuzawa et al. 2003) and as 
mentioned earlier, Nanog. SOX2 also regulates Nestin (Tanaka et al. 1998). SOX9 
binds the chondrocyte-specific Col2al (collagen II) enhancer in the first intron of the 
gene (Bell et al. 1997). Together with SOX6 and SOX5, the activation of Col2al by 
SOX9 is greater, and this cooperative activation has also been exhibited for the 
aggrecan gene, which is also a chondrocyte marker. Other examples include the co­
operation of SOX11 and BRN-1 or BRN-2 and SOXIO with PAX3, CREB, MITF or 
TST1/OCT6/SCIP.
There are examples of SOX proteins expressed throughout development, in many 
cases with overlapping expression in specific tissues. As SOX proteins have the 
ability to recognise very similar DNA motifs, they may function in the same 
processes. Moreover, for members of a subfamily, with a high degree of sequence 
similarity, they may have very similar functions. Indeed, functional redundancy has
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been demonstrated for several SOX proteins. One well-characterised subgroup whose 
members exhibit functional redundancy is B1 (Soxl, 2 and 3). The three genes are 
expressed throughout the nervous system from its earliest stage. Inhibition of SOX2 
function leads to delamination of neural progenitors from the ventricular zone and exit 
from the cell cycle, a phenotype that can be rescued by co-expression of Soxl 
(Graham et al. 2003). Soxl, 2 and 3 have all been shown to suppress neurogenesis in 
order to maintain CNS cells in an undifferentiated state (Bylund et al. 2003; Graham 
et al. 2003). Outside the CNS, other SOX proteins have also been shown to act in 
similar ways: SOX 10 (group E) inhibits differentiation of neural crest progenitors 
(Kim et al. 2003) and SOX 15 (group G) inhibits muscle differentiation (Beranger et 
al. 2000). Group B also contains the subgroup B2 members Soxl4 and Sox21, whose 
encoded proteins are similar to each other but resemble B1 proteins only in the HMG 
box and immediately proximal to the HMG box in their C-terminal domains. As 
shown in the chick, SOX21 promotes neuronal differentiation, thus counteracting the 
activity of the SOXB1 subgroup factors (Sandberg et al. 2005). This study also 
demonstrated that, although Sox21 is upregulated by proneural bHLH factors, its 
proneural action is independent of their expression. Members of other groups also 
have overlapping expression patterns, such as the genes Sox4, and Soxll, both 
members of group C. When co-expressed, members of the same group may show 
redundancy. However they can have unique roles in other tissues, and it remains 
possible that they also have subtly different roles even within the same tissue.
In the chicken, Soxll (group C) is co-expressed with Soxl, Sox2 and Sox3 in specific 
regions of the neuroepithelium and is transiently up-regulated in maturing neurons 
after they leave the neuroepithelium and as they down-regulate Sox2 and Sox3
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(Uwanogho et al. 1995). This switch in Sox genes indicates that Soxll may be 
involved in the differentiation or maturation of particular neuronal populations. Its 
expression in the murine CNS is strong during development and it persists in 
differentiating neuronal populations in the cortical plate and the inferior colliculus 
(Kuhlbrodt et al. 1998). Soxll shows high sequence homology with another group C 
gene, Sox4. Like Soxll, Sox4 expression seems associated with maturing cells of the 
CNS and the two genes have an overlapping expression pattern. The expression of 
Sox4 is sustained for longer periods than Soxll in the brain, but the opposite occurs in 
the spinal cord. (Cheung et al. 2000).
1.4.1 Expression ofSOXBl subgroup genes
The expression patterns of the Sox Group B members have been extensively described 
elsewhere (Collignon 1992; Ishii et al. 1998; Uchikawa et al. 1999; Wood and 
Episkopou 1999; Cheung et al. 2000; Avilion et al. 2003; Pevny and Rao 2003; Bell 
2004). Sox2 is the first of the genes to be expressed in the embryo where it is found in 
the inner cell mass of blastocysts at 3.5 dpc (Avilion et al. 2003). By 6.0 dpc, Sox3 is 
expressed together with Sox2 in the extraembryonic ectoderm and throughout the 
epiblast. Their expression becomes restricted during gastrulation to the chorion and 
anterior ectoderm. By early headfold stages (7.25 dpc), Sox3 is downregulated in the 
extraembryonic component whilst Sox2 maintains expression (Wood and Episkopou
1999). At this stage Soxl expression can also be detected in the neural plate. The three 
genes show overlapping expression in the neuroectoderm at the onset of 
somitogenesis (Collignon 1992; Wood and Episkopou 1999). The expression of Sox2 
does not overlap with Soxl or Sox3 in the floor plate and roof plate regions of the 
neural tube. Soxl and Sox2 are largely restricted to the neuroectoderm until
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midgestation and Sox2 in expressed in the surface ectoderm region from where the 
sensory placodes will form, from the six somite stage onwards, and then becomes 
resticted to the placodes within this area (Collignon 1992). Sox2 and Sox3 are both 
expressed in the olfacory placodes but Sox2 alone is expressed in the otic placodes 
(Wood and Episkopou 1999). During lens formation, Sox2 is expressed at the earliest 
stages in the optic cup and prospective lens tissue, being replaced in the latter by Soxl 
from about 11.5 dpc (Kamachi et al. 1998). Sox2 and Sox3 expression patterns 
partially overlap in the endoderm of the posterior foregut (Collignon 1992; Kamachi 
et al. 1998; Wood and Episkopou 1999) whilst Sox2 is also expressed throughout the 
gut and lung endoderm and by 11.5 dpc also in the oesophagus. In developing hair 
follicles Sox2 is expressed in the dermal papilla from 12.5 dpc and later in the dermal 
sheath and in epithelial cells within the bulge region (Bell 2004). Sox2 in also 
expressed in the nasal epithelium at 12.0 dpc, in the prospective sensory placodes in 
the ear and in the prospective fungiform papillae in the tongue by 13.5 dpc (Bell 
2004). In the CNS Sox2 expression persists and from 13.5 dpc onwards it becomes 
more restricted as cells differentiate. It remains in the ventricular layer and by 16.0 
dpc also in the subventricular layer of the forebrain, the ependymal layer of the spinal 
cord and the olfactory epithelium. This expression is maintained in the adult. Cells 
migrating along the rostral migratory stream (RMS) express Sox2, as do cells 
migrating from the ventricular zones of the lateral ganglionic eminence to populate 
the nucleus accumbens and olfactory tubercle (Bell 2004). In the latter population, 
Soxl and Sox3 are also expressed. Soxl expression is more extensive in the adult 
olfactory tubercle than that of the other B1 subgroup genes.
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1.5 Microarrays
Determining the set of genes that are active in neural stem cells in comparison with 
those that are active in their differentiated derivatives, is a prerequisite in the attempt 
to understand the factors necessary to define the stem cell state. Expression analysis 
using northern blotting or RT-PCR employs hybridisation of oligonucleotide probes 
to mRNA. Single probes are used to hybridise with the sample and signals revealed in 
such a way as to yield quantitative information about each gene. Spatial information 
on gene expression can be obtained through in situ hybridisation analysis. Microarray 
technology revolutionises the speed and effectiveness of these assays, as several 
thousand probes are immobilised on a substrate and assayed at the same time. This 
reverses the situation in northern blot analysis, where the target is immobilised and 
the probes are added* individually. Fluorescent labeled target cRNA or cDNA 
samples, prepared from the tissues under investigation are then allowed to hybridise 
with the probes, and a confocal laser scanner is used to detect the fluorescence 
emitted by the successfully hybridised probes. An expression profile is obtained for 
each sample, providing information in a qualitative and quantitative manner on 
thousands of mRNAs according to their extent of hybridisation with the immobilised 
probes. A variety of sources have been used to compile this introductory section to 
microarrays, including books (Knudsen 2002; Bowtell and Sambrook 2003), 
publications (The Chipping Forecast I, II and III, 1999, 2002 and 2005, respectively) 
and manuals (GeneSpring User Manual 2002, Ambion TechNotes articles on Array 
Analysis), as well as personal experience.
Two types of probes are commonly used for microarrays: cDNA and long 
oligonucleotides (short oligonucleotides are also used but have progressively become
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less common due to their low specificity). Both of these can be immobilised in spots 
on a glass substrate (usually coated with poly-L-lysine) using a robot spotter. Their 
major advantage is that they can be custom made and tailored according to need, 
allowing specific pools of genes to be analysed in different areas of research. For 
routinely used sets of spotted arrays, the cost is low, but a custom-made chip with 
thousands of probes can be very expensive. Problems regarding spotted arrays usually 
arise from their printing. Spotting of the same probe over several slides may not be 
uniform, and within one slide, smearing and irregularity of spots can occur due to 
various printing problems, resulting in the loss of information from large portions of 
the array. The ideal spotted array has round, equidistant, evenly sized spots of uniform 
concentration and volume, generating images of low background fluorescence and 
uniform spot intensity*across the entire slide. Successful hybridisations on spotted 
arrays of high quality can provide a relative measure of the expression levels of genes 
assayed by the entire probe set. Binding of labeled target to a probe spot is an indirect 
measure of the expression of that gene, as the fluorescence intensity emitted is 
proportional to how many copies of labeled target bind, the latter having been 
generated from the expressed mRNA.
cDNA probes are usually amplified from clone sets by high-throughput PCR. 
Unreliability of the probe sets can be a result of inefficient PCR and/or contamination 
by primers or enzymes used in their production. Oligonucleotide probes are more 
cost-effective and reliable. Long oligonucleotide probes are now commonly used, and 
these can be designed accurately and specifically against regions with low homology 
to related genes. Their synthesis per base is lower than that of cDNA probes and they 
typically represent 50 to 75 nucleotide fragments, making them highly specific.
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Appropriate positive and negative controls for the specific probe set are normally 
incorporated on the slide. Spotted arrays are normally used for the simultaneous 
assessment of two targets (representing all the transcripts of two cell or tissue 
samples). This is useful in order to compare the relative expression of genes between 
them. Different fluorescent labeling of the targets (Cy3 and Cy5) allows the samples 
to be distinguished after scanning. When such a protocol is followed, dye- 
incorporation can be biased giving a stronger intensity signal for e.g. the Cy3 labeled 
sample compared to the Cy5 labeled sample. This can lead to errors in the 
interpretation of their expression profiles. To minimise this error it is usual to perform 
dye-swaps in two-colour experiments. Where one target sample (A) is labeled with 
Cy3 and the other (B) with Cy5 in one hybridisation, in a replicate hybridisation their 
dyes are reversed (A labeled with Cy5 and B with Cy3). Any intensity bias can be 
normalised after scanning, by using the dye-swap sample as a reference. This type of 
quality control in an experiment is essential to generate reliable results. Another 
important aspect of quality control is the replication of the experiment. Replicates can 
be of technical or biological significance. Technical replicates would involve 
repetition of a protocol at any stage of the sample preparation, such as a hybridisation 
using independent cDNA transcription or an independent round of labeling of the 
target sample. However, error is less likely to be introduced in the handling of the 
sample than it is in the generation of the sample itself. When comparing a treated 
sample versus a normal sample in an experiment, the treated sample may not be 
affected in an identical manner when the treatment is reproduced. Therefore at least 
one biological replicate is required in a two-colour experiment. Minimising biological 
variability by pooling samples prior to or after RNA extraction is not advisable, 
because any significant outlier values cannot be traced to a specific sample and
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eliminated. This could bias the experiment. However, if performed carefully, pooling 
can increase the reliability of the experiment. For example, in mouse studies involving 
outbred strains, pooling can average differences due to genetic heterogeneity. It is 
appropriate in cases where starting material is limited and the classification of 
samples is clear-cut; e.g. treated versus non-treated. For two-colour experiments, 3 
replicates are normally performed, including a dye-swap and an independent 
biological repeat. In this way, if there is differential expression for one gene between 
two repeats, the third one may be used to clarify the situation. In all cases, subsequent 
validation of the microarray results using independent samples and a different assay 
(e.g. quantitative real-time PCR (qRT-PCR)) is required.
A more reliable microarray platform than spotted arrays is provided by Affymetrix 
GeneChip technology. GeneChips consist of oligonucleotide probes, synthesised in 
situ on a glass surface. Each probe that is perfectly complementary to the mRNA of 
that gene (perfect match probe) is represented more than once on the array, and it is 
synthesised adjacent to a series of probes with a single nucleotide change in a central 
position of the probe, to a complementary nucleotide (mismatch probe). The 
mismatch oligonucleotides are used to detect background and non-specific 
hybridisation. For perfect match probe design, a region of the gene with low 
homology to other genes is selected. For eukaryotic genomes they are chosen with a 
bias to the 3’ end to minimise effects of partial mRNA degradation and incomplete 
cDNA or cRNA synthesis. 11 to 20 perfect match probes, typically 25-mer 
oligonucleotides, are designed against this region along with their mismatch probes. 
All together, these form one probe-set specific for a target gene. Target genes may be 
represented in independent probe sets more than once, typically against alternate
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published sequences for the gene. Controls such as bacterial spikes, housekeeping and 
consistently expressed genes are represented in such a way so the mRNA input 
quality can be assessed, based on a ratio of hybridisation to 3’ end and 5’ end specific 
probes. The reliability of this technology extends to the high reproducibility in array 
manufacturing. The probes are synthesised at high densities (400,000 different probes 
in a 20 x 20 mm area) using photolithography in conjunction with combinatorial 
chemistry (McGall et al. 1996). Photolithography uses light to remove photolabile 
protecting groups from linkers bound to a glass substrate, which enables nucleoside 
phosphoramidite addition in specific locations specified by a mask. For the synthesis 
of an array, around 80 cycles of this are required.
A disadvantage of Affymetrix GeneChip arrays is their relative high cost. 
Hybridisation protocol's involving GeneChips, which are encased in protective plastic 
throughout the hybridisation and washing, require GeneChip- specific hardware such 
as a fluidics station and scanner, which may not be accessible to all users. They can 
however, cut costs through the high specificity and the nature of the hybridisations. 
There is less of a requirement to perform technical replicates for a hybridisation, as 
the GeneChip methodology is highly reproducible. However, it is still recommended 
that an independent biological repeat is performed, or alternatively pooling of sample 
material. In a single hybridisation, one biotin-labeled target sample is used to 
hybridise one GeneChip. Other target samples are compared to it through subsequent 
software analysis. When a larger number of samples are to be compared, this system 
results in fewer hybridisations in relation to spotted arrays, where samples have to be 
compared pair-wise, with no flexibility to create new comparisons through software 
analysis. However, the design of spotted array experiments can be modified to
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overcome this problem; a reference sample can be used to hybridise alongside the 
target samples. By keeping the reference constant, more targets can be incorporated in 
the study and compared to each other in any combination using appropriate software.
From both spotted and GeneChip platforms, results have to be interpreted and 
normalised in order to be analysed further. The initial collection of the results is in the 
form of fluorescence intensity emitted from the hybridisations. The scanning process 
generates an image of the array chip with assigned colours to represent the fluorescent 
hybridised probes. For spotted arrays, this image has to be processed in order to let 
the software (such as ImaGene) know where the spots are located. Pre-designed grids 
are available for commercially available spotted arrays. A manual quality control has 
to take place in order to define the spot location and size as plenty of variation occurs 
during robotic spotting’. Spot locations with no probe, merged spots or smears have to 
be ‘flagged’ (tagged with a label in the software) so that they are not processed as true 
data. Intensities are given arbitrary values, usually ranging from 0 to around 50,000. 
Two-colour experiments receive independent values for the Cy3 and Cy5 channels. 
Each probe is then assayed for signal intensity after background intensity has been 
subtracted. In spotted arrays, raw intensities under 200 are considered potential 
background (depending on the specific slide), and in Affymetrix arrays this number is 
generally lower. (In this thesis, this number ranges between 50 and 100, always taking 
the value providing highest stringency, depending on expression levels of known 
negative controls.) Each probe or probe set in the case of GeneChip is assigned a label 
as detected (Present, P), not detected (Absent, A) or marginally detected (Marginal, 
M). For probe sets, P is assigned only when the majority of probes against a specific
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target are in agreement. Changes of intensity 1.8 times higher than background noise 
are generally detected as P.
Comparison analysis of two-colour experiments takes place by dividing the intensity 
of one channel by the other and generating a relative value. For one-colour GeneChip 
experiments, probe pairs in a set are checked for changes between two experiments 
and are labeled as increasing (I), decreasing (D) or showing no change (NC), the latter 
incorporating probes that were previously deemed marginal. In order to calculate fold 
change of expression levels between target samples, a minimum possible intensity 
denominator above zero is set, which is based on the levels of noise.
In order for different target samples to be compared, their intensity values need to be 
adjusted to a baseline. This primary analysis can be done in the GCOS software of the 
Affymetrix platforms. For spotted arrays, the normalisation is performed in 
downstream analysis software such as GeneSpring. A measurement of variance has to 
be calculated between samples to identify whether differences between them are 
likely to be significant or not. For two samples, a Student’s t-test is commonly applied 
and for multiple samples Analysis of Variance (ANOVA) tests are appropriate. Their 
performance can be specified in the software and are automatically performed by the 
software upon data entry between probe replicates on a slide or between the same 
probes across slides with replicate hybridisations. They are used to identify outliers, 
which may be an entire chip that deviates from its replicates, or one or more genes 
deviating from the same genes on other samples. Outliers are given a low significance 
and can be removed from the analysis.
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Normalisations of samples needs to be specified and typically involves a per chip 
normalisation, and a per gene normalisation. A per chip normalisation can be carried 
out with reference to a median, percentile or positive control e.g. normalising each 
measurement to the 50th percentile of the total measurements in that sample. A per 
gene normalisation can be carried out with reference to the median of the 
measurements in all samples. If, after normalisation, sample intensities do not follow 
a comparable normal distribution when plotting normalised log intensity against all 
samples (i.e. non-continuous mode), e.g. if there is an abnormal shift in the 
distribution of log intensities, various further statistical correction methods may be 
applied before the samples are compared.
Data can be represented in various forms such as a graph of normalised intensities 
across samples or a scatter plot of logarithmic intensities of one sample compared to 
another. In scatter plots, expression differences can be assessed as fold change. Fold 
change is calculated by dividing the expression level of a gene in one sample (A) by 
the expression level of the same gene in another sample (B). Genes whose expression 
does not change between samples have a fold change of 1 and follow a linear 
distribution on the plot. Genes expressed higher in sample A will have a value over 1, 
e.g. 2-fold higher in A = 2 (2/1), and genes expressed higher in B will have a value 
under 1, e.g. 2-fold higher in B = 0.5 (1/2). For this type of data analysis to be useful 
it has to be calculated on a logarithmic scale, otherwise the scale becomes asymmetric 
as up-regulated genes can range from 1 to infinity and down-regulated genes can only 
range from 1 to 0. Problems with fold change values arise if an expression value is 
zero or even negative. To overcome this problem, a data transformation in the 
normalisation step can be applied to assign a set value to such data, e.g. setting
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measurements of less than 0.01 to 0.01. Data points, which are expressed at different 
levels between samples, are seen to deviate from the linear distribution. A significant 
fold change value has to be set for each experiment. Typically, in the experiments 
described in this thesis, and in line with other reports (Geschwind et al. 2001; Ahn et 
al. 2004) a 2-fold change in expression when comparing two target samples is 
considered significant. In order to determine what fold change is significant, the 
change in expression has to be compared to the standard deviation for each gene and 
the more it exceeds the standard deviation, the more significant it is (Tusher et al. 
2001). For higher expressed genes, which have a low variance between replicates, a 
fold change of even less than two can be determined as significant. For very weakly 
expressed genes, a much higher fold change is required to reach significance.
The first point of data analysis, as discussed, is looking at genes expressed 
significantly higher and lower between two samples. Further analysis, which becomes 
essential when more than two experimental samples are included, involves grouping 
genes into clusters that behave in a similar fashion under different conditions. There 
are several types of clustering including hierarchical clustering, Af-means clustering 
and the creation of self-organising maps. Hierarchical clustering calculates the 
distance between all the genes, taking account of the number of samples as the 
number of different dimensions, to produce a distance matrix. Genes that are closest 
together in this hypothetical space are grouped in the same cluster. A point falling in 
the middle of each cluster, or centroid, is used to calculate the distance of each gene to 
it and to other centroids to verify the cluster that each gene should be in (if it is closer 
to another centroid, it will be reassigned to this cluster). For large numbers of genes, 
AT-means clustering may be more appropriate. It will classify genes into clusters but
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not compute the relationship between clusters. In this algorithm, a user-defined 
number of clusters are set and all genes are randomly assigned in clusters. Genes are 
then reassigned to the cluster whose centroid they are closest to and the centroids are 
re-calculated after every reassignment. Once the value of the centroids does not 
change, the algorithm stops. Self-organising maps are similar to ^-means clustering, 
but constrain centroids in a two-dimensional grid. For the experiments described in 
this thesis, only £-means clustering has been applied.
At the time when the experiments for this thesis were initiated, cost limitations and 
lack of support facilities ruled out the possibility of using Affymetrix GeneChips. 
Oligonucleotide spotted arrays were selected as a platform due to increasing evidence 
of their reliability at the time and because they were available free of charge through 
the HGMP. The ‘Mouse Known Gene Oligo’ array was selected incorporating 7,445 
known gene sequences and 79 controls (bacterial spike probes and negative spots, 
ubiquitously expressed genes, tissue-specific genes and pure Cy3 spots termed 
‘landing lights’ to aid in orientation and Cy3-labeled target hybridisation quality 
control). These sequences were represented by 65-mer oligonucleotides that showed 
average cross-homology of 30.5%. Each probe was represented in duplicate on the 
array. The experiments were performed at the Medical Research Council Mammalian 
Genetics Unit, which runs a ‘hoteling’ facility, allowing microarray users to perform 
their experiments using the provided reagents, hardware and software. In 2004, the 
HGMP stopped making these arrays available. However, by this time an accessible 
Affymetrix GeneChip facility had been established at NIMR. From this point, all 
microarray experiments were performed on the Mouse 430A GeneChip, containing 
22,690 known genes. The experiments performed are described through Chapters 4, 5
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and 6. Following guidelines set out by Brazma and co-workers (Brazma et al. 2001) a 
‘Minimum Information About a Microarray Experiment’ (MIAME) protocol was 
compiled for each experiment and is accompanied by an experimental outline. 
MIAME information is an integral feature of microarray experiments in order to aid 
in the reproducibility and understanding of the experimental design. This information 
will be deposited on publication of any work arising from this thesis.
1.6 Aims of Thesis
General Aim
The aim of this thesis is to explore and understand the characteristics of neural stem 
cells and lineage-restricted progenitor cells and to determine if there are distinct 
neural stem cell populations within the CNS or a single stem cell type that displays 
diverse potential in response to environmental signals.
Specific Aims
• To standardise optimal culture conditions for different NSC populations so as 
to characterise them and perform comparative studies.
• To investigate the role of SOX2 in NSCs by:
(i) Characterisation of the expression pattern of SOX2 in neural stem cell
generating regions as well as it’s sub-cellular localisation in 
proliferating and differentiating NSCs
(ii) Determining the effects of reducing the levels of SOX2 in NSCs; this
can also be used to indentify potential downstream target genes.
• To compare the properties and gene expression profiles of stem cell-enriched 
neurosphere cultures to non-enriched cultures in order to identify properties of 
NSCs.
• To identify novel candidates that can be used as markers for neural stem cells.
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CHAPTER 2 
Establishment of neural stem cell culture conditions 
2.1 Background
2.1.1 Neurospheres as a culture system to study stem cells
Monolayer culture was the first method used to allow the survival of neuroepithelial 
cells, including NSCs. When these neuroepithelial cultures where plated under non­
adherent conditions, some cells had the ability to survive in suspension and form 
clonal, spherical colonies which are known as neurospheres (Reynolds and Weiss 
1992). These methods were then adapted to select for floating neurosphere colonies, 
eliminating the differentiating adherent cells. The neurosphere system is the best- 
characterised in vitro assay for neural stem cells and a good model to study their 
differentiation and to ’search for new cell type-specific markers, but they do not 
recapitulate the in vivo situation. The cultures may encourage NSCs with a particular 
phenotype to survive, and suppress others. Also, such spherical structures do not exist 
in the mouse CNS and stem cells reside in distinct zones alongside differentiated 
cells. Also, any interactions observed between cells in the neurosphere will not 
necessarily take place in vivo. Moreover, neurospheres contain a mixed population of 
NSCs and their differentiated progeny (see Results). All this has to be borne in mind 
when interpreting experiments.
The presence of neural stem cells can be identified through the formation of 
neurosphere colonies from single cells in culture that subsequently differentiate into 
cells of all major neural types i.e. neurons, glia and oligodendrocytes. However, there 
is a lack of markers to distinguish neural stem cells from committed progenitor cells
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that are incapable of self-renewal. There is a lot of circumstantial evidence that neural 
stem cells express the neuroepithelial marker Nestin as well as SOX2- indeed the 
former is a direct transcriptional target of the latter (Tanaka et al. 2004). However, 
some differented cells can also express stem cell markers. For example, cells of the 
ependymal zone of the adult CNS express both SOX2 and Nestin (Ferri et al. 2004; 
Dahlstrand et al. 1995). There is evidence that radial glial cells are the stem cells in 
the embryonic CNS from midgestation stages and that these subsequently give rise to 
specific astrocytes that act as stem cells in the adult (Malatesta et al. 2000; Merkle et 
al. 2004). However, it is not clear wether all radial glia are NSCs and radial glial cell 
morphology is not seen in cells of the neurosphere unless the cells are allowed to 
attach and differentiate. Moreover, not all astrocytes will have neural stem cell 
properties in the adult, so further markers are required to characterise this 
subpopulation. For example, GFAP marks astrocytic stem cells but also committed 
astrocytes. It is also not clear if cells other than astrocytes and radial glia can act as 
stem cells. This poses a major problem in isolating murine NSCs based on marker 
expression and pure populations of NSC cannot presently be achieved through 
neurosphere culture. A recent study has described the culture of radial glia-like NSCs 
as a pure stem cell population grown as a monolayer (Conti et al. 2005), but this 
method was published only late during the progress of this thesis. Apart from 
expressing Nestin and Sox2, we know that NSCs of the adult forebrain expressing 
Ssea-1 (also referred to as LeX or CD 15) have the ability to generate neurospheres 
(Capela and Temple 2002).
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2.1.2 NSC in vitro culture methods
Protocols for NSC or neuroepithelial precursor culture have been extensively 
described in the literature. Culture conditions differ for progenitors or NSCs isolated 
from different regions of the CNS and at different developmental stages. When 
evaluating NSCs isolated from different regions or developmental stages, it is 
important to minimise the differences between protocols so that the resulting 
populations are comparable. For the experiments in this thesis, standard protocols 
were applied and were modified in order to improve survival efficiency and to 
increase the proportion of the undifferentiated cells being cultured, as will be 
described in this chapter. Serum free media has commonly been used in the expansion 
of neural stem and progenitor cell lines. Some groups have introduced the addition of 
serum only for the first few days of culture to increase survival. Serum however, 
encourages growth of the cells as a monolayer attached to a substrate, such as poly-D- 
lysine coated surfaces, but is not suitable for long-term suspension cultures. DMEM- 
F12 is used as the basic medium as it has a high glucose to lactate ratio (3:1) that 
encourages CNS cell growth. The HAMS F12 component of the DMEM-F12 contains 
a range of supplements and amino acids. Alongside the antibiotics penicillin and 
streptomycin to prevent infection, N2 supplement is often added, which specifically 
encourages neural progenitor growth and is a commercially available hormone mix 
(containing insulin, human transferrin, putrascine and progesterone). Another 
supplement that can be added is B27, which increases survival of proliferating cells as 
it contains antioxidants (Svendsen et al. 1995), an attribute especially advantageous in 
the initial establishment of primary cultures. The mitogens EGF or bFGF can also be 
used alone or in combination, while the addition of heparin to the medium can 
enhance the mitogenic effects of bFGF on neural progenitors (Caldwell and Svendsen
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1998). NSCs isolated from early murine CNS (-12.0 dpc) initially respond only to 
bFGF as they do to not have EGF receptors. NSCs isolated from later stages respond 
to both bFGF and EGF (Kilpatrick et al. 1995). Studies suggest that bFGF-dependent 
neural stem cells give rise to progenitors that are also able to respond to EGF 
(Ciccolini and Svendsen 1998). Progenitors only responsive to EGF have also been 
characterised as stem cells (Reynolds and Weiss 1996).
Growing NSCs as neurospheres under clonal conditions provides several advantages. 
The greatest one is that an assessment of proliferating cells from the initial cell 
population can be achieved through counting the numbers of neurospheres generated. 
Passaging neurospheres weekly results in an expansion of the stem cell population. 
Although serial passaging without a decrease in stem cell activity should be a 
characteristic of a healthy and established stem cell line, certain factors in the 
methodology can affect this outcome. The action of enzymes such as trypsin to 
dissociate neurospheres into single cells induces spontaneous differentiation when 
applied long-term, however it is useful for short-term studies involving a couple of 
passages. When performed to completion, mechanical dissociation of neurospheres 
bypasses the problem of excess spontaneous differentiation but results in high levels 
of cell death, probably due to damage. Passaging of neurospheres too frequently also 
results in differentiation and a decline in proliferation rates. This may be attributed to 
regular passing of cells to a post-mitotic type or to the frequent removal of cell-cell 
contact that seems to play an important role in NSC maintenance and/or proliferation.
Dissociation of neurospheres and, embryonic CNS tissue can be achieved by 
mechanical dissociation or short enzymatic treatment. Adult CNS tissue requires
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extensive enzymatic as well as mechanical treatment using a fine-polished Pasteur 
pipette, or similar. Papain treatment is widely used, frequently in conjunction with 
DNase. More gentle enzymes are also used, such as the neutral metalo-protease 
dispase from Bacillus polymyxal, which cleaves fibronectin, collagen IV and to a 
lesser extent collagen I. Since it does not cleave collagen V and laminin, it is often 
combined with collagenase from Vibrio algionolyticus. The latter two enzymes are 
not inhibited by serum that may be used in the culture. When cells are plated at a 
very low density, proliferation and cell survival rates drop. As an optimal guideline, 
neural stem cells should be cultured as neurospheres at 2 x 105 cells per ml (Lanza et 
al. 2004). To encourage single-cell proliferation when cultured as a monolayer during 
clonal analysis, the addition of 10% chick embryo extract (CEE) has been suggested 
(Stemple and Anderson 1992; Kalyani et al. 1997).
Table 2.1. Outline of pioneering culture conditions described in the literature, for the 
generation of neurospheres from CNS regions at various stages of development.
Age Region Medium Supplement Mitogens References
10.0
dpc
Mesencephalon DMEM+ 1% or 
10% FBS
N2/ none bFGF + heparin
Murphy et al, 1990 
Kilpatrick et al, 
1993
10.0
dpc
Telencephalon DMEM+ 1% or 
10% FBS
N2/ none bFGF + heparin
14.5
dpc
Striatum DMEM-F12 N2 EGF Reynolds et al, 1992 
Vescovi et al, 1993
3-18
months
Striatum DMEM-F12 N2 EGF/ bFGF + 
heparin
Reynolds & Weiss 
1992, Gritti et al, 
1996
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Culture conditions need to be standardised as much as possible to avoid both culture 
artefacts and selective expansion or diminution of particular cell types, both of which 
could significantly distort or complicate the interpretation of any experimental result. 
The aim of this chapter is to determine the optimal treatment for healthy isolation and 
culture on neural stem cells so that spatial and temporal comparisons can be 
performed with minimal bias.
2.2 Results
2.2.1 Establishment o f optimal culture conditions
Neurospheres from the 14.5 dpc dorsal telencephalon are first identifiable after 60 
hours of culture. After 4 days in culture, new neurospheres are seen, smaller in size 
than the primary neurospheres that initially formed. This secondary population 
appears to grow at the same rate as the primary population. Approximately three days 
later (i.e. day 7 in culture), a new set of neurospheres is observed even if primary and 
secondary neurospheres are selectively picked and re-plated to eliminate remaining 
single cells and debri from the culture. These waves are not frequent after 10 days of 
culture and become irregular and are demonstrated in Figure 2.1. Possibilities for their 
generation may be the proliferation of latent cells (either NSCs or more committed 
progenitors with proliferative capacities) in culture at delayed points, slower 
proliferation rates of some NSCs or the detachment of NSCs from primary 
neurospheres that subsequently generate secondary structures.
A range of different methods was used in order to establish the optimal conditions for 
neurosphere generation by CNS stem cells. Preliminary results from wild type dorsal 
telencephalon-derived neurospheres from 14.5 dpc suggest that the combined addition
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of the mitogens EGF and bFGF during the entire length of culture leads to increased 
numbers of initial neurospheres formed and of secondary and tertiary sets, in 
comparison to using bFGF or EGF alone. I aimed to define a set of culture conditions 
as similar as possible to each other, in order to culture different NSC populations with 
spatial and temporal differences and use these in comparative investigations.
Figure 2.1 Sequential waves of wild type 14.5 dpc dorsal telencephalon neurospheres. 
After 8 days of culture in proliferation medium, three generations of neurospheres can 
be seen (distinguished by the red, blue and black arrows) Scalebar represents 250 pm.
Variations in the methods used to dissociate primary tissue and to culture NSCs and 
the efficiency of each method is outlined in Tables 2.2 and 2.3 below. In summary, 
mechanical dissociation of tissue and culturing in DMEM-F12 with the addition of 
N2, B27, EGF and bFGF (termed ‘proliferation medium’) lead to an increased
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number of primary neurospheres from various CNS regions at embryonic stages. For 
the generation of neurospheres from the adult subventricular zone, enzymatic 
dissociation of the tissue using papain yields the highest neurosphere numbers when 
cultured in proliferation medium as described above. For all populations, the 
dissociation of neurospheres in culture during passaging to generate secondary 
neurospheres is most successful after digestion with trypsin for 2 minutes followed by 
mechanical dissociation.
Table 2.2 Summary of the methods of tissue dissociation for the generation of primary 
neurospheres, rated overall (- to ♦***) for enhanced neurosphere formation and low 
levels of differentiation based on morphological observations.
Treatment 
(optimal culture medium) Observations Rating
Mechanical High neurosphere formation, little 
differentiation
Trypsin (1.33 mg/ml) High neurosphere formation, medium 
differentiation- best for 2ry neurosphere 
dissociation
***
Trypsin (1.33 mg/ml) 
/Hyaluronic acid(0.7mg/ml)/ 
Kynureic acid (0.2 mg/ml)
Low neurosphere formation, high 
differentiation -
Dispase (lU/ml) Neurosphere formation, medium 
differentiation
*
Collagenase (0.1U/ml)/Dispase 
(0.8 U/ml)
Neurosphere formation, low 
differentiation
**
Papain (adult SVZ only **♦*) 
(75U/5ml + 12pg/ml DNase)
High neurosphere formation, low 
differentiation
***
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Table 2.3 Summary of results using different compositions of culture medium. Rated 
overall (* to ****) for efficiency of neurosphere formation and low levels of 
differentiation based on observations of cellular morphology in culture.
Culture Medium Observations Rating
"o ' NSC hormone mix in 
DMEM-F12
Neurosphere formation
* * *
go
3
jg
a<d
o
G
B27 in DMEM-F12 Neurosphere formation, sustainable for 
> 2 weeks
**
3■*->
3
N2 + B27 in DMEM-F12 High neurosphere formation
*-•o
Q
N2 + CEE + bFGF in Adherent neuroepithelial culture only
*
'Tj
Q«
T3
DMEM-F12. E9
3
O
o
15
G
‘B h
C/2
N2 + B27 + CEE +bFGF 
in DMEM-F12
Adherent culture, high differentiation. 
Some neurosphere formation
* *
N2 + B27 + bFGF/EGF 
in DMEM-F12
High neurosphere formation
3
03
NSC hormone mix in 
DMEM-F12
Very low neurosphere formation
*
ao
N
B27 in DMEM-F12 Low neurosphere formation * *
3
o
’C
G
<U>
■§
C/3
N2 + B27 in DMEM-F12 Neurosphere formation. High numbers
only with papain dissociation (see 
below)
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2.2.2 Establishment o f clonal density
Preliminary observations on neurosphere cultures suggest that the density at which 
primary neural cells are plated affects the total number of primary neurospheres that 
form: when plated at clonal density (less than 1 x 10 cells/ml) or as single cells per 
individual well, 0.3% of cells give rise to neurosphere colonies (standard error of 
mean ± 0.09%). These neurospheres appear unhealthy, i.e. individual cells within the 
structure appear loosely adhered and the spheres do not appear completely round due 
to cells detaching from the periphery. By one week of culture they either attach to the 
well surface and differentiate or die. However, when wild type single cells are plated 
at a density of 1 x 104 cells/ml, 1% (embryonic 14.5 dpc spinal cord) to 4% 
(embryonic dorsal telencephalon) of the cells generate neurospheres that are healthy 
in appearance and have the ability to give rise to secondary neurospheres upon 
dissociation. I aimed t© determine if these primary neurospheres are generated from 
single cells or from several cells that have adhered to form clusters prior to 
proliferation. For this, R26Eyp^/Ey^  14.5 dpc dorsal telencephalon cells, which 
ubiquitously express EYFP, were plated together with wild type 14.5 dpc dorsal 
telencephalon cells at equal numbers, at a range of cell densities. At the densities of 1 
x 104, 1 x 105, and 1 x 106 but not 1 x 103 cells/ml, chimeric neurospheres formed 
(Table 2.4), incorporating both fluorescent and wild type cells (Figure 2.2 A and B). 
More detailed analysis involving intermediate densities, determined that the initial 
plating density of dissociated primary CNS cells has to be less than 5 x 103 cells/ml in 
order to ensure the clonal generation of neurospheres. No neurospheres incorporating 
both fluorescent and non-fluorescent cells were seen at this density (n — 54).
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Figure 2.2 Establishment of clonal density in neurosphere cultures. (A,B) Example of 
chimeric neurospheres formed at a 1 x 104 plating density. Confocal imaging of these 
neurospheres, showing Rosa26-EYFP fluorescent in green and the nuclei of all cells 
in blue, stained with DAPI (A). Higher magnification of one such neurosphere (B) 
reveals the extent of aggregation and random distribution of the fluorescent cells. 
Scalebars represent 100pm.
Table 2.4 summarises the numbers of chimeric neurospheres formed at different 
densities, expressed as a percentage of the total number of neurospheres in the culture. 
Neurospheres that are formed through aggregation of fluorescent and non-fluorescent 
cells were used as an indicator of the extent of aggregation at various densities.
Cell density/ml
1 X 103 lx lO 4 1x10" l x lO 6
% Chimeric 
neurospheres 0% 4.2% 35.9% 97.0%
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2.3 Discussion
2.3.1 Establishment o f neurosphere culture conditions
General observations of wild type neurosphere formation suggest that not all NSCs 
proliferate to generate neurospheres at the same time. In primary cultures from 
embryonic or adult CNS, secondary waves of neurospheres form after the initial 
primary neurospheres have become established (Figure 2.1). The possibility that there 
are quiescent NSCs in culture that do not proliferate initially is likely, based on high 
numbers of viable single cells in the culture that do not become incorporated in the 
primary neurospheres. These cells may become activated in culture in response to 
secreted factors, or they may have a distinct stem/progenitor profile from the initial 
neurosphere-forming NSCs as well as slower rates of proliferation. However, at even 
later stages, a tertiary neurosphere wave is seen, even when only whole neurospheres 
are re-plated. This suggests that cells from established neurospheres become detached 
and proliferate forming independent neurospheres. Indeed, from BrdU analysis, it is 
known that proliferating cells do reside on the surface of the neurosphere (data not 
shown). It is likely that delayed growth and detachment from established 
neurospheres are both taking place in long-term cultures.
As determined from the results summarised in Tables 2.2 and 2.3, embryonic 
neurospheres from the dorsal telencephalon and spinal cord can be cultured under 
identical conditions and the tissue dissociated using the same methods. For adult SVZ 
neurospheres, the same culture conditions as for embryonic neurospheres can be used 
but mechanical dissociation alone is not sufficient to effectively obtain a single-cell 
suspension. It frequently results in more cell damage than with the generation of 
embryonic neurospheres, due to repeated mechanical treatment, which in turn can
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lead to higher levels of differentiation in culture. For this reason papain was 
determined to be the most appropriate enzymatic treatment for the dissociation of 
adult primary SVZ tissue.
2.3.2 Establishment o f clonal density
The clonal plating density at which NSCs are able to give rise to neurospheres at a 
regular frequency was established so that subsequent experiments, assaying 
neurosphere formation as a proportional measure of the numbers of proliferating 
NSCs in culture, were not influenced by the potential aggregation of several NSCs 
giving rise to a single neurosphere. At very low densities, such as 1 x 103 cells per ml, 
long-term neurosphere cultures are not successful. The same applies to true clonal 
density assays when single cells are picked and plated in individual wells. This
i
suggests that there may be- a requirement for soluble factors, secreted by the cultured 
cells into the medium, which only reach threshold levels above a particular cell 
density, or that efficient survival and growth only occur when colonies are formed by 
more than one cell. By mixing equal numbers of fluorescent and non-fluorescent cells, 
any aggregation from the two populations is evident. However, at low cell plating 
densities, there may still be low levels of aggregation, which can pass undetected in 
the experiments outlined in section 2.2.2 if these events occur between same- 
phenotype cells. To overcome this, a larger sample size needs to be examined. Here, 
the highest density at which no aggregation was seen was determined by a 20-fold 
smaller sample size compared to the regular experimental scale used in other 
experiments this thesis. Therefore, the value of clonal density as less than 5 xlO3 cells 
per ml has been used as a guideline and not an assurance for the lack of aggregation.
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CHAPTER 3
SOX2 in neural stem cells 
3.1 Background
3.1.1 Tools to study Sox2 expression
The Sox2^geo/+ mutant allele, generated by homologous recombination in ES cells, 
contains a pgeo sequence, encoding a p-galactosidase-neomycin fusion (Friedrich 
and Soriano 1991), which has replaced the open reading frame of the Sox2 locus and 
is under the transcriptional control of Sox2 regulatory elements (Avilion et al. 2003). 
Mice, which are homozygous null for Sox2 die around implantation as the epiblast 
fails to form in the absence of Sox2. Neurosphere cultures derived from heterozygote 
targeted mutants show no apparent differences with wild type cultures. Hence, in the 
neurosphere experiments in this study Sox2^geol+ animals were used. The expression 
of P-galactosidase in Sox2^geol+ heterozygous mice can be used to monitor the 
expression of Sox2 as these mice are viable and do not demonstrate any phenotype 
that may interfere with these studies. This allows for the visualisation of cells in 
which the Sox2 promoter is active, through performing X-gal staining to assay for p~ 
galactosidase activity. This assay cannot reveal the sub-cellular localisation of 
SOX2, so immunofluorescence staining using an antibody raised against SOX2 can 
be used. It does however, have another advantage: as the pgeo cassette confers 
neomycin resistance, the cells that do not express Sox2 can be eliminated from the 
culture through the addition of G418. This tool will be used to investigate the role of 
SOX2 in NSCs, through assaying the differentiation and proliferation capacities of 
cells selected for Sox2{igeo expression, as well as to aid in determining the expression
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pattern of Sox2^eo in the regions of neural stem cell generation used in this study and 
in cultured neurosphere populations.
3.1.2 The association between the sub-cellular localisation o f SOX2 and the state o f  
differentiation
Several of the regions of the adult CNS that retain Sox2 expression harbour neural 
stem cells, as defined by their culture properties and neurosphere generation 
capability. Some regions of the CNS however, still express Sox2 in terminally 
differentiated populations such as purkinje neurons in the cerebellum where SOX2 is 
cytoplasmic, and in ependymal cells of the lateral ventricles and some neurons of the 
cortex, in both of which SOX2 localises in the nucleus (Lovell-Badge, unpublished 
data). Therefore the persistence of Sox2 expression in such cell types is not an 
indicator of the stem cell state. However, the sub-cellular localisation of SOX2 may 
provide an insight into the differentiation state of the cells, depending on the region 
or tissue. In undifferentiated, pluripotent cells of the early embryo up until blastocyst 
stages, SOX2 localises in the nucleus. The first differentiation event in the early 
embryo leads to the formation of trophectoderm. In this tissue, Sox2 is 
downregulated and the protein translocates to the cytoplasm. In vivo, nuclear SOX2 
is generally observed in multipotent lineages while it tends to be seen in the 
cytoplasm of terminally differentiated cells.
The HMG box sequence of Sox2 has two nuclear localisation signals (NLS), as do 
other members of the Sox family. One of these signals (NLS2) overlaps a consensus 
phosphorylation site for the cyclic AMP (cAMP) dependent protein kinase A (PKA). 
Through kinase assays on mutated forms of SOX2, it has been demonstrated that 
SOX2 is an in vitro substrate of PKA (Sockanathan et al, unpublished data). Initial
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experiments suggested that treatment with db-cAMP induces the nuclear export of 
SOX2 to the cytoplasm, presumably through the activation of the PKA pathway. 
Other members of the SOX family (SRY and SOX9) exhibit nuclear-cytoplasmic 
shuttling and there is evidence to suggest that this is mediated by calmodulin (Harley 
et al. 1996). Calmodulin is an intracellular calcium receptor and is responsible for the 
inhibition and activation of numerous factors. It interacts directly with bHLH factors 
and inhibits their DNA binding capacity. Both SRY and HMG1 have been 
demonstrated to bind calmodulin (Harley et al. 1996). Therefore, it may be possible 
for SOX2 to also interact with calmodulin.
In this chapter, I aim to investigate the role of SOX2 in NSCs selected for Sox2^eo 
expression and to determine the expression pattern of Sox2^geo in regions of neural 
stem cell generation.* Furthermore, I aim to characterise the sub-cellular localisation 
of SOX2 in proliferating and differentiating NSCs and to gain insight on the 
mechanism of SOX2 translocation from the nucleus to the cytoplasm.
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3.2 Results
S. 2.1 Sox2 in NSC-generating regions and in populations o f neurospheres from the 
dorsal telencephalon at 14.5dpc
Wholemount embryos at 14.5 dpc where fixed and assayed for P-galactosidase 
activity through X-gal staining. This recapitulated the endogenous expression pattern 
of Sox2 (Figure 3.1 A). X-gal staining on paraffin sections of adult brain reveals 
prominent staining in the SVZ (Figure 3.1 D and E). To obtain a stronger and more 
detailed expression pattern in the neural stem cell generating regions than by staining 
on paraffin sections, X-gal staining was performed following cryosectioning of fixed 
14.5 dpc embryos (Figure 3.1 B and C). The expression of Sox2^eo can also be seen 
in neurospheres generated from NSC-generating regions that are defined by Sox2 
expression. When neurospheres from the 14.5 dpc dorsal telencephalon are selected 
for Sox2^eo expression in culture using G418, all the cells appear blue after X-gal 
staining (Figure 3.1 Fi). In neurospheres that have been cultured in the absence of 
selection, just as wild type neurospheres would be, a variable staining pattern is 
obtained (Figure 3.1 Fii). This ranges from 10% of the cells in the neurosphere being 
positive for LacZ in 5% of the cases to 98% of the cells being LacZ positive in 60% 
of the neurospheres studied. Commonly, large patches of cells expressing figeo are 
seen together, and less often, a salt and pepper distribution of expressing and non­
expressing cells.
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Figure 3.1 The expression pattern of Sox2j3geo in Sox2^geo/+ mice and neurosphere 
cultures. Sox2j3geo expression can be visualised through X-gal staining in the 14.5 
dpc Sox2Pgeol+ embryo (A) and specifically in NSC generating regions such as the 
dorsal telencephalon (B) and the spinal cord (C). Sox2j3geo is expressed in the adult 
brain (D) and most prominently in the subventricular zone (E). In neurospheres 
derived from the 14.5 dpc dorsal telencephalon all cells stain when they are selected 
for the expression of Sox2j3geo (i) and in the non-selected situation Sox2j3geo cells 
show variable distribution patterns (ii).
Sox2^geo,+ cells can be analysed by flow cytometry, through treating the cells with a 
substrate for p-galactosidase (CMFDG) that generates a fluorescent product. When 
G418-selected neurospheres (homogenously expressing Sox2) undergo FACS 
analysis by this method, two overlapping populations are seen, one with high levels 
of Sox2 expression (60%) and one with low levels (40%). FACS analysis of 
Sox2^geo/+ neurospheres that have not undergone selection indicates that on average, 
79% of cells are &wr2-expressing (standard error of mean ±1).
3.2.2 NSCs and the generation of neurospheres
3.2.2.1 Neurosphere formation under proliferation conditions
The average number of cells cultured from both lobes of the 14.5 dpc dorsal 
telencephalon is 1.4xl06 (result from FACS quantifications, N  = 24 embryos). On 
average, after 3 days* in culture 0.95% of cells (± 0.12%) give rise to primary 
neurospheres (N > 40). The number of cells in each neurosphere varies and by 7 days 
in culture neurospheres can be composed of lxl03 to lxlO7 cells. This diversity is 
reflected by neurosphere size, which after 7 days is between 200 and 800pm in 
diameter, with the mean diameter of the spheres being -550pm.
3.2.2.2 FACS analysis o f Sox2^geo/+ neurospheres to determine i f  Sox 2 is required for 
neurosphere generation
To determine if Sox2 is required by NSCs for neurosphere generation, Sox2^eo,+ 
neurospheres were flow sorted after being cultured in the absence of selection in 
order to allow for the establishment of both Sox2 positive and negative cells. 
Subsequent culturing of the sorted Sox2 positive and negative cellular components 
reveals that the Sox2 positive component generated neurospheres whereas the Sox2
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negative component did not (Table 3.1). The generation of neurospheres from the 
Soxi-expressing cells was found to be 10-fold reduced compared to neurosphere 
generation from primary tissue. The neurospheres that formed survived in culture for 
approximately 7 days without selection pressure. After this time they either adhered 
to the surface of the culture dish and differentiated, or the neurosphere dissociated 
and the individual cells died. Cells that survived in culture from the Sox2 negative 
component adhered to the dish surface and showed signs of differentiation 
(projections, elongated morphology). These results indicate that the multipotent 
NSCs that have the ability to proliferate, reside within the Sox2 positive component 
of the neurosphere. Similar values were obtained when neurosphere populations 
derived from spinal cords of Sox2^geol+ 14.5 dpc embryos and adult SVZ were used 
(no neurospheres could be cultured from the Sox2 negative component in all cases).
Table 3.1 Generation of neurospheres after FACS sorting. Sox2j3geo expressing and 
non-expressing cellular components of non-selected primary neurospheres, where 
cultured separately in the absence of selection. Three repeats where carried out.
Total cells
FACS
sorted
Cells 
sorted 
Sox2 +ve
Neurospheres 
from +ve
Cells 
sorted 
Sox2 -ve
Neurospheres 
from -ve
Trial 1 3.5 x 10b 2.7 x 10° 3521 (0.13%) 1.3x10° 0
Trial 2 1.7 x 10b 1.3 x 10° 2715(0.21%) 4.3x10° 0
Trial 3 4.8 x 10° 3.9 x 10° 4326 (0.11%) 7.7x10° 0
3.2.23 Secondary neurosphere formation as an indicator o f NSC numbers 
When the single cells dissociated from primary neurospheres are re-plated under 
proliferation conditions, they give rise to secondary neurospheres. The numbers of 
secondary neurospheres that form are a good retrospective indicator of the number of 
NSCs present in the primary culture. On average, 1.3% of cells (± 0.07%) from
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neurospheres that have been maintained under selection for the expression of 
Sox2/3geo give rise to secondary neurospheres.
3.2.2.4 BrdU incorporation as an indicator o f proliferating NSCs 
G418-selected neurospheres where treated in culture with a 40-minute pulse of BrdU 
before fixation and immunofluorescence staining using an anti-BrdU antibody 
(results summarised in Table 3.2). The average number of BrdU labelled cells 
(15.98% of the total cell in a neurosphere) is much higher than the percentage of 
cells that gives rise to secondary neurospheres in culture (1.3%, determined in 
section 3.2.2.3) indicating that not all proliferating cells are capable of neurosphere 
generation in the presently used culture conditions.
Table 3.2 Numbers of BrdU positive cells in Sox2pgeo/+ selected neurospheres. The 
numbers of BrdU positive cells are expressed as a percentage of the total cells, in 
four independent trials. The average of all four trials is highlighted in red.
N eurosphere
Population
% BrdU +ve 
(repeat 1)
% BrdU +ve 
(repeat 2)
% BrdU +ve 
(repeat 3)
% BrdU +ve 
(repeat 4)
Average%  
BrdU +ve
Sox2®“ '*
Selected
15.7% 16% 18% 14.2% 15.98%
3.2.3 Immunofluorescence analysis on proliferating and differentiating 14.5 dpc 
dorsal telencephalon neurospheres
3.2.3.1 Proliferation
Immunofluorescence using antibodies against SOX2 in G418-selected neurospheres 
confirms the homogenous Sox2 expression, previously seen through X-gal staining in 
Figure 3.1 (Figure 3.2 B). Other markers reported to identify neural stem cells such 
as the uncommitted neuroepithelial marker Nestin and the surface antigen Ssea-1,
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which has been described as an adult subventricular zone stem cell marker are also 
expressed in neurospheres derived from the dorsal telencephalon of Sox2^geol+ mice 
(Figure 3.2 A-C). These mostly co-locaiise in cells expressing Sox2. In neurospheres 
cultured under proliferation conditions, some differentiated progeny are also seen 
(Figure 3.2 D to F). High numbers of GFAP positive glial cells are seen, located all 
over the sphere. TuJl immunoreactive neurons as well as some oligodendrocytes are 
typically seen in proliferating neurospheres. The latter are commonly seen localised 
in patches rather than spread equidistantly around the sphere (as seen in Figure 3.2 
F). To establish if differentiated cells still express Sox2, neurospheres were induced 
to differentiate as described in section 3.2.3.2, but with the continuous addition of 
G418 in the medium in order to eliminate 5bx2-negative cells from the culture. Glia 
and oligodendrocytes persisted in the culture, but at lower numbers compared to 
neurospheres differentiating in the absence of selection. A small number of TuJl 
positive neurons were observed (12 across 25 differentiating neurospheres) with no 
identifiable axons.
3.23.2 Differentiation
To determine if NSCs in Sox2^geol+ dorsal telencephalon neurospheres are 
multipotent, differentiation is encouraged by the attachment of spheres on a support 
matrix. For these studies, a Matrigel support has been used, as it does not promote 
preferential differentiation into a particular lineage as found for other supports such 
as laminin. In the absence of the mitogens EGF and bFGF, NSCs rapidly 
differentiate. After 5-days under differentiation conditions, neurospheres have given 
rise to neurons, glia and oligodendrocytes (Figure 3.2 G to I).
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Figure 3.2 Immunofluorescence analysis of selected Sox2^eo/+ neurospheres. Cells in 
the neurosphere are immunoreactive for the candidate stem cell markers Ssea-1 (A), 
SOX2 (B) and Nestin (C). They also contain low numbers of differentiated progeny 
(D to F). Once in differentiation conditions, neurospheres have the ability to generate 
glia (G), neurons (H) and oligodendrocytes (I). Scalebars represent 100pm except in 
G and I where they represent 10pm.
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3.2.4 The sub-cellular localisation of S0X2
3.2.4.1 Immunofluorescence analysis to determine the sub-cellular localisation o f 
S0X2 in neurosphere cultures
S0X2 is expected to localise in the cytoplasm of most terminally differentiated cell 
types. Double immunofluorescence antibody staining was performed against SOX2 
and against known markers of differentiated neural cells (GFAP, RC2, S100P, TuJl, 
CNPase, 04, GalC). These cell types were analysed in neurosphere populations 
derived from embryonic and adult CNS tissue. After 5 days under differentiation 
conditions, S0X2 localises predominantly in the cytoplasm of these differentiated 
cell types. In all neurosphere populations examined, S0X2 localises in the nucleus of 
a subpopulation of GFAP and/or RC2 positive glial cells (Figure 3.3 A, i). It also 
localises in the nucleus of some GalC positive oligodendrocytes (Figure 3.3 A, iii). 
S0X2 is not normally seen in neurons (Figure 3.3 A, ii) but when it is expressed in 
neurons derived from embryonic neurospheres, it localises in the cytoplasm. 
Interestingly, when this experiment was performed using adult SVZ cultures, the 
S0X2 antibody is seen to mark both the nucleus and the cytoplasm in mature TuJl 
positive neurons differentiating for 5 days (Figure 3.3 B). After 10 days however, its 
localisation becomes mostly cytoplasmic.
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Figure 3.3 Localisation of SOX2 in differentiated cell types. SOX2 (green in A, red 
in B) is localised in the nucleus of some GFAP positive glia (red, A, i) and GalC 
positive oligodendrocytes (A, iii) but it is not expressed in neurons (A, ii) 
differentiating from 14.5 dpc dorsal telencephalic neurospheres. In neurospheres 
isolated from the adult SVZ, Sox2 is expressed in neurons differentiating for 5 days 
and the protein localises transiently in the nucleus as well as in the cytoplasm (B). 
Scalebars represent 100 pm.
3.2.4.2 Investigating the mechanism ofSOX2 nuclear-cytoplasmic shuttling 
To determine the pathway used by SOX2 to translocate from the nucleus to the 
cytoplasm, the PI9 embryonal carcinoma (EC) cell line was used. When neural 
differentiation of P I9 cells is induced through the addition of trans-reiinoic acid 
(tRA), SOX2 translocates from the nucleus to the cytoplasm (Remboutsika et al, 
unpublished data). Since previous work suggests that treatment with db-cAMP 
induces the nuclear export of SOX2, these experiments were reproduced to confirm 
this result. Initially, SOX2 was found to localise primarily in the cytoplasm of both 
treated and untreated cells, which was not an expected finding. The experimental 
conditions employ methanol as the fixation agent and immunofluorescence staining 
on sections of cryopreserved tissue, using antibodies against SOX2, has shown that 
fixation with methanol results in artefactual cytoplasmic SOX2 staining in regions 
where SOX2 is known to be in the nucleus (Dr Ariel Avilion, personal 
communication). Since fixation of undifferentiated PI 9 cells with methanol results in 
cytoplasmic or perinuclear localisation of SOX2 (depending on the temperature and 
length of fixation), the fixation conditions required optimisation (Figure 3.4 A ii and 
iv). Fixation with MEMFA leads to nuclear staining using an antibody against SOX2 
in untreated P19 cells (Figure 3.4 A i and iii), and cytoplasmic SOX2 staining in P19 
cells treated with tRA, so was chosen as a reliable fixative. When PI9 cells were 
treated with cAMP, SOX2 remained located in the nucleus over a period of 24 hours 
(shown here for up to 4 hours, Figure 3.4 B v and vi). Cells that have been treated 
with tRA and subsequently with cAMP for 24 hours retain the cytoplasmic SOX2 
localisation induced by tRA. Leptomycin B blocks the nuclear export of proteins via 
the cAMP-mediated PKA pathway and was added as a control alongside cAMP in all 
experiments for a maximum of 4 hours (PI 9 cell survival is limited to 4 hours with
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leptomycin treatment). As expected, there was no effect on the localisation of SOX2 
in cells treated with leptomycin B (Figure 3.4 B i-iii). These results demonstrate that 
the addition of cAMP to PI9 cells does not induce the translocation of SOX2 
between the nucleus and the cytoplasm, indicating that the nuclear-cytoplasmic 
shuttling of SOX2 is independent of the cAMP-dependent PKA pathway.
Figure 3.4 Localisation of SOX2 in P I9 EC cells after cAMP treatment. Fixation is 
important to determine the correct localisation of SOX2. MEMFA fixation leads to 
nuclear fixation in undifferentiated P I9 cells where SOX2 is known to be nuclear (A, i, 
iii) whereas methanol fixation leads to cytoplasmic localisation (A, ii, iv), irrespective of 
temperature conditions. Treatment with db-cAMP does not result in nuclear-cytoplasmic 
shuttling of SOX2 (B, v, vi) and is also not inhibited by leptomycin, which blocks cAMP- 
dependent shuttling (B, i to iii). As a negative control for the immunofluorescence, SOX2 
pre-immune antibody was used (iv). Scalebars represent 100pm
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3.3 Discussion
3.3.1 Characterisation o f Sox2 expressing and non-expressing cells in neurosphere 
populations
FACS sorting primary neurosphere cells maintained in the absence of selection for the 
expression of Sox2, and subsequently culturing them in conditions that favour 
neurosphere generation, reveals that neural stem cells reside within the Sox 2- 
expressing component, as demonstrated in section 3.2.2.2. Through selection for 
Sox2^eo, neurospheres can be enriched for NSCs. This selection increases the 
likelihood that higher numbers of stem cells are present in the culture, as determined 
by an increase in the numbers of secondary neurospheres from primary cultures 
selected for the expression of Sox2^eo (1.3% compared to 0.95%, demonstrated in 
section 3.2.2.3 and also in Chapter 4, section 4.2.2). However, it also creates an 
abnormal situation where no Sox2 negative cells are present. Assays involving pulsing 
cells with BrdU reveal that the percentage of BrdU incorporation is higher than 
percent neurosphere formation in Sox2^eo -selected neurospheres (Table 3.2). This 
result indicated that not all of the proliferating cells are capable of neurosphere 
generation. There are at least three, non-mutually exclusive explanations fro this: (i) it 
is possible that proliferating progenitor cells cannot form neurospheres in culture, in 
contrast to neural stem cells; (ii) all proliferating cells may be capable of initiating 
neurosphere formation, but the survival of neurospheres may be impaired for some 
originating cell types; (iii) aggregation of cells in culture leads to a falsely reduced 
number of neurospheres. If the latter is true, it should be a constant error and should 
not affect the assessment of fluctuations in NSC numbers through assays involving 
secondary neurosphere formation. BrdU incorporation assays have to be performed 
with an extension of the BrdU treatment time in order to obtain more accurate Figures
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for the number of proliferating cells in the neurosphere. X-gal staining on Sox2^geo,+ 
neurospheres reveals that the number of Sox2 negative cells varies significantly 
between neurospheres in a single culture, indicating that there is no requirement for a 
specific proportion of Sox2 negative cells (Figure 3.1 Fii). This variation in the non­
selected neurospheres poses a problem, as it is difficult to accurately reproduce 
comparisons between individual Sox2^geo/+ selected and non-selected neurospheres. In 
both neurosphere populations, the neuroepithelial stem cell marker Nestin is 
expressed by the Sox2 positive cells, consistent with their stem cell character (this is 
not surprising as it has been shown that Nestin is regulated by Sox2 (Tanaka et al. 
1998)), and both cultures are capable of differentiating into neurons, glia and 
oligodendrocytes (Figure 3.2, shown for Sox2^eo/+ selected cultures). They also 
express Ssea-1, which has been identified as a stem cell marker in the adult SVZ 
(Capela and Temple 2002). Aside from the inability to from neurospheres, after FACS 
sorting, Sox2 negative cells also show signs of differentiation. However, the absence 
of Sox2 is not an essential criterion for differentiation. When selected neurospheres 
were induced to differentiate with continuing selection for five days, cells expressing 
differentiation markers for glia and oligodendrocytes and on some occasions, neurons 
were present (3.2.3.1). It may be the case that the persistence of neomycin 
phosphotransferase permitted the survival of these cells, irrespective of their SOX2 
status. The observation that there were only very few TuJl-immunoreactive neurons 
and that these had no axons, suggests that the maintenance of Sox2 expression inhibits 
neurogenesis, consistent with findings that ectopic expression of Sox2 in chick neural 
tubes inhibits neurogenesis (Bylund et al. 2003; Graham et al. 2003). The overall 
lower numbers of differentiated cells, in the situation where selection for Sox2 
continues, can be attributed to two possible reasons: (i) Sox2 non-expressing cells are
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being eliminated from the cultures as predicted; (ii) the continued expression of Sox2 
exerts pressure to maintain an uncommitted character.
2.3.2 Sub-cellular localisation ofSOX2
In undifferentiated neurospheres, nuclear SOX2 is seen in the majority of the cells. 
SOX2 localises predominantly in the cytoplasm of differentiated cells, as revealed 
through double immunofluorescence analysis on neurospheres cultured under 
differentiation conditions. At least in some cases, SOX2 shuttles from the nucleus of 
undifferentiated cells to the cytoplasm, upon differentiation. This observation is 
supported by the fact that after 5 days in differentiating culture conditions, neurons 
derived from adult SVZ neurosphere cultures exhibit both nuclear and cytoplasmic 
SOX2, which becomes fully cytoplasmic after a further 5 days (Figure 3.3 B). One 
exception with respect to cytoplasmic SOX2 localisation, where differentiated cells 
have nuclear SOX2, is in a subpopulation of glial cells that are also immunoreactive 
for RC2 and/or GFAP (Figure 3.3 A). Cells within this population exhibit both 
astrocytic and radial glial morphologies. A possible explanation for these results is the 
NSC identity of some embryonic radial glial cells, which are capable of generating 
astrocytic progeny that retain stem cell properties. The nuclear-cytoplasmic shuttling 
of SOX2 is a common feature of several SOX proteins as discussed earlier. 
Experiments to investigate if SOX2 nuclear export occurs through induction of the 
cAMP-mediated PKA pathway suggest that this pathway is not responsible (section 
3.2.4.2). It is possible the PKA pathway was not correctly induced in these 
experiments so to refine the experimental design a positive control is required. 
Ideally, the localisation of a known protein whose export depends on the PKA 
pathway and which is expressed in P19 cells should be examined alongside the
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localisation of SOX2. Other signaling pathways such as Wnt signaling may be 
responsible for SOX2 shuttling. The possibility of calmodulin-mediated shuttling of 
SOX2 should be next investigated, as calmodulin is involved in the localisation of 
other SOX family members (Harley et al. 1996). It would be possible to demonstrate 
the involvement of calmodulin in the localisation of SOX2 through inhibiting 
calmodulin signaling, but a suitable method could not be established in order to 
proceed with these experiments.
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CHAPTER 4
Comparisons between NSC cultures homogeneously expressing Sox2 
and cultures that have not been selected for Sox2 expression
4.1 Background
If NSCs require cues through cell-cell interactions to maintain their state or 
function, an altered environment within the neurosphere may provide cues 
for a particular fate. We can manipulate this environment in neural stem cell 
cultures, to select for cells expressing Sox2pgeo, generating a population 
that homogenously expresses Sox2. Comparing these cultures that 
homogenously express Sox2 to a mixed population of cells similar to wild 
type cultures hence more comparable to published literature, can help 
characterise the roles of the Sox2 expressing and non-expressing cells. 
Besides proliferation and differentiation assays for the two populations, 
their global gene expression profiles can be investigated through microarray 
analysis, in order to obtain further insight into their cellular character. Two 
different array platforms were used: the Mouse 430A GeneChip 
(Affymetrix)- an oligonucleotide array encompassing 44,000 known mouse 
genes and their mismatch controls and the Mm_SGC_Av2 spotted 
oligonucleotide array (named Mouse ‘Known’ Gene Oligo Array, produced 
by Codelink-Amersham and the MRC Rosalind Franklin Centre for 
Genomic Research- former HGMP), which represents 7,500 genes including 
controls. The initial availability of the spotted array allowed for several pilot 
studies to be performed, and these preliminary results were then compared 
to results from the more reliable GeneChip platform.
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In this chapter, the differences between the differentiation and proliferation 
properties as well as in the gene expression profiles of neurospheres 
homogenously expressing Sox2, and neurospheres composed of a mixed 
population with respect to Sox2 status will be investigated. This chapter also 
aims to examine the effects of varying the proportion of 5bjc2-expressing 
cells, in the neurosphere microenvironment, on proliferating NSCs.
4.2 Results
4.2.1 Comparisons between Sox2^e0/+ neurospheres that have or have not 
undergone selection for the expression of Sox2
4.2.1.1 Differences in differentiation into glia, neurons and 
oligodendrocytes *
Cells derived from embryonic and adult CNS tissues (14.5 dpc dorsal 
telencephalon, 14.5 dpc spinal cord and adult subventricular zone) from 
wild type mice (MF1) do not survive in culture past ten days with the 
addition of G418 in the proliferation growth medium. This confirms that 
selection for 10 days with G418 is sufficient to ablate any Sox2 negative 
cells resulting in neurospheres homogenously expressing Sox2. Indirect 
immunofluorescence analysis of differentiation markers reveals differences 
in the unrestricted differentiation of neural stem cell progeny in 
homogeneous and heterogeneous populations between selected and non­
selected population with respect to Sox2 expression. Neurospheres cultured 
under proliferation conditions for 3 weeks, in the absence of selection, were 
allowed to differentiate for 5 days in the absence of growth factors on an
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adherent matrix. Under these conditions, cells from these neurospheres give 
rise to Gfap expressing glia, at higher numbers than in neurospheres 
cultured under selection during proliferation. Semi-quantitative PCR for 
Gfap expression (Figure 4.1 B) as well as FACS sorting analysis using an 
anti-GFAP antibody on proliferating neurospheres also confirm this 
observation (Figure 4.1 A). Higher numbers of TuJl positive neurons are 
also observed in the majority of differentiating neurospheres not enriched 
for Sox2 expression (Figure 4.2 C and D). Differentiation into these cell 
types can be attributed to the Sox2 negative cellular component. There 
appears to be no significant difference in the numbers of oligodendrocytes 
(marked by antibodies against 04, CNPase and GalC), but in enriched 
neural stem cell cultures selected for Sox2 expression, mature 
oligodendrocytes are seen alongside cells with perinuclear 04 localisation 
without oligodendroglial projections that resemble more immature 
oligodendrocytes or oligodendrocyte precursor cells (OPCs). In cultures not 
selected for the expression of Sox2, only the latter cells have been observed 
(Figure 4.2 A and B). In 14.5 dpc spinal cord-derived neurospheres, higher 
numbers of oligodendrocytes are seen in differentiating neurospheres that 
have not undergone selection, which highlights a regional difference.
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Figure 4.1 Differences in the number of GFAP positive cells between 14.5 
dpc neurospheres from the dorsal telencephalon selected or not selected for 
the expression of Sox2J3geo. FACS sorting reveals that the GFAP positive 
component is higher in neurospheres that have not been selected (iii) than 
neurospheres that homogenously express Sox2/3geo (ii). Cells in the non­
selected population also show higher levels of fluorescence intensity (iv 
green), than in their Sox2/3geo selected counterpart population (iv red) 
indicating higher levels of GFAP. Differences in the levels of Gfap 
expression where confirmed by semi-quantitative RT-PCR (B). 
Neurospheres from the 14.5 dpc dorsal telencephalon not selected (B i, ‘DT- 
‘) express Gfap at higher levels than selected neurospheres (B i, ‘DT+’). 
Levels of expression of Actb (p-Actin) where used as a control to ensure no 
differential loading of template (B ii).
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Figure 4.2 Differences in oligodendrocytes and neurons between G418 selected and 
non-selected neurospheres from the 14.5 dpc dorsal telencephalon of Sox2f3geol+ mice. 
Although the numbers of oligodendrocytes do not change significantly between the 
two cultures, neurospheres that have undergone selection generate more mature 
oligodendrocytes (A) than non-selected neurospheres (B) as revealed by 
immunofluorescence staining using the 04 antibody. More TuJl positive neurons are 
seen in non-selected neurospheres (D) than in selected neurospheres (C). Scalebars 
represent 100pm.
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4.2.1.2 Differences in proliferation
BrdU incorporation assays on neurosphere-derived cells indicate higher levels of 
proliferation in neurosphere populations that have been selected for the expression of 
Sox2J3geo compared to neurospheres that have not undergone selection (Table 4.1).
Table 4.1 Proliferation in selected and non-selected neurospheres. BrdU 
incorporation was used as an indicator of proliferation and was expressed as a 
percentage of BrdU labelled cells of the total cells in the population. More cells in 
neurospheres selected for Sox2j3geo expression incorporate BrdU than cells in 
neurospheres not selected for the expression of Sox2j3geo. The average percentage of 
the four repeats is highlighted in red. After angular transformation of the percentages 
(angle = arcsinVpercentage), a one-way analysis of variance test (ANOVA) was 
performed. In the ANOVA table: SS is sum of squares, df is degrees of freedom, MS 
is mean squares (ratio SS/df), F is F-statistics (ratios of the mean squares). The p- 
value generated is lower than 0.05, confirming that the two sets of experiments yield 
significantly different results (p-value in blue).
N eurosphere
Population
% BrdU +ve 
(repeat 1)
% BrdU +ve 
(repeat 2)
% BrdU +ve 
(repeat 3)
% BrdU +ve 
(repeat 4)
Average% 
BrdU +ve
S0X2®6"*
Selected
♦15.7% 16% 18% 14.2% 15.98%
Sox2/*eoJ+
Non-selected
12% 11.8% 13.6% 9.1% 11.63%
SUMMARY
G roups Count Sum A verage Variance
Selected 4 94.16 23.54 1.4784
Non-selected 4 79.56 19.89 2.891933
ANOVA
Source of 
Variation SS df MS F p-value F crit
Between Groups 26.645 1 26.645 12.19358 0.012953 5.987374
Within Groups 13.111 6 2.185167
Total 39.756 7
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Cells from neurospheres that have been maintained under selection for the expression 
of Sox2pgeo give rise to higher numbers of secondary neurospheres compared to 
non-selected primary neurosphere cells. On average 1.3% of cells (± 0.07%) give rise 
to secondary neurospheres after G418 selection whereas only 0.4% of cells (± 
0.11%) give rise to secondary neurospheres without selection.
4.2.1.3 Differences in the migration patterns of differentiating cells
The attachment of neurospheres on an adherent matrix and the removal of growth 
factors, results in the differentiation of the cells and their migration outward from the 
centre of the sphere. When neurospheres that have been maintained under selection 
for the expression of Sox2 undergo this induced differentiation (Figure 4.3 A), cells 
that migrate away from the neurosphere do so in a homogenous manner, forming an 
organised periphery. Cell-to-cell contact in this radius gives the appearance of a 
lattice structure. The migration patterns of Sox2Pgeol+ neurospheres not selected for 
the expression of Sox2 and of wild type neurospheres are more disorganised (Figure
4.3 B and C). In these, cells may predominantly migrate in single directions around 
the sphere and rarely appear to form organised lattice structures.
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Figure 4.3 Differentiation and subsequent X-gal staining in neurospheres derived 
from the 14.5 dpc dorsal telencephalon of Sox2^geol+ mice and selected (A) or not 
selected (B) for the expression of Sox2pgeo, and in neurospheres derived from wild 
type mice (C). More organised migration patterns are seen in the periphery of 
selected neurospheres (A) than in the other two conditions. Scalebar represents 
250pm.
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4.2.1.4 Differences in the gene expression profiles determined through microarray 
analysis
Differences in the gene expression profiles between cells positive and negative for 
the expression of Sox2 have been investigated through microarray analysis according 
to the experimental outline in Figure 4.4 and the microarray minimum information 
documents in Tables 4.2 and 4.3. Neurosphere cultures selected for the expression of 
Sox2j3geo were compared to neurospheres maintained in the absence of selection. 
Any significant differences in gene expression profiles can be attributed to the Sox2 
negative cells of non-selected neurospheres. It is possible that these cells have an 
influence on the gene expression profiles of the Sox2 expressing cells. General gene 
expression trends in these experiments conform with predictions generated from 
immunofluorescence and real-time PCR experiments previously performed (Figure 
4.1) e.g. Gfap is expressed at significantly higher levels in non-selected populations 
(average 6-fold increase in experiments performed using the Affymetrix Mouse 
430A chip and the Mm_SGC_Av2 2-colour spotted oligonucleotide array chip).
Figure 4.4 Microarray experimental outline of comparing Sox2^geol+ cultures +/- 
G418. Experiment to determine the differences between NSC-enriched neurospheres, 
which have been selected for the expression of Sox2j3geo and neurospheres from that 
have not been treated. Both the populations where derived from the dorsal 
telencephalon of 14.5 dpc Sox2^geol+ mice.
DT Neurospheres (+G418) DT Neurospheres (-G 418)
Neural Stem Cell-Enriched
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Table 4.2 MIAME: Comparing untreated neurospheres with NSC-enriched 
neurospheres using the spotted oligonucleotide platform_______________________
Experiment
Design
Type Normal neurospheres v Treated 
neurospheres (NSC enriched)
Experimental
Factors
Selection (for NSC enriched) or no 
selection of primary and subsequent 
secondary neurospheres for Sox2j3geo 
expression with neomycin (G418)
Number of 
Hybridisations
1 two-colour
Reference Sample None
Hybridisation
Design
Neural stem cell (NSC) enriched v non 
enriched neurosphere cultures, see diagram
Quality Control 3 replicates, one biological repeat, one 
dye-swap
Samples Origin 14.5 dpc murine dorsal telencephalon of 
Sox2^eol+ mice (MF1 outbred background)
Manipulation Mechanical tissue dissociation, culture in 
NPM as neurospheres. Continuous 
addition of neomycin (G418) after 72 
hours for NSC enriched sample, 2^ 
neurosphere generation on day 10, culture 
of2ry spheres for a further 7 days
Sample
Preparation
Extraction of total RNA using RNeasy 
Midi kit (Qiagen). DNase treatment using 
DNA-free (Ambion). One-cycle synthesis 
of cDNA using Transcriptor First Strand 
cDNA Synthesis kit (Roche)
Labeling Protocol Klenow labeling with Cy3 or Cy5
Hybridisation
Procedures
Parameters See Methods for overnight hybridisation 
and post-hybridisation washes protocols
Measurement
Specifications
Hardware
Information
Two-colour 428 scanner (Affymetrix), 
BioAnalyzer 2100 (Agilent Technologies) 
for RNA quality control and quantitation
Software
Information
ImaGene 4.0 (BioDiscovery), GeneSpring 
7.2 (Silicon Genetics)
Measurements
used
Data transformation: Dye swap. Per spot 
and per chip: intensity dependent 
normalisaion (Lowess). Lowess curve 
fitted to log-intensity versus log-ratio plot. 
40.0% of the data was used to calculate the 
fit at each point. This curve was used to 
adjust the control value for each 
measurement. Set measurements < 0.01 set 
to 0.01 (GeneSpring)
Array Design Platform Spotted oligonucleotide array
Type Mm_SGC_Av2: Mouse Known Oligo 
Array on CodeLink Activated Slides 
(Amersham Biosciences)
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Table 4.3 MIAME: Comparing untreated neurospheres with NSC-enriched 
neurospheres using the GeneChip platform__________________________________
Experiment
Design
Type Normal neurospheres v Treated 
neurospheres (NSC enriched)
Experimental
Factors
Selection (for NSC enriched) or no 
selection of primary and subsequent 
secondary neurospheres for Sox2pgeo 
expression with neomycin (G418)
Number of 
Hybridisations
2 one-colour
Reference Sample None
Hybridisation
Design
Neural stem cell (NSC) enriched v non 
enriched neurosphere cultures, see diagram
Origin 14.5 dpc murine dorsal telencephalon of 
Sox2^eol+ mice (MF1 outbred background)
Quality Control 2 replicates, repeated on another array 
platform (see later)
Samples Manipulation Mechanical tissue dissociation, culture in 
NPM as neurospheres. Continuous 
addition of neomycin (G418) after 72 
hours for NSC enriched sample, 2^ 
neurosphere generation on day 10, culture 
of 2^ spheres for a further
Sample
Preparation
Extraction of total RNA using RNeasy 
Midi kit (Qiagen). DNase treatment using 
DNA-free (Ambion)
Labeling Protocol Biotin labeling
Parameters Affymetrix ‘Eukaryotic Sample and Array 
Processing’ guide followed for all 
protocols (see Methods)
Hybridisation
Procedures
Hardware
Information
GenAmp PCR System 9700 (Applied 
Biosystems), GeneChip Hybridization 
Oven 640, GeneChip Fluidics Station 450 
and GeneChip Scanner (all Affymetrix). 
NanoDrop ND-1000 spectrophotometer 
(Labtek) and BioAnalyzer 2100 (Agilent 
Technologies) for RNA quality control and 
quantitation
Measurement
Specifications
Software
Information
GCOS (Affymetrix), GeneSpring 7.2 
(Silicon Genetics)
Measurements
used
Raw values after GC RMA Normalisation, 
per chip: normalise to 50th parcentile, per 
gene: normalise to median and data 
transformation: set measurements <0.01 
set to 0.01 (GeneSpring)
Array Design Platform Affymetrix GeneChip
Type Mouse 430A
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Sox2 expression remains at the same levels between the two populations, on both 
microarray platforms used. In the Affymetrix GeneChip platform, after GCRMA 
normalisation, the levels of Sox2 transcripts are higher in non-selected neurospheres 
but not over the 2-fold significance limit imposed (1.2-fold increase from 9,383 
arbitrary units in selected neurospheres to 11,181 in non-selected neurospheres), as 
are levels of expression of genes involved in myelination and nerve ensheathment. 
Compared to non-selected populations, selected Sox2^eol+ neurospheres show an 
increase in expression levels of genes classified by the Gene Ontology Consortium as 
being implicated in cell cycle (108 genes compared to 50 genes in non-selected 
populations, Figure 4.5). This observation suggests that higher levels of proliferation 
are taking place in pure Sox2 expressing populations, which was previously 
suggested by secondary neurosphere formation numbers and BrdU incorporation 
assays. Further inspection of the ontologies mentioned, reveals that a large 
proportion of the genes expressed at significantly higher levels in neurosphere 
populations enriched for neural stem cells, are involved in double-strand break repair 
of DNA and are mainly expressed in the second growth phase of the cell cycle (G2)
Figure 4.5 Gene Ontology classifications of microarray results. Pie charts depicting a 
break down of the categories of the Gene Ontologies classification of genes involved 
in the regulation of the cell cycle, for genes expressed 2-fold significantly higher in 
either selected (B) or non-selected Sox2^geo/+ neurospheres (A). More genes are 
involved in these processed in selected neurospheres (108) compared to non-selected 
(50). The key can be found on the side of each pie chart.
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Cell cycle associated genes expressed over 2-fold higher in S ox2^ eo/+ 
neurospheres than S ox2^ eo/+ selected neurospheres
■  GO:74: regu lation  of 
p ro g re s s io n  th rough  cell 
cycle
(24 g e n e s )
□  GO:278: mitotic cell 
cycle
(9 g e n e s )
□  GO:279: M p h a s e  
(8 g e n e s )
■  G O :51321: m eiotic cell 
cycle
(5 g e n e s )
■  G O :7113: endom ito tic  
cell cycle
(2 g e n e s )
□  GO:67: DNA replication 
an d  c h ro m o s o m e  cycle 
(1 g e n e)
■  G O :51325: in te rp h a se  
(1 g en e)
Cell cycle associated genes expressed over 2-fold higher in Sox2^ eo/+ 
selected neurospheres than Sox2^geo/+ neurospheres
GO:7049: cell cycle
■  GO:278: mitotic cell 
cycle
(39 g e n e s )
□  GO:74: regulation  of 
p ro g re ss io n  through  cell 
cycle
(38 g e n e s )
□  GO:279: M p h a s e  
(34 g e n e s )
■  G O :7049: cell cycle 
(25 g e n e s  not further 
c lassified )
B  G O :51325: in te rp h ase  
(6 g e n e s )
□  G O :51321: m eiotic cell 
cycle
(4 g e n e s )
■  G O :7098: c en tro so m e  
cycle
(2 g e n e s )
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Validation confirms that the results generated from these and the remaining 
microarray experiments in this thesis can be reproduced through semi-quantitative 
RT-PCR and quantitative real-time RT-PCR (qRT-PCR) for specific genes, and can 
also be reproduced using independent RNA samples. Examples of this validation 
using qRT-PCR can be found in Figure 9.2.1 of the Appendix.
4.2.2 Effects on the NSCs, of varying the numbers of cells that express Sox2 within 
the neurosphere microenvironment
Cells that are not expressing Sox2 and which do not show neurosphere-forming 
potential in culture may have a role in maintaining the stem cell niche. When 
Sox2^geol+ neurospheres cultured with G418 are removed from selection, Sox2 non­
expressing cells emerge. To investigate the effects of the neurosphere composition 
with respect to Sox2 expression on NSCs, an experimental outline was developed 
(Figure 4.6) in order to assess neurosphere formation in the presence and absence of 
selection, i.e. in the presence and absence of Sox2 positive cells.
Initial selection appears to be important in the maintenance of high numbers of neural 
stem cells. When the selection is removed in the subsequent generation as in D, higher 
neurosphere numbers may form due to the withdrawal of G418 cytotoxicity. 
However, tertiary neurospheres from these populations that form at a higher 
percentage (H) imply that the Sox2 negative cellular component within the 
neurosphere encourages stem cell enrichment. This is surprising as in primary 
neurospheres, where the neurosphere-forming stem cells reside in the Sox2 expressing 
component, G418 selection of Sox2^geol+ NSC cultures provides enrichment for stem 
cells. The reasons as to why population H has a higher neurosphere-forming
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component have not been investigated. The stem cells giving rise to tertiary 
neurospheres are unlikely to reside in the Sox2 non-expressing component, so it seems 
that higher numbers of Sox2 expressing cells retain their stem cell properties in the 
presence of a more differentiated population. These results indicate that the initial 
stem cell microenvironment can have a significant influence on the stem cells and 
their future progeny even after passaging. In this situation, the differences in the niche 
have been dictated by whether cells express Sox2 or not. This is also known to 
influence differentiation into the three neural lineages. Thus, changes in the 
neurosphere microenvironment with respect to differentiated cell types, affects stem 
cell properties.
In order to assess whether the differentiation of secondary neurospheres that have 
been cultured in the absence of selection from primary neurospheres maintained under 
selection is similar to that of neurospheres that have never been selected, the 
neurospheres from conditions C, D, E and F were differentiated for 5 days. Secondary 
neurospheres generated as in D differentiate in a similar way to primary and 
secondary neurospheres A and C, which have been cultured under selection. They 
generate a low number of TuJl positive neurons and show a regular lattice formation 
in the periphery of the neurosphere, which arises from cells that migrate away from 
the centre and differentiate. Secondary neurospheres cultured in the absence of 
selection generated from similar primary neurospheres as in F, exhibit typical 
differentiation patterns for non-selected Sox2^eol+ neurospheres, such as those 
differentiating from condition B. However, secondary neurospheres from condition E, 
cultured with G418 selection show lower levels of differentiation into neurons than in 
F, but higher than in A, C or D. These observations suggest that pressure to maintain
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the expression of Sox2/5geo as in E, restricts but does not completely inhibit
differentiation into neurons. This may be the case, as cells that have stopped 
expressing Sox2 prior to selection and have initiated neurogenesis, would not survive 
the G418 treatment.
Figure 4.6 Varying the selection for Sox2j3geo in subsequent neurosphere generations. 
This was performed on dorsal telencephalon neurospheres from 14.5 dpc Sox2^eo,+ 
mice. Flow chart (A’): blue panels (B, D, F, G, H, I and J) indicate the absence of 
selection and grey panels (A, C and E) indicate selection with G418. The results of 
how many neurospheres were generated in each condition are shown as percentages 
on the panels, calculated in Table 4.4. The outline for the experiment is shown in B \
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Table 4.4 Neurosphere counts for the experiment outlined in Figure 4.6. Neurosphere 
forming units are expressed as a percentage of the total number of cells plated in each 
condition.
Condition Cells plated Neurospheres
counted
Neurosphere 
forming units %
2ry +G418-»+G418(C) 1.2 x 106 6146 0.5
2ry +G418-* -G418 (D) 1.2 x 106 3675 1.23
2ry -G418-> +G418 (E) 3.5 x 106 2128 0.24
2ry -G418-> -G418 (F) 3.5 x 106 2744 0.31
3ry from C (G) 1.5 xlO5 3525 2.35
3ry from D (H) 1.5 x 105 8066 5.37
3ry from E (I) 1.5 x 105 219 0.15
3ry from F (J) 1.5 xlO5 525 0.35
4.3 Discussion
4.3.1 Comparisons between neurospheres that have or have not undergone 
selection for the expression of Sox2
4.3.1.1 Differences in differentiation into glia, neurons and oligodendrocytes 
Differentiation of Sox2^geol+ neurospheres cultured with or without G418 reveals that 
more GFAP positive astrocytes derive from neurospheres that have not undergone 
selection (section 4.2.1.1). This effect may not just be due to the differentiation of the 
Sox2 negative cells. More GFAP positive cells are present in the non-selected versus 
selected neurospheres during proliferation, as confirmed through FACS analysis, and 
in the non-selected population, the number of GFAP positive cells is higher than the 
average total number of SOX2 negative cells (up to 70% GFAP positive versus 20- 
30% SOX2 negative). It is possible that Sox2 negative cells influence the Sox2
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expressing component, an effect which would be absent in the stem cell-enriched, 
selected neurospheres (also demonstrated in section 4.2.2). RT-PCR shows that the 
levels of Gfap transcripts are higher in the non-selected neurospheres. However, 
FACS analysis reveals that there are two distinct GFAP positive cell types, with either 
high or low expression, in both selected and non-selected neurospheres, so any 
quantitative analysis needs to take into account their relative potential. If as proposed 
in the literature, Gfap expressing cells can have distinct NSC or astrocytic characters, 
the two distinct populations differentiated by FACS sorting could correspond to these. 
There is evidence to suggest that LIF-mediated signaling promotes Gfap positive 
NSCs and that BMP mediated signaling through BMP4 leads to Gfap positive 
astrocytes (Bonaguidi et al. 2005). As will be demonstrated in Chapter 5, St at3 has 
been identified as a candidate NSC marker, which is in agreement with the notion that 
LIF promotes a NSC fate. Furthermore, from the microarray analysis performed in 
this chapter between Sox2/3geo selected and non-selected populations (section 
4.2.1.4), non-selected cultures where found to express higher levels of Bmp4 than 
selected neurospheres (3.75-fold difference), consistent with the high proportion of 
astrocytes seen by immunofluorescence in Sox2j3geo non-selected cultures and by the 
increased levels of Gfap determined through RT-PCR.
The observation that non-selected neurospheres give rise to higher numbers of 
neurons compared to very few and sometimes no neurons in differentiating cultures 
from selected neurospheres (Figure 4.2) suggests that the Sox2 negative cells are 
mainly responsible for neurogenic differentiation. Indeed it has been previously 
suggested that the absence of Sox2 promotes neurogenesis (Kondo and Raff 2000).
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No differences in the numbers of oligodendrocyte generation were observed between 
selected and non-selected neurospheres derived from the dorsal telencephalon. 
However cells with a more mature oligodendroglial morphology were observed with 
those originally in selection than without (Figure 4.2). Repeating the same 
experiments using spinal cord-derived cultures, a clear increase in the numbers of 
oligodendrocytes was seen from non-selected cultures, which could again be 
attributed to the presence of the Sox2 negative component.
These results highlight both intrinsic regional differences and the possibility that more 
differentiated cells can influence fate choices made by the stem cells (or vice versa). It 
is likely that in non-selected neurospheres the influence on Sox2 expressing cells by 
the Sox2 negative component prevents maturation of oligodendrocytes or terminal 
differentiation, whereas this influence is absent in selected neurospheres. This 
speculation does not correlate with data yielded from the spinal cord cultures 
(demonstrated in Chapter 5), highlighting potential regional differences in the 
intrinsic differentiation mechanism. When dissociated into single cells, both selected 
and non-selected cultures give rise to secondaiy neurospheres. Therefore, both of 
these cultures meet the requirements for containing self-renewing, multipotent NSCs. 
This leads to the conclusion that the composition of the Sox2 negative component 
may be responsible for creating an influential microenvironment for the NSCs. This 
affects differentiation capacity and potential, as well as proliferation, as demonstrated 
by the experiments in this chapter that have studied the effects of varying the 
composition of the neurosphere with respect to Sox2 expression status.
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4.3.1.2 Differences in the migration patterns o f differentiating cells
The migration of cells away from the neurosphere under differentiation conditions 
highlights the differences between selected and non-selected Sox2^eol+ neurospheres 
(Figure 4.3). The disorganised migration seen in non-selected neurospheres is similar 
to that of wild type cultures, suggesting that the Sox2^geol+ selected neurosphere has a 
more homogenous array of cell types migrating away from the centre. A similar 
organised lattice arrangement has been described by Conti and co-workers, generated 
by ES-derived homogenous populations of radial glial-like cells (Conti et al. 2005). 
Sox2^eol+ selected neurospheres are enriched for cells expressing radial glial markers 
(Remboutsika et al, unpublished data), which may explain this phenotype. Given that 
radial glia have been described as stem cells in the embryonic brain (Alvarez-Buylla 
et al. 2001; Campbell and Gotz 2002; Doetsch 2003; Kriegstein and Gotz 2003), these 
findings combined withjiigher numbers of NSCs in the selected neurospheres indicate 
that a higher proportion of radial glia may be found in neurospheres derived from the 
dorsal telencephalon and maintained under selection for the expression of Sox2j3geo.
4.3.1.3 Differences in the gene expression profiles determined through microarray 
analysis
Microarray analysis to investigate differences between the selected and non-selected 
Sox2^geol+ neurosphere populations generated similar results from both the spotted 
oligonucleotide and the GeneChip platforms (section 4.2.1.4). For a more detailed 
bioinformatic analysis of the results, the GeneChip array data were used as they 
incorporate a much larger number of genes, are more reliable due to the unique 
specific and mismatch probe system and have updates available for the annotations of 
the sequences (the Mm_SGC_Av2 chips have been discontinued). Considering the
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stem cell-enriched population has more cells that express Sox2 than the non-selected 
population, we would expect it to show a bias towards higher relative levels of Sox2. 
Surprisingly however, this has not been the case in either platform and in all 
replicates. It is a fact that more cells are expressing Sox2 in the selected cultures; 
hence the levels of expression of Sox2 in the Sox2-expressing cells of the non-selected 
cultures must be proportionately higher. This may be due to underlying differences in 
the cell types composing the neurosphere, for example an increased number of highly 
S0jc2-expressing astrocytes in the non-selected neurospheres compared to an increased 
number of radial glia in the selected neurospheres. The large group of genes involved 
in cell cycle control and promoting mitosis, seen at significantly elevated levels in 
Sox2 selected neurospheres suggests that a higher proportion of cells are undergoing 
mitosis, hence proliferation in this population is increased, as other functional assays 
in this chapter have suggested (Figure 4.5, also section 4.2.1.2). Differences were also 
seen in the expression of components that may be involved in maintaining the NSC 
niche. Several genes responsible for the production of laminin {Lamb 1-1, Lamcl, 
Lama4, LamaS) are expressed at significantly higher levels (over 2-fold expression) in 
NSC-enriched neurosphere populations. Similarly, genes controlling the expression of 
collagen {Colllal, Col4a6, Col4a3bp, Col4a5, Col9al) are preferentially expressed 
at higher levels in non-enriched populations suggesting that non-NSC’s, in the 
neurosphere produce more collagen than laminin. In NSC-enriched populations, Itgbl 
is expressed over 2-fold higher that in the non-selected population. This gene encodes 
P1 -integrin, a receptor of laminin and fibronectin. The expression of pl-integrin has 
been proposed to mark NSCs although its expression is not required for the growth of 
neurospheres (Leone et al. 2005). Similarly, the levels of expression of Tnc are 
significantly increased in NSC-enriched neurospheres. Tnc has been identified as a
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NSC candidate gene in Chapter 5, being expressed at significantly higher levels in 
neurosphere populations of the dorsal telencephalon and spinal cord compared to their 
respective tissues of origin. These results suggest that NSCs are responsible for the 
production of components associated with positive regulation of NSCs in their niche.
4.3.2 The effects, of varying the numbers of cells that express Sox2, within the 
neurosphere microenvironment, on the NSCs
Selection for the expression of Sox2f3geo impacts on the subsequent fate of cells 
within neurospheres. Experiments involving consecutive periods of selection and no 
selection with successive passaging of neurospheres were used to establish if the 
composition of the neurosphere had an effect on stem cell potential. From these 
experiments, it is clear that an initial selection for Sox2/3geo in primary neurospheres 
results in an overall enrichment for NSCs in subsequent cultures, irrespective of 
downstream selection. However in subsequent generations, selection for Sox2/3geo 
does not necessarily result in enrichment. It appears that when pure Sox2^geo,+ 
populations are cultured as secondary and tertiary neurospheres with the removal of 
selection, they are able to give rise to higher proportions of neurosphere-forming 
cells. One hypothesis is that the cytotoxicity of G418 used to select for Sox2pgeo 
expressing cells, is compromising the full potential of the neural stem cells in these 
cultures. This hypothesis has not been tested, but can be done so using cells from 
mice ubiquitously expressing a neomycin resistance gene in the ROSA26 locus. 
Primary neurospheres from these mice can be grown with or without G418, which 
will not have an impact on the cellular composition of the neurospheres as all cells are 
resistant. The generation of a secondary neurosphere population from these cells and 
an assessment of their neurosphere-forming capacity would be sufficient to determine
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if G418 is responsible for lower neurosphere formation when comparing populations 
with or without G418 that are derived from primary neurospheres treated in the same 
way. Reservations for this experiment are that strain-specific differences may impair 
the results and an MF1 out-bred background (as is the background of the Sox2/3geo/+ 
mice used) ubiquitously resistant to neomycin should be used if possible. If G418 
cytotoxicity is responsible for the compromised ability to generate neurospheres, 
further experiments will be necessary to determine if the extended culture of a pure 
population of Sox2 expressing cells results in NSC enrichment. The current results 
suggest that NSCs have a long-term requirement for Sox2 non-expressing cells to 
maintain their stem cell status.
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CHAPTER 5
Identification of candidate genes that mark neural stem cells
5.1 Background
5.1.1 Comparisons between CNS neurospheres
In Chapter 3, characterisation of neurospheres from the dorsal telencephalon of 14.5 
dpc mice was performed. In this chapter, these neurospheres will be compared to
14.5 dpc spinal cord neurospheres in order to obtain information that will lead to the 
identification of candidate genes that commonly define several populations of neural 
stem cells. As established in Chapter 4, selection for the expression of Sox2^eo leads 
to enrichment in the numbers of NSCs in culture. Hence, the culture of Sox2^eo/+ 
neurospheres under G418 selection will be employed in all further studies.
5.1.2 Formation o f brain and spinal cord- changes in properties o f NSCs
During gastrulation, the neural plate is patterned from a portion of the ectoderm. The 
ventral part of the ectoderm is induced to become epidermis, in response to BMP 
signalling, which blocks neural differentiation. BMP inhibitors, such as noggin, 
chordin and follistatin, produced by the organizer, lead to the specification of neural 
tissue, as this portion inhibits BMP signals. In vertebrates, the neural plate is initially 
composed of a population of neural progenitors with uniform capabilities in their 
properties i.e. their fate. However, they may have already acquired anterior-posterior 
patterning. During primary neurulation, the ectoderm becomes divided into the 
externally positioned epidermis of the skin, neural crest cells and the neural tube. For 
the formation of the latter, proliferation in the cells of the neural plate (in the dorsal 
part of the ectoderm) ceases to be uniform, resulting in folding to form the neural
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groove and subsequent closure of the neural folds to form the neural tube. The rostral 
neural tube forms three brain vesicles: the prosencephalon (forebrain), from which 
the telencephalon and diencephalon later form, the mesencephalon (midbrain) and 
the rhombencephalon (hindbrain), from which the metencephalon and the 
myelencephalon later form. At this three-vesicle stage, the brain flexes at the 
junction between the hindbrain and the caudal neural tube, which is the prospective 
spinal cord (cervical flexure) and at the midbrain-hindbrain junction (cephalic 
flexure). Later, another flexure, called the pontine flexure, develops between the 
cephalic and cervical flexures. The cephalic flexure is the only one that remains 
prominent throughout development and causes the longitudinal axis of the forebrain 
to differ from that of the brain stem and spinal cord.
Figure 5.1 Cartoon depicting the major regional specifications of the murine CNS at 
11.5 dpc. Each region has been coloured separately: purple- telencephalon, blue- 
diencephalon, green-metencephalon, orange-myelencephalon, yellow-spinal cord.
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Figure 5.2. Cartoon outlining the major stages in the formation of the neural tube, 
based on chick development.
Migrating neural
Neural tube
Somite
Neural plate
Elevation
Key
n Neural Plate 
Neural C rest 
Ectoderm 
M esoderm 
Endoderm 
Notochord
Convergence
Lateral 
plate me-
Meoial neural
Folding
Paraxial mesoderm
Closure
Shaping
crest cells
Dorsolateral 
hinge point
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Table 5.1 Outline of the derivatives of the three major domains of the ectoderm germ 
layer (adapted from (Gilbert 2000)).
Epidermis (outer ectoderm)
Epidermis
Hair
Nails
Sebaceous glands
Olfactory epithelium
Mouth epithelium
Lens, cornea
Otic vesicle
Neurogenic placodes
Cranial ganglia
Neural crest
Peripheral nervous system
Enteric nervous system
Melanocytes
Facial cartilage/bone/muscle
Dentine
Adrenal medulla
Neural tube
Brain
Posterior pituitary
Spinal cord
Motor neurons
Retina
Table 5.2 Summary of the mature adult structures derived from the embryonic CNS 
(adapted from (Kandel et al. 2000)).
Structure at five- 
vesicle stage
Major derivatives
Related
cavity
Telencephalon
Cerebral cortex, basal ganglia, hippocampal 
formation, amygdala, olfactory bulb
Lateral
ventricles
Diencephalon
Thalamus, hypothalamus, subthalamus, 
epithalamus, retina, optic nerves & tracts
Third
ventricle
Mesencephalon
Midbrain Cerebral
aqueduct
Metencephalon Pons and cerebellum Fourth
ventricleMyencephalon Medulla
Caudal neural tube
Spinal cord Central
canal
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During the development of the nervous system in the mouse, a period of extensive 
cellular proliferation is followed by a period of enhanced neurogenesis (~ 13.5 dpc) 
and later gliogenesis (-17.5 dpc). Patterning of the neural tube results in spatially 
well-defmed areas of specialised differentiation of neuroepithelial precursors into 
neurons. In the adult mouse, several hundreds of distinct neuronal cell types are 
thought to exist. Proneural factors such as the bHLH neurogenin proteins play an 
important role in NSC fate decisions. They promote expression of neuronal 
differentiation genes, activate neuronal subtype genes, promote cell-cycle exit and 
inhibit glial differentiation by suppressing glial-specific genes such as Gfap. This 
commitment to precursor or terminally differentiated cells leads to the progressive 
restriction of zones where undifferentiated neural stem cells can be found. In the late 
mouse embryo, regions lining the ventricles and cavities throughout the CNS are rich 
in proliferating cells, the most abundant being the dorsal telencephalon. In the adult, 
the proliferative regions in the brain are restricted to the subventricular zone of the 
lateral ventricles and to the subgranular layer of the dentate gyrus in the 
hippocampus.
In this study, similarities between spatially different progenitor populations have 
been investigated, in order to identify genes that are important in the stem cell state. 
Alongside the intrinsic programming of NSCs, the influence of environmental cues 
on these populations has been taken into account. If neural stem cells are able to 
retain properties arising from the impact of environmental cues, their unique 
differentiation patterns will be reflected in culture.
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5.2 Results
5.2.114.5 dpc spinal cord neural stem cells
5.2.1.1 Localisation of Sox2 expressing cells in the spinal cord
The proliferating NSCs are thought to reside in the ependymal layer surrounding the
central canal of the spinal cord. Immunofluorescence staining using antibodies
against SOX2 reveals that cells expressing Sox2 are found mainly in the ependymal
layer and SOX2 localises in the nucleus of these cells (Figure 5.3). Isolated SOX2
immunoreactive cells are also sometimes seen in the tissue surrounding the
ependymal layer but their incidence is low.
Figure 5.3 Immunofluorescence staining for SOX2 on a section through the 14.5 dpc 
spinal cord. SOX2 localises in the nucleus of cells in the ependymal layer (ep). The 
part of the spinal cord shown is indicated by the blue box in the cartoon, where D is 
dorsal, V is ventral, cc is central canal and nc is notochord. Scalebar represents 
lOOjum.
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5.2.1.2 Generation o f neurospheres from the 14.5 dpc spinal cord
For the generation of neurospheres derived from the 14.5 dpc spinal cord, whole 
spinal cords were dissociated and cultured under optimal conditions as determined in 
Chapter 2. Only 0.2% of cultured spinal cord cells at 14.5 dpc generate neurospheres 
in culture. The inclusion of many cells in the culture that lie outside of the restricted 
proliferative ependymal zone is likely to be responsible for this reduced proportion 
of neurosphere generating cells compared to 14.5 dpc dorsal telencephalon. 
Preliminary results of spinal cord culture at different embryonic stages reveal that 
similar neurosphere formation levels to the 14.5 dpc dorsal telencephalon cells can 
be obtained using 11.5 dpc spinal cords where the proportion of undifferentiated cells 
is likely to be much higher.
5.2.1.3 Proliferation marker analysis o f spinal cord neurospheres
The majority of cells in stem cell-enriched Sox2^geol+ neurospheres express SOX2 
and Nestin as shown by immunofluorescence staining (Figure 5.4 B and C). Ssea-1, 
which is used as a brain stem cell-specific marker, is not expressed in these cultures 
(Figure 5.4 A). This result highlights differences in stem cells isolated from different 
regions, and should be taken into account when aiming to identify ubiquitous neural 
stem cell-specific genes. But this also highlights regional differences and anterior- 
posterior patterns already established, and that cells have a memory that reflects their 
region of origin.
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Figure 5.4 Immunofluorescence staining in neurospheres derived from the 14.5 dpc 
spinal cord of Sox2J3geol+ mice that have been selected for Sox2j3geo expression. Cells 
are immunoreactive for SOX2 (B) and Nestin (C), which co-localise. Ssea-1 levels 
are not detectable (A). Scalebar represents 100pm.
5.2.1.4 Differentiation marker analysis o f spinal cord neurospheres 
Differentiation analysis of 14.5 dpc stem cell-enriched spinal cord cultures confirms 
their potential to form neurons, glia and oligodendrocytes. Neurons are often seen in 
the main body of the sphere, but rarely in the periphery. Neurospheres that have been 
selected for the expression of Sox2^eo, differentiate to give TuJl positive neurons 
with long axons, in contrast with TuJl positive neurons differentiating from Sox2^eo 
selected neurospheres from the dorsal telencephalon.
5.2.2 Selection of candidate neural stem cell markers
By analysing the gene expression patterns of several neural stem cell populations, it 
was hoped that we could establish similarities that could be attributed to their stem 
cell character. Comparisons between different NSC populations will highlight many 
similarities between them, other than the expression of genes unique to neural stem 
cells, such as similar expression of housekeeping genes and genes required for 
metabolic pathways. Such genes can be partly eliminated through the use of a non­
stem cell reference. As well as identifying similarities, these comparisons will also 
highlight differences between the populations, including some that define the regions 
and stages from which the NSCs where originally isolated.
5.2.2.1 Direct and indirect comparisons o f NSCs using a reference sample: spotted 
oligonucleotide array platform
As a pilot study to test this experimental approach, 14.5 dpc Sox2^eol+ dorsal 
telencephalon and spinal cord-derived neurospheres selected with G418 were 
indirectly compared through pair-wise analysis using a reference sample. The 
reference sample selected was 14.5 dpc whole CNS tissue from MF1 out-bred mice. 
In order to recruit additional cell populations in the study for future comparisons, a
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highly reproducible reference sample was chosen. The similarities between the dorsal 
telencephalon (DT) and spinal cord (SC) cultures were compared indirectly (DT v 
reference, SC v reference) and directly (DT v SC) as outlined in Figure 5.5 and based 
on the parameters outline in the microarray minimum information document outlined 
in Table 5.3.
Figure 5.5 Microarray Experimental Outline of a pilot experiment to determine 
candidate factors of NSCs. Neurospheres from the dorsal telencephalon and from the 
spinal cord of 14.5 dpc Sox2^geol+ mice where selected for the expression of 
Sox2J3geo for NSC enrichment. These two populations where compared directly and 
indirectly through a reference sample (14.5 dpc CNS).
DT N eurospheres (+G418) SC N eurospheres (+G418)
Reference
121
Table 5.3 MIAME: Determining NSC canc idates using the spotted platform (A)
Experiment
Design
Type Cultured NSCs from spinal cord v 
Cultured NSCs from dorsal telencephalon
Experimental
Factors
Neurosphere culture of neural stem cells 
and enrichment for NSCs through 
selection for Sox2pgeo expression
Number of 
Hybridisations
3 two-colour
Reference Sample 14.5 dpc whole CNS (wild type MF1 
outbred)
Hybridisation
Design
Indirect: Dorsal telencephalon 
neurospheres v reference, spinal cord 
neurospheres v reference, Direct: dorsal 
telencephalon neurospheres v spinal cord 
(see diagram)
Quality Control 3 replicates, one independent cDNA 
synthesis with amplification, one dye- 
swap of for unamplified synthesis.
Samples Origin 14.5 dpc dorsal telencephalon, 14.5 dpc 
spinal cord of Sox2^eol+ mice (MF1 
outbred background)
Manipulation Mechanical tissue dissociation, culture in 
NPM as neurospheres. Addition of G418 
after 72h for 15 days
Sample
Preparation
Extraction of total RNA using RNeasy 
Midi kit (Qiagen). DNase treatment using 
DNA-free (Ambion). Direct synthesis of 
cDNA using Transcriptor First Strand 
cDNA Synthesis kit (Roche), cDNA 
synthesis with amplification using 
SMART PCR cDNA Synthesis Kit 
(Clontech)
Labeling Protocol Klenow labeling with Cy3 or Cy5
Hybridisation
Procedures
Parameters See Methods for overnight hybridisation 
and post-hybridisation washes protocols
Measurement
Specifications
Hardware
Information
Two-colour 428 scanner (Affymetrix),
Bio Analyzer 2100 (Agilent Technologies) 
for RNA quality control and quantitation
Software
Information
ImaGene 4.0 (BioDiscovery), GeneSpring 
7.2 (Silicon Genetics)
Measurements
used
Per spot and per chip: intensity dependent 
normalisaion (YASMA). Data 
transformation: Dye swap. Set 
measurements less than 0.01 in the control 
channel were set to 0.01 (GeneSpring)
Array Design Platform Spotted oligonucleotide array
Type Mm__SGC_Av2: Mouse Known Oligo 
Array on CodeLink Activated Slides 
(Amersham Biosciences)
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For efficient microarray interpretation using spotted oligonucleotide arrays, 3 
replicates are normally performed for each sample to ensure the validity of the 
results. cDNA is synthesized from total RNA samples and at least one independent 
synthesis reaction is performed, that can serve as one replicate, preferably using an 
independent RNA source. The most likely source of variation in microarray 
experiments is between biological replicates, as variation between technical 
replicates is unlikely if experiments are performed in parallel. Each cDNA sample is 
labelled with either Cy3 or Cy5 and hybridised onto the chip alongside the sample it 
will be compared to, which has been labelled with the alternate dye. To ensure no 
dye bias in the hybridisations, a dye-swap was performed, an example of which, 
taken from the hybridisations performed for this experiment, is shown in Figure 5.6. 
Limitations in the RNA yield for this set of experiments made it necessary to use a 
method of cDNA synthesis that employs amplification (SMART cDNA synthesis), 
which served as the independent replicate. This also provided a means to assess the 
reliability of amplified cDNA compared to direct cDNA synthesis.
Using different methods to generate cDNA should not affect the end result, given 
that the same RNA template was used. However, studying replicates with and 
without amplification demonstrated that these two methods are not comparable 
within this study. Comparisons between amplified and unamplified cDNA 
hybridisations for all targets resulted in little overlap in the genes that were 
significantly expressed at higher or lower levels compared to a reference target. The 
highest number of genes shared between candidate lists generated by the two 
different methods was 25 in a total sample size of 7,500. This led to the conclusion 
that the amplified results cannot be taken into consideration, as error muse have been
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introduced during the amplification (PCR amplification cycles range from 25 to 32). 
This left an insufficient number of replicates to conclude the study. However, as the 
similarities between the two populations were of direct interest, and the differences 
less so, this pilot study highlighted an experimental flaw: the expression of over 
5,000 genes remained significantly similar between the two populations, which are 
too many to process in order to identify NSC candidates.
Figure 5.6 Outline of a dye-swap experiment. The two samples (‘sample’ and 
‘reference’) are labelled with Cy3 or Cy5 in one hybridisation and the reciprocal in 
the other. The individual grids from two chips illustrate the dye swap. Spots to which 
‘sample’ probe preferentially hybridises to is green in A and red in B (white arrows). 
When both probes show the same affinity for a spot it is yellow. Blue arrows indicate 
control spots of only Cy3 (landing lights), which serve as hybridisation controls.
S a m p le  R eference S a m p le  R e fe re n ce
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5.2.2.2 Comparing enriched-NSC neurospheres to their tissue o f origin: spotted 
oligonucleotide array platform
A very large number of genes were commonly expressed at significantly high levels 
between neurosphere populations in the previous study. To refine this list of genes 
that potentially define NSCs, one approach is to introduce an increasing number of 
different neurosphere populations as regional and temporal differences are bound to 
reduce the similarities. However an alternative approach was taken to identify genes 
commonly expressed between neural stem cell populations. When compared to their 
tissue of origin, stem cell-enriched neurospheres should exhibit higher levels of 
expression for genes important in neural stem cells. Therefore, the experimental 
design was changed to compare neurospheres populations to their respective tissue of 
origin. To minimise error, the cDNA was synthesised without amplification. The 
Mm_SGC_Av2 spotted oligonucleotide arrays were again used for these 
experiments. Labeled cDNA generated from RNA of the 14.5 dpc Sox2J3geot+, G418- 
selected dorsal telencephalon neurospheres was hybridised against cDNA from 14.5 
dpc dorsal telencephalon tissue. Similarly, labeled cDNA generated from RNA of the
14.5 dpc Sox2^geol+, G418-selected spinal cord neurospheres was hybridised against 
labeled cDNA generated from RNA of 14.5 dpc spinal cord tissue, as outlined in 
Figure 5.7 and according to the parameters summarised in Table 5.4. Genes whose 
expression level was two-fold higher in each neurosphere population compared to the 
tissue of origin were considered significantly different. These were short-listed for 
each of the neurosphere and spinal cord samples and the overlapping genes from 
both of these shortlists from the neurosphere populations were identified as candidate 
intrinsic factors, important in neural stem cells (Figure 5.8). These 48 candidate 
markers are listed in Figure 5.10 and are classified based on their molecular function.
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Figure 5.7 Microarray Outline to determine candidate markers of NSCs. Sox2j3geo- 
selected neurospheres (NSC enriched) from the dorsal telencephalon (DT) and from 
the spinal cord (SC). They where compared directly to their tissue of origin and 
genes significantly higher in both populations compared to their respective tissue 
where short-listed as NSC candidates.
SC Neurospheres (+G418)DT Neurospheres (+G418)
Identify Similarities 
in Gene Expression 
Profiles
DT Tissue SC Tissue
Table 5.4 MIAME: [Determining NSC candidates using the spotted platform (B)
Experiment
Design
Type Cultured cells v Tissue of origin
Experimental
Factors
Neurosphere culture of neural stem cells 
and enrichment for NSCs through 
selection for Sox2j3geo expression. Tissue 
of origin of neurosphere cultures 
remained untreated
Number of 
Hybridisations
2 two-colour
Reference Sample None
Hybridisation
Design
DT neurospheres v DT tissue, SC 
neurospheres v SC tissue (see diagram)
Quality Control 3 replicates, one biological repeat, one 
dye-swap. Repeated with independent 
samples on another array platform (see 
later)
Samples Origin 14.5 dpc dorsal telencephalon, 14.5 dpc 
spinal cord of Sox2^geo,+ mice (MF1 out- 
bred background)
Manipulation For neurospheres: mechanical tissue 
dissociation, culture inNPM. G418 added 
after 72h for 15 days. For tissue: 
dissection and removal of membranes
Sample
Preparation
Extraction of total RNA using RNeasy 
Midi kit (Qiagen). DNase treatment using 
DNA-free (Ambion). One-cycle synthesis 
of cDNA using Transcriptor First Strand 
cDNA Synthesis kit (Roche)
Labeling Protocol Klenow labeling with Cy3 or Cy5
Hybridisation
Procedures
Parameters See Methods for overnight hybridisation 
and post-hybridisation washes protocols
Measurement
Specifications
Hardware
Information
Two-colour 428 scanner (Affymetrix),
Bio Analyzer 2100 (Agilent Technologies) 
for RNA quality control and quantitation
Software
Information
ImaGene 4.0 (BioDiscovery), GeneSpring 
7.2 (Silicon Genetics)
Measurements
used
Data transformation: Dye swap. Per spot 
and per chip: intensity dependent 
normalisaion (Lowess). Lowess curve 
fitted to log-intensity versus log-ratio plot. 
40.0% of the data used to calculate the fit 
at each point. The curve was used to 
adjust the control value for each 
measurement. Set measurements <0.01 
set to 0.01 (GeneSpring)
Array Design Platform Spotted oligonucleotide array
Type , Mm_SGC_Av2: Mouse Known Oligo 
Array on CodeLink Activated Slides 
(Amersham Biosciences)
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Figure 5.8 Overlap of candidate markers shared between 14.5 dpc dorsal 
telencephalon and spinal cord NSCs using data generated from experiments 
performed on the spotted microarray platform. Venn diagram outlining the overlap 
between the two gene lists generated on the Mm_SGC_Av2 spotted oligonucleotide 
platform. The 48 overlapping genes are short-listed as candidates for their 
significance in neural stem cells and are listed in Figure 5.9.
DT SC
7293 
all genes
128
Figure 5.9 Candidate markers shared between 14.5 dpc dorsal telencephalon and 
spinal cord NSCs. These genes were selected for future further investigation into 
their significance in neural stem cells. This list was generated by comparing 
candidates expressed higher in enriched stem cell populations of the spinal cord and 
of the dorsal telencephalon as described in Figures 5.7 and 5.8. Their Gene Ontology 
classification according to their known molecular function is indicated by colour. 
Known markers of committed progenitors/differentiating cells are included under 
one category (Differentiation markers). Genes with multiple function where only 
included in one category.
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5.2.2.3 Comparing enriched-NSC neurospheres to their tissue o f origin: Affymetrix 
GeneChip platform
The experiments described in section 5.2.2.2 were repeated using the Affymetrix 
Mouse 430A GeneChip arrays (22,690 genes), which are high-density 
oligonucleotide probe arrays. As stated in section 1.5, this type of platform is more 
reliable than spotted arrays and does not require the same level of technical 
repetition. Each sample was hybridised individually on one chip and different targets 
were compared digitally. One hybridisation was performed for each sample and 
independent samples from the previous experiment were used (acting as biological 
replicates for the genes investigated). Some genes on this platform are represented 
more than once by probe sets against independent sequences on the array. A larger 
list of candidates than for the spotted arrays was expected, reflecting the greater total 
number of genes (22,690 compared to 7,500 genes). GCRMA normalisation was 
performed using GeneSpring 7.2 and 7.3 (Silicon Genetics) software and the ‘Raw’ 
value data were used for all comparisons. Following the experimental outline in 
Figure 5.7 and using the parameters in Table 5.5, a list of 339 candidates of 
significance to neural stem cells was identified (535 prior to removal of duplicates, 
Figure 5.10) that had 2-fold significantly higher expression levels in the neurosphere 
populations compared to the tissue of origin, and that had expression levels of over 
100 arbitrary units to eliminate false-positives (maximum expression level reached in 
this experiment is 47,500 arbitrary units). To refine this list further, genes were 
filtered on expression levels of over 1,000 arbitrary units in order to obtain the 
highest expressing candidates. There are some genes, which are represented by more 
than one probe set on the arrays. These where manually removed, and after their 
exclusion, 96 candidates were short-listed, listed in Table 5.6.
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Table 5.5 MIAME: Determining NSC candidates using the GeneChip platform
Experiment
Design
Type Cultured cells v Tissue of origin
Experimental
Factors
Neurosphere culture of neural stem cells 
and enrichment for NSCs through 
selection for Sox2j3geo expression. Tissue 
of origin of neurosphere cultures remained 
untreated
Number of 
Hybridisations
4 one-colour
Reference Sample None
Hybridisation
Design
Dorsal telencephalon neurospheres v 
dorsal telencephalon tissue, spinal cord 
neurospheres v spinal cord tissue
Quality Control Repeated on another array platform (see 
later)
Samples Origin 14.5 dpc dorsal telencephalon, 14.5 dpc 
spinal cord of Sox2^eol+ mice (MF1 out- 
bred background)
Manipulation For neurospheres: mechanical tissue 
dissociation, culture in NPM as 
neurospheres. Addition of G418 after 72h 
for 15 days. For tissue: dissection and 
removal of membranes
Sample
Preparation
Extraction of total RNA using RNeasy 
Midi kit (Qiagen). DNase treatment using 
DNA-ffee (Ambion)
Labeling Protocol Biotin labeling
Hybridisation
Procedures
Parameters Affymetrix ‘Eukaryotic Sample and 
Array Processing’ guide followed for all 
protocols (see Methods)
Measurement
Specifications
Hardware
Information
GenAmp PCR System 9700 (Applied 
Biosystems), GeneChip Hybridization 
Oven 640, GeneChip Fluidics Station 450 
and GeneChip Scanner (all Affymetrix). 
NanoDrop ND-1000 spectrophotometer 
(Labtek) and BioAnalyzer 2100 (Agilent 
Technologies) for RNA quality control 
and quantitation
Software
Information
GCOS (Affymetrix), GeneSpring 7.2 & 
7.3 (Silicon Genetics)
Measurements
used
Raw values after GC RMA 
Normalisation, per chip: normalise to 50th 
parcentile, per gene: normalise to median 
and data transformation: set 
measurements < 0.01 set to 0.01 
(GeneSpring)
Array Design Platform Affymetrix GeneChip
Type Mouse 430A
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Figure 5.10 Overlap of candidate markers (prior to removal of duplicates) between 
14.5 dpc dorsal telencephalon and spinal cord NSCs using data generated from 
experiments performed on the Mouse 430A GeneChip platform.
SCDT
19748 
all genes
Table 5.6 Short-list of candidate markers. This list was determined from comparisons 
of NSC-enriched neurosphere populations to their tissue of origin, on the Mouse 
430A GeneChip platform. All genes are expressed significantly higher in the NSC- 
enriched populations with expression levels > 1,000 arbitrary units. They have been 
arranged in alphabetical order of their common gene name.
Gene Name Com m onName D escription
1448412 a at o o> o o o CO £ * RIKEN cDNA 0610009M14 gene
1423909 at 0610011 l04Rik RIKEN cDNA 0610011104 gene
1418004 a at 1810009M01Rik RIKEN cDNA 1810009M01 gene
1460344 at 2310033F14Rik pre-B-cell leukemia transcription factor interacting protein 1
1437671 x at 2310046G15Rik BB378796 RIKEN full-length enriched, 16 days embryo head
1428288 at 2310051E17Rik basic transcription element binding protein 1
1451385 at 2310056P07Rik RIKEN cDNA 2310056P07 gene
1426856 at 2610207l16Rik RIKEN cDNA 2610207116 gene
1452354 at 2810459M11Rik RIKEN cDNA 2810459M11 gene
1434542 at 4631422C05Rik RIKEN cDNA 4631422C05 gene
1416315 at Abhd4 abhydrolase domain containing 4
1448987 at Acad I acetyl-Coenzyme A dehydrogenase, long-chain
1416094 at Adam9 a disintegrin and metalloproteinase domain 9 (meltrin gamma)
1432466 a at Apoe apolipoprotein E
1434449 at Aqp4 clone:A330077C20 product:aquaporin 4. Adult male spinal cord cDNA
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1452308 a  at Atp1a2 ATPase, Na+/K+ transporting, alpha 2 polypeptide
1435148 at Atp1b2 ATPase, Na+/K+ transporting, beta 2 polypeptide
1435559 at BC029719 myosin VI
1416718 at Bean brevican
1422470 at Bnip3 BCL2/adenovirus E1B 19kDa-interacting protein 1, NIP3
1422845 at Canx calnexin
1417327 at Cav2 caveolin 2
1450017 at Ccngl cyclin G1
1416066 at Cd9 CD9 antigen
1424638 at C dknla cyclin-dependent kinase inhibitor 1A (P21)
1437458 x at Clu clusterin
1437341 x at Cnp1 BB251922 RIKEN full-length enriched 7day neonate cerebellum
1450966 at Crot carnitine O-octanoyltransferase
1438610 a  at Cryz crystallin, zeta
1422577 at C s citrate synthase
1417065 at Egrl early growth response 1
1433670 at Emp2 epithelial m em brane protein 2
1422438 at Ephxl epoxide hydrolase 1, microsomal
1449324 at Eroll Transcribed seguences
1416209 at Glud glutam ate dehydrogenase
1433485 x at Gpr56 G protein-coupled receptor 56
1416368 at Gsta4 glutathione S-transferase, alpha 4
1448330 at G stm l glutathione S-transferase, mu 1
1448429 at Gyg1 glycogenin 1
1426522 at Hadhb hydroxyacyl-Coenzyme A dehydrogenase beta subunit
1455972 x at Hadhsc L-3-hydroxyacyl-Coenzyme A dehydrogenase, short chain
1423780 at Hibadh 3-hydroxyisobutyrate dehydrogenase
1418072 at Hist1h2bc histone 1, H2bc
1416344 at Lamp2 lysosomal m em brane glycoprotein 2
1449893 a  at Lrigl leucine-rich repeats and immunoglobulin-like domains 1
1433532 a  at Mbp myelin basic protein
1420911 a  at Mfge8 milk fat globule-EGF factor 8 protein
1415897 a  at Mgstl microsomal glutathione S-transferase 1
1448139 at Mlc1 m egalencephalic leukoencephalopathy w subcortical cysts 1 (Hum Homl)
1424534 at Mmd2 monocyte to m acrophage differentiation-associated 2
1416632 at Modi malic enzyme, supernatant
1422557 s  at Mt1 metallothionein 1
1428942 at Mt2 metallothionein 2
1433942 at Myo6 myosin VI
1417568 at Ncald neurocalcin delta
1448154 at Ndrg2 N-myc downstream  regulated 2
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1416816 at Nek7 NIMA (never in mitosis gene a)-related expressed  kinase 7
1460303 at Nr3c1 nuclear receptor subfamily 3, group C, m em ber 1
1427475 a  at Nrap Mus musculus cDNA clone IMAGE:3495171, partial cds.
1416149 at Oligl oligodendrocyte transcription factor 1
1416232 at Olig2 oligodendrocyte transcription factor 2
1454714 x at Phgdh S eguence with similarity to protein sp:Q61753 (M.musculus)
1430700 a  at Pla2g7 phospholipase A2, group VII
1417288 at Plekha2 pleckstrin homology domain-containing, family A m em ber 2
1416178 a  at Plekhbl pleckstrin homology domain containing, family B m em ber 1
1434180 at Plekhcl pleckstrin homology domain containing, family C m em ber 1
1425468 at Pip proteolipid protein (myelin)
1448908 at Ppap2b phosphatidic acid phosphatase type 2B
1433691 at Ppp1 r3c protein phosphatase 1, regulatory (inhibitor) subunit 3C
1423223 a  at Prdx6 peroxiredoxin 6
1426246 at P rosl protein S (alpha)
1416211 a  at Ptn pleiotrophin
1427019 at Ptprzl protein tyrosine phosphatase, receptor type Z, polypeptide 1
1417481 at Rampl receptor (calcitonin) activity modifying protein 1
1415850 at Rasa3 RAS p21 protein activator 3
1423254 x at Rps27l ribosomal protein S27-like
1460235 at Scarb2 scavenger receptor class B, member 2
1415964 at Scd1 stearoyl-Coenzyme A desaturase 1
1415823_at Scd2 stearoyl-Coenzyme A desaturase 2
1420764 at Scrgl scrapie responsive gene 1
1449084 s  at Sh3d19 SH3 domain protein D19
1417600 at Slc15a2 solute carrier family 15 (H+/peptide transporter), m em ber 2
1426340 at Slc1a3 solute carrier family 1 (glial high affinity glutam ate transporter), m em ber 3
1434210 s  at Slc25a26 solute carrier family 25 (mitochondrial & phosphate carrier), m em ber 26
1430542 a  at Slc25a5 solute carrier family 25, m em ber 5
1452071 at Slc4a4 solute carrier family 4 (anion exchanger), m em ber 4
1448321 at Sm oci SPARC related modular calcium binding 1
1435192 at Sox3 AV306664 RIKEN full-length enriched, 8 days embryo
1449264 at Syt11 synaptotagmin 11
1449929 at Tctell t-complex-associated-testis-expressed 1 -like
1423405 at Timp4 tissue inhibitor of metalloproteinase 4
1416342 at Tnc tenascin C
1426641 at Trib2 expressed seguence AW319517
1422694 at Ttyhl tweety homolog 1 (Drosophila)
1433916 at Vamp3 vesicle-associated m em brane protein 3
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The changes in the expression profiles of these candidate markers across the different 
conditions are shown in Figure 5.11. The candidates have been classified based on 
their biological process and their molecular function according to the Gene Ontology 
Consortium classifications (Figure 5.12). A degree of overlap between categories in 
each classification is seen. The largest proportion of the candidates involved in similar 
biological processes fall under ‘cellular physiological process’, which includes cell 
proliferation and cell cycle regulation, ‘cell communication’, and ‘cell differentiation’ 
(only 6 out of the 63 genes fall into this category). From the classification according 
to molecular function, the largest proportion of gene products is categorized as having 
a role in binding, which includes protein and nucleic acid binding.
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Figure 5.11 Graph of changes in the expression of candidate NSC markers. The 
expression of 535 NSC candidate genes is measured as arbitrary normalised intensity 
across the different target conditions (14.5 dpc dorsal telencephalon NSC-enriched 
neurospheres (DT+), 14.5 dpc dorsal telencephalon tissue (DTt), 14.5 dpc spinal cord 
NSC-enriched neurospheres (SC+) and 14.5 dpc spinal cord tissue (SCt). Values are 
shown after GC RMA normalisation of data generated on the GeneChip platform.
File Name
Y-axis: GC RMA NSC factors, Default Interpretation
Colored by: DT +
Gene Ust Higher in both 2X (535)
Figure 5.12 Pie charts of classification of candidate NSC markers by Gene Ontology 
NSC candidate marker genes are classified into groups based on their biological 
process (A) and molecular function (B), as classified by the Gene Ontology 
Consortium. The colour key is on the side of each pie chart.
Classification of NSC candidate markers based on biological process
GO:8150: biological_process
■ GO:9987: cellular 
process
(63 genes)
□ GO:7582: physiological 
process 
(61 genes)
■ GO:50789: regulation of 
biological process
(13 genes)
■  GO:7275: development 
(10 genes)
■  GO:50896: response to 
stimulus
(7 genes)
■ GO:4: biological process 
unknown
(3 genes)
■  GO:3: reproduction 
(1 gene)
■ GO:7610: behavior 
(1 gene)
B Classification of NSC candidate markers based on molecular function
GO:3674: molecular_function
■  GO:5488: binding 
(37 genes)
□  GO:3824: catalytic 
activity 
(34 genes)
■  GO:5215: transporter 
activity
(9 genes)
■  GO:4871: signal 
transducer activity 
(7 genes)
■  G0:30528: transcription 
regulator activity
(6 genes)
■  GO:30234: enzyme 
regulator activity
(5 genes)
■  GO:5198: structural 
molecule activity
(4 genes)
■  GO:5554: molecular 
function unknown
(3 genes)
■  GO:3774: motor activity 
(2 genes)
■  GO:16209: antioxidant 
activity
(1 gene)
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There is a significant level of overlap of the candidate genes between the two different 
microarray platforms. 20 out of the 46 short-listed genes (that have annotations) from 
the list generated on the spotted platform are present in the second list generated on 
the GeneChip platform (These are Acadl, Apoe, Atplb2, Bean, Ccngl, Cdknla, 
Ephxl, Glud, Modi, Oligl, Olig2, Pgaml, Pla2g7, Ppplr3c, Rampl, Scarb2, Scd2, 
Scrgl, Timp4, Tnc). A further 21 genes from this list (Lxn, Stat3, Gfap, Gpm6b, 
Cntnl, Serpine2, Gpil, Slc38a3, Glul, Igfbp4, Odf2, Pgkl, Nab2, S100al3, Slcl2a4, 
Slc6al, Ptn, Cd81, Ckb, Ldhl, Qk) are included in the list of potential candidates that 
were not short-listed (Table 9.2.1 of Appendix). There are three reasons why these 
genes where not be included in the main candidates list. First, because their 
expression level may be below 1,000 arbitrary units on the GeneChip array despite 
having very high fold-differences in expression e.g. Slcl2a4 has a fold expression of 
15.9-fold higher in dorsal telencephalon neurospheres and 2.09-fold in spinal cord 
neurospheres, but its highest arbitrary intensity expression value is 714.8. Secondly, 
because they did not meet the imposed 2-fold expression difference criteria in both of 
the dorsal telencephalon and spinal cord experiments, e.g. Stat3 is expressed 12.83- 
fold higher in the dorsal telencephalon neurospheres compared to tissue, but only 
1.49-fold higher in spinal cord neurospheres compared to tissue. Finally, both these 
attributes may have occurred, e.g. Nab2 is expressed 14.9-fold higher in dorsal 
telencephalon neurospheres and only 1.85-fold higher in spinal cord neurospheres and 
its highest arbitrary expression value is 463.15, which is lower than the 1,000 
arbitrary unit filtering level. Only five genes did not meet the criteria for either list 
and these are Mobp, Pfkm, Scn8a Cd63 and Pde3b. The latter two are not represented 
in the Affymetrix Mouse 430A chip. Mobp shows no expression from the sequences 
that represent it on the array, Scn8a is surprisingly higher in both tissue samples and
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Pfkm is expressed higher in both neurosphere populations but under the 2-fold 
significance level. These differences may be products of the variation in sensitivity 
and accuracy between the two platforms. Overall, results from both platforms were 
comparable and this fact increases the reliability of the results, providing confidence 
in the list of candidate NSC markers.
5.2.3 Bioinformatic analysis of expression traits of NSCs
5.2.3.1 Genes revealing potential interaction o f NSCs with endothelial cells in the 
niche
Microarray data sets generated from stem cell-enriched NSC cultures derived from 
the 14.5 dpc dorsal telencephalon and spinal cord compared to their corresponding 
tissues of origin were inspected for the expression of genes of likely importance in 
interactions with cells that may surround their in vivo environment such as endothelial 
cells, and for the expression of genes that may reveal responsiveness to factors 
controlling the NSC niche. After computational filtering to eliminate factors with low 
expression levels (less than 100 arbitrary units in all conditions), the expression of 12 
genes of known potential importance to niche interactions was found to be higher in 
one or both of the NSC-enriched neurosphere populations compared to the more 
differentiated tissue of origin in both telencephalon and spinal cord populations 
(Table 5.7).
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Table 5.7 List of genes with elevated expression in NSC-enriched neurospheres, 
important to niche interactions. The following genes, which are potentially involved 
in niche interactions, show an increase in expression levels in NSC-enriched 
neurospheres compared to their tissue of origin in microarray experiments on the 
GeneChip platform.
Gene Fold-expression higher in 
D.T. NSC than D.T. tissue
Fold-expression higher in 
S.C. NSC than S.C. tissue
Vcaml 1.29 1.58
Gjal 3.76 1.44
Tjpl 1.72 1.41
Vegfa 7.96 1.88
Bmp4 6.5 1.84
Pdgfra 17.23 1.88
Bmprla 1.56 1.94
Smo 2.51 1.43
Itgav 7.3 3.3
Lamb2 1.79 1.54
Abcal 2.57 2.95
Abcg2 1.87 1.45
For the genes Vegfb, Pdgfa, Fgfrl and Rarb, an increase was seen in the neurosphere 
population compared to tissue only for the dorsal telencephalon and not the spinal 
cord. The endothelial-specific genes Fltl, Flt4 and Tek (Tie-2) had low levels of 
expression in neurosphere populations (lower than 50 arbitrary units potentially 
indicating no expression). As described, previous reports indicate that NSCs can be 
stimulated to express the endothelial specific markers PECAM-1, VE-cadherin and
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Flk-1 (Oishi et al. 2004). Endothelial cells present membrane-bound bFGF, which can 
induce proliferation of NSCs, also supporting the notion that NSCs external to the 
vessels are in direct contact with endothelial cells. Alvarez-Buylla and co-workers 
have provided evidence that NSCs of the adult SVZ are radial glial-derived astrocytes 
(Merkle et al. 2004). Consistent with this, these results suggest that NSCs residing 
outside of blood vessels may be in direct contact with endothelial cells. These cells 
could have an astrocytic character as astrocytes form tight junctions with endothelial 
cells to establish and maintain the blood-brain barrier. An increase in expression 
levels of Tjpl (tight junction protein 1) is seen from the microarray data to define the 
neural stem cell populations. NSC-enriched neurospheres were also shown to express 
St at 3 higher than their tissue of origin (the role of STAT3 is examined in more detail 
in section 5.2.4). STAT3 has been shown to regulate proangiogenic Vegf expression 
in embryonic and adult endothelial cells (Hilfiker-Kleiner et al. 2005), which may be 
a requirement in the immediate vascular niche to the NSCs. ES cells and 
haematopoietic stem cells can be enriched through FACS sorting based on their 
Hoechst efflux properties. Dual wavelength analysis, by flow cytometry, of bone 
marrow cells labeled with Hoechst 33342 reveals a distinct side-population of cells 
that readily efflux Hoechst dye mediated by high expression of MDR (multi-drug 
resistance protein)-like transporters, such as ABC-binding cassette (ABC) 
transporters. Side-population (SP) cells make up 0.03% to 0.07% of total cells and 
85% of these express long-term HSC lineage markers. The side-population cells have 
bona fide stem cell activity and cells with the highest dye efflux are the most potent in 
vivo (Goodell et al. 1997). Higher levels of ABC-transporter expression in the NSC- 
rich populations (Abcal, Abcg2) reinforces the concept that some NSCs may have 
dye-efflux properties and can appear as the side population in scatter profiles in blue
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and red spectra after Hoechst labeling. A side population of NSCs through Hoechst 
33342 staining has previously been reported (Hulspas and Quesenberry 2000). In this 
study it was reported that the side population is capable of neurosphere generation but 
that the dye-efflux phenotype cannot be used for neurosphere-generating NSC 
enrichment, as is the case with HSCs. A small side population is observed when this 
assay was performed on Sox2^geo/+ neurospheres (data not shown) although these 
failed to form neurospheres in culture. This property may define cells that have no 
neurosphere-generating potential or perhaps more interestingly, quiescent neural stem 
cells that would not necessarily generate neurospheres in short-term culture and under 
the conditions used.
5.2.3.2 Genes revealing potential interaction of NSCs with the basal lamina in the 
niche
Direct contact between the basal lamina and NSCs has previously been proposed 
(Mercier et al. 2002) and our data supports this hypothesis. NSC-enriched 
neurosphere populations, compared to their tissue of origin, preferentially express 
some extracellular matrix components that have been shown to encourage the stem 
cell state (laminin genes, Itgbl and Tnc). The expression of these transcripts is found 
at higher levels in NSC-enriched neurospheres compared to non-enriched 
neurospheres, supporting the idea that NSCs contribute to the extracellular matrix that 
in turn also has a role in the stem cell niche. It has been reported that Tenascin-C is 
expressed by astrocytes in the adult CNS in regions of stem cell generation (Jankovski 
and Sotelo 1996) and by embryonic radial glia (Malatesta 2003). Since it has been 
demonstrated that both of these cell types have stem cell properties our findings 
through microarray analysis that Tnc is a potential candidate marker, highly expressed
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in in vitro NSC-enriched cultures, is in support of the reported in vivo phenotype of 
NSCs.
5.2.4 NSC candidate marker analysis-the role of STATS
From the short-listed candidates, I decided to investigate the role of StatS in neural 
stem cells. The necessity for STAT3 to drive ES cell proliferation through LIF- 
mediated signalling is well defined. This led to the association that St at3 expression 
may be playing an important role in NSC proliferation. The localisation of STAT3 
was investigated in proliferating stem cell-enriched Sox2^eol+ neurospheres as well as 
in differentiated cell types from these cultures. As expected from a predominantly 
undifferentiated population, STAT3 localises in the nucleus of the majority of cells in 
the neurosphere (Figure 5.13 A). In differentiated glia, neurons and mature 
oligodendrocytes, STAT3 localises mainly in the cytoplasm (Figure 5.13 B).
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Figure 5.13 STAT3 in neural stem cell cultures derived from the 14.5 dpc dorsal 
telencephalon. STAT3 mainly localises in the nucleus of cells in neurospheres under 
proliferating conditions (A) and in the cytoplasm of differentiated cell types generated 
under differentiation conditions (B). STAT3 is in red in all panels, differentiation 
markers in green and nuclei in blue, stained with DAPI. Scalebars represent 100pm.
A
DAPI STA T3 Merge
B Glia Neurons Oligodendrocytes
G F A P C N P a s e
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To test the effects of over-expressing and under-expressing St at3 in cultured 
neurospheres, dissociated single cells from primary neurospheres were electroporated 
with constitutive active and dominant negative forms of St at3 (kind gifts from 
Professor Shizuo Akira and Dr Torn Kondo). An increase in the number of 
neurospheres was observed 3 days following electroporation of the constitutive active 
construct, compared to control electroporations using the EGFP-N1 vector. Cultures 
that were electroporated with the dominant negative form of St at3 showed a severe 
decrease in the number of neurospheres and a large proportion of cell death. The 
results are summarized in Table 5.8. Chi-Square tests were performed between the 
Stat3-DN and EGFP-N1 results and the Stat3-C and EGFP-N1 results, to determine if 
neurospheres were generated at significantly lower and higher numbers respectively. 
In both cases, p  has a value of less than 0.001, hence both distributions are significant 
(Table 5.9). Following electroporation with the constitutive active construct, cells 
were induced to differentiate for 2 days through attachment on an adherent matrix and 
withdrawal of the mitogens EGF and bFGF from the culture medium. GFAP positive 
glial cells were detected as the majority of the differentiating population. No TuJl 
positive neurons were observed in the culture and the proportion of oligodendrocytes 
was not assayed (data not shown).
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Table 5.8 Effects of dominant negative inhibition of STAT3 on neurosphere 
formation. The EGFP-N1 vector was used as a transfection control.
Plasmid Cells plated after electroporation Neurospheres after 72h % Formation
Stat3-DN 1.7 x 105 58 0.03%
Stat3-C 1.7 x lO5 2231 1.3%
EGFP-N 1 
(control)
1.7k 105 1603 0.9%
Table 5.9 Chi-Square test results for Stat3-DN compared to EGFP-N1 (A) and Stat3- 
C compared to EGFP-N1 (B). ________ _________________________________
A Column
1
Column
2
Total B Column
1
Column
2
Total
Row 1 58 1603 1661 2231 1603 3834
Row 2 169942 168397 338339 167769 168397 336166
Total 170000 170000 340000 170000 170000 340000
A: Stat3-DN B: Stat3-C
Chi-square value = 1444.15627 Chi-square value = 104.038075
In both cases, there is one degree of freedom and since Chi-square values are greater 
than 10.827 (see Chi-square Table 5.10 below)p  is less than 0.001
Table 5.10 Chi-Square values for one degree of freedom (df).
For d f = l P = 0.05 P = 0.01 P = 0.001
Chi-square value: 3.841 6.635 10.827
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5.3 Discussion
5.3.1 SOX2 in dorsal telencephalon and spinal cord cultures
X-gal staining of Sox2^eol+ embryos (Figure 3.1) confirms that Sox2 is expressed in 
stem cell-generating regions of the embryonic CNS such as the dorsal telencephalon 
and spinal cord. In the spinal cord, cells in the ependymal layer express Sox2, and as 
expected, the SOX2 protein localises in the nucleus (Figure 5.3). The low proportion 
of Sox2 expressing cells in the spinal cord as opposed to the dorsal telencephalon can 
account for the reduced numbers of neurospheres generated from the dissociated 
spinal cord. This presents problems in comparing spinal cord primary neurosphere 
formation to primary dorsal telencephalon cultures but not when comparing spinal 
cord Sox2^eol+ stem cell-enriched population to other spinal cord NSC cultures (e.g. 
wild type). However, dorsal telencephalon neurospheres can be directly compared to 
spinal cord neurospheres with respect to secondary neurosphere formation. When 
culturing 11.5 dpc spinal cord NSCs, a higher percentage of cells are capable of 
neurosphere formation in culture (data not shown and Charlotte Scott, personal 
communication). At this earlier stage of spinal cord development a larger proportion 
of cells retain undifferentiated neuroepithelial properties and the Sox2 expression 
domain is not as restricted as in 14.5 dpc embryos. Investigation of gene expression 
profiles of 14.5 dpc spinal cord and dorsal telencephalon reveals differences that can 
be attributed to differentiation of the more mature progenitors of the spinal cord. 
Genes with expression differences highlighted in this way have to be excluded from 
lists of potential neural stem cell marker genes, which should be similarly expressed 
in both populations. This does not negate the fact that expression of some genes 
uniquely in one population is a characteristic of NSCs from that region, although it 
does not help with the identification of candidates for pan-NSC markers.
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5.3.2 NSC markers in dorsal telencephalon and spinal cord cultures 
Marker analysis through immunofluorescence showed that spinal cord neurospheres 
express Nestin and SOX2 and that their expression patterns largely co-localise as with 
dorsal telencephalon neurosphere cultures (section 5.2.1.3). Spinal cord cultures do 
not express SSEA-1, however, which has been characterised as a forebrain stem cell 
marker (Capela and Temple 2000), eliminating this gene as a candidate pan-NSC 
marker. It has been reported that spinal cord cultures derived from 14.5 dpc embryos 
express Ssea-1 (Terry Kelly, personal communication). In this case the researchers 
were using different culture conditions (mechanical as well as enzymatic dissociation 
for passaging every 3 days as well as addition of FCS in the medium) from those 
reported here, which may result in the acquisition of this marker. SSEA-1 is 
upregulated in CNS cultures in response to injury, which may be induced by 
mechanical dissociation (Professor Masato Nakafuku, personal communication). 
Other genes such as Musashil, Dlx2 and Proml (Prominin-1, CD 133) are also 
implicated in the literature as candidate NSCs markers (Kaneko et al. 2000; Lee et al. 
2005). Microarray analysis could not provide information on Musashi-1 and Dlx2, 
however Proml is downregulated in dorsal telencephalon cultures compared to dorsal 
telencephalon tissue (3.8-fold difference) suggesting that the Proml in vivo 
expression domain may be including a larger proportion of cells that the total in vitro 
progenitors. In spinal cord cultures the levels of Proml expression do not change 
between neurosphere cultures and tissue indicating that if Proml expression is not 
unique to NSCs, this may be forebrain-specific. The prominin surface antigen is also 
expressed in other tissues and stem cell populations and its expression has been used
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to isolate endothelial progenitors (Bussolati et al. 2005) and human HSCs (Miraglia et 
al. 1997; Yinetal. 1997).
5.3.3 Selection o f candidate NSC markers
There are many factors to consider when identifying genes that play an important role 
in all undifferentiated NSC populations. Ideal outcomes from the experimental plan 
are if these genes are expressed with similar patterns in NSCs both in vivo and in 
vitro, if they are only expressed in proliferating progenitors or also in differentiating 
cells (perhaps at lower levels or with varying sub-cellular protein localisation) and if 
they are involved in the promotion of self-renewal or the suppression of 
differentiation. Microarray analysis has previously been used to characterise neural 
stem cell/ CNS progenitor populations (Geschwind et al. 2001; Ivanova et al. 2002; 
Ramalho-Santos et al. 2002; D'Amour and Gage 2003; Hu et al. 2004; Abramova et 
al. 2005). It is difficult to compare the data presented in this thesis with these studies, 
as the approaches taken are different. One study comparing proliferating and 
differentiating neurospheres from the postnatal SVZ (Karsten et al. 2003) yields 
results with similar trends to the NSC-enriched neurosphere populations derived from 
the 14.5 dpc dorsal telencephalon compared to their tissue of origin. Apart from 
differences in gene expression arising from different developmental stages, a custom- 
made cDNA array platform was used, with large probe set differences compared to 
the Affymetrix Mouse 430A GeneChip. The use of markers to enrich stem cell 
populations for microarray analysis has also been previously performed: the 
expression of Sox2-Gfp has been used to purify NSCs and to compare them to Sox2 
expressing ES cells in order to identify common ‘sternness’ genes (D'Amour and 
Gage 2003). Similarly, Abramova and co-workers used the expression of the surface
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marker LeX (Ssea-1) to purify populations of neural stem and progenitor cells from 
the embryonic cortex (10 dpc, 13 dpc and 17 dpc) and the adult SVZ and compared 
these through microarray analysis to ES cells (Abramova et al. 2005). The use of LeX 
as a marker resulted in NSC enrichment but not purification and allowed for the 
identification of developmental stage-dependent gene expression differences within 
the LeX positive population. Further studies have compared NSCs to ES cells and to 
HSCs (Ivanova et al. 2002; Ramalho-Santos et al. 2002) in order to identify genes 
enriched in all three populations. These studies aim to characterise the similarities 
across stem cell populations, however NSCs may have properties that are essential for 
the stem cell state that are not shared by other populations of cultured stem cells. 
There is a low degree of overlap between the stem cell candidate gene lists of these 
studies (Abramova et al. 2005). Differences in statistical approaches can generate 
highly dissimilar results. This was demonstrated by Ivanova and co-workers through 
reanalysing their data using the statistical methods of Ramaldho-Santos and co­
workers, resulting in a 65.7% overlap from an initial 10% overlap ((Ivanova et al. 
2002) and reviewed in (Li and Akashi 2003)). The low overlap correlation may also 
highlight a potential pitfall in the methodologies: using stem cell populations from 
different ages or locations may lead to short-listing of genes specific to the temporal 
and spatial identity of the NSC populations as ‘sternness’ genes. The aim of the 
microarray experiments between NSC-enriched populations and their tissue of origin 
described in this chapter (section 5.2.2) is to identify a shortlist of candidate genes 
shared amongst all NSC populations irrespective of their developmental status and 
origin. The modular properties of the Affymetrix GeneChip system, allowing for 
more NSC populations to be incorporated in the study in the near future, can help
150
establish this list, which can then be used to compare ‘sternness’ properties across 
stem cell populations of different tissues.
The mixed composition of the neurospheres has to be also taken into account when 
interpreting expression-profiling results. Microarray analysis for neural stem cell 
cultures can only be performed using a mixed, impure stem cell population as starting 
material, except if the recently reported culture of a pure ES cell-derived radial-glial 
like stem cell population was used (Conti et al. 2005). Therefore, it may be impossible 
to attribute the expression of some genes to a particular cell type without further 
analysis, especially in cases where gene function is unknown and the expression has 
not been described in the literature. Pilot experiments on spotted oligonucleotide 
arrays, comparing neurosphere populations from the 14.5 dpc dorsal telencephalon 
and spinal cord to a reference sample, helped identify various pitfalls in the 
experimental design (section 5.2.2.1). Using a reference sample provides a distinct 
advantage for future experiments in that more neurosphere populations can be 
incorporated into the study through performing hybridisations against the reference 
sample. The reference sample can then be statistically eliminated from the results and 
aid in expression level normalisations, allowing the neurosphere samples to be 
compared to one-another. Through comparing neurosphere samples to a suitable 
reference of non-stem cell origin, genes involved in metabolism and other 
housekeeping genes, which will be common between all populations can be identified 
and excluded to allow lists of more interesting stem cell candidates common to 
neurosphere populations to emerge. However, comparing just two neurosphere 
populations via a reference sample was not sufficient to detect similarities unique to 
NSCs, as the list of genes expressed in common between spinal cord and dorsal
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telencephalon neurospheres was very large. This experiment also helped to determine 
that the amplification of cDNA was not suitable for this study. After reverse 
transcription, each cDNA sample underwent a different number of amplification 
cycles, deemed optimal for the particular sample. However, the number of cycles may 
have been high enough to introduce error in the hybridisation probes. Gene expression 
profiles obtained via hybridisation with non-amplified cDNA probes were very 
dissimilar to those generated from amplified cDNA probes even if they were 
generated from the same starting total RNA. This suggests that errors have been 
introduced through the cDNA preparation, as all other steps were kept identical. 
Taking these issues into account, the experimental plan was altered. Only non­
amplified cDNA was used for the remaining experiments of spotted arrays. Since 
G418-selected Sox2^eo/+ neurospheres are enriched for proliferating stem cells 
(section 4.2.1.2) and more secondary neurospheres form from primary enriched 
neurospheres rather than from dissociated tissue (section 4.2.2), comparing enriched 
neurospheres to their tissue of origin should demonstrate stem cell-related genes being 
expressed at higher levels in the neurosphere populations. The tissue of origin of each 
neurosphere population had to specifically be used, as using whole CNS (as was used 
as a reference sample in the pilot experiments) would dilute region-specific 
differences in gene expression profiles that may be retained in the neurospheres. Thus, 
by overlapping lists of genes enriched for their expression in the neurospheres, which 
eliminates regional differences, a set of candidates expressed specifically in 
neurosphere populations, hence in NSCs, was established (Figure 5.8). This list can be 
refined further by incorporating data from neurosphere populations with further 
spatial and temporal differences compared to their tissue of origin. One potential 
disadvantage of this experimental plan is that 14.5 dpc neurospheres are not only
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enriched for NSC, but also contain populations of committed progenitors as well as 
terminally differentiated cells (Figure 3.2 D-F). Although the proportion of 
differentiated cells to NSCs and progenitors may be low, the types and extent of 
terminal differentiation found in the neurospheres is less likely to be found in the 
tissue, as at 14.5 dpc the majority of differentiating cells are more likely to be 
committed to progenitor stages rather than be terminally differentiated. The array data 
confirms this concern, as within the list of candidate genes are factors that are known 
to mark differentiating lineages. This does not exclude the possibility that these 
factors are implicated in aspects of the stem cell state. For example, differentiated 
astrocytes are GFAP positive but radial glia of the embryonic and astrocytes of the 
adult brain, both characterised as NSCs, express GFAP (a subset of radial glia are an 
exception to this). The subsequent availability of the Affymetrix GeneChip arrays 
allowed for these experiments to be repeated on this platform, with the advantages of 
both higher specificity and a larger gene library (section 5.2.2.3). Similar results were 
obtained with this platform, although more stringent criteria than normal had to be 
applied to generate a manageably sized candidate list. If these criteria had not been 
applied, and the same criteria were used across both platforms, then 41 out of 43 
candidates comprising the first list would have been shared between the two 
platforms, revealing the high level of reliability and reproducibility of the results.
5.3.4 Stat3 as a promising NSC candidate
Out of both lists of candidates, only one identifiable factor known to be associated 
with multipotent lineages was found. St at3 is one of the short-listed candidates from 
the spotted array data. This gene was not included in the candidate list from the 
GeneChip array as its expression in the spinal cord neurosphere populations was
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higher compared to spinal cord tissue but not above the significance threshold. 
However, in dorsal telencephalon neurospheres on the GeneChip platform, it shows 
an increase of over 12-fold compared to the dorsal telencephalon tissue.
Recently, through chromatin immunoprecipitation and subsequent microarray 
analysis, it was demonstrated that SOX2 together with OCT4 and NANOG all bind 
active STAT3 in undifferentiated human ES cells (Boyer et al. 2005). The potential 
regulation of STAT3 by these transcription factors is also likely to take place in 
murine ES cells, where the expression of St at3 is essential for the regulation of self­
renewal (Chambers and Smith 2004). The overlap in expression patterns of Stat3 and 
Sox2 in the developing CNS and NSC cultures derived from the CNS, make it 
increasingly likely that an association between these two genes may play an important 
role in the control of the stem cell state.
Binding of the gpl30 receptor by IL-6 family cytokines results in the activation of 
Janus kinase type tyrosine kinases (JAKs), which phosphorylate STAT3. In retinal 
explants, it has been shown that STAT3 can be activated in response to extrinsic 
factors, including CNTF, LIF, FGF1, FGF2, EGF, IFNct and IFNy (Zhang et al. 
2005). Phosphorylated STAT3 dimerizes, translocates to the nucleus and binds to 
target genes acting as a transcriptional activator. In response to activated STAT3, 
retina precursor cells demonstrate an increase in proliferation (Zhang et al. 2005). 
STAT3 has been strongly implicated in the promotion of gliogenesis. Transfection of 
rat NSCs with a dominant negative form of STAT3 results in the promotion of 
neurogenesis and a significant decrease of GFAP positive cells (Gu et al. 2005). This 
is consistent with results presented in this chapter, where overexpression of Stat3
154
leads to an increase in GFAP positive glial cells. CNTF can activate the Jak-Stat 
signaling pathway and promote glial differentiation of rat cerebral cortical precursors 
through the activation of the Gfap promoter (Bonni et al. 1997; Rajan and McKay 
1998). Also, oncostatin M (OSM) has been shown to contribute to the differentiation 
of astrocytes in mouse neuroepithelial cultures through downstream activation of 
Stat3 (Yanagisawa et al. 1999).
There is evidence to suggest that Hesl and Hes5 are associated with the proliferative 
NSC state (Ohtsuka et al. 2001). HES proteins, which are Notch effectors, promote 
STAT3 phosphorylation by associating with both JAK2 and STAT3 and they 
suppress the expression of proneural genes (Kageyama and Nakanishi 1997). In the 
presence of active Notch, STAT3 is activated while suppression of Hesl reduces the 
phosphorylation of STAT3 (Kamakura et al. 2004). The dominant negative inhibition 
of STAT3 has been shown to result in a decrease of Hes5 mRNA levels (Gu et al. 
2005). From the microarray experiments in section 5.2.2.3, designed to establish a list 
of potential NSC candidate markers, Hesl and Hes5 mRNA levels where found to be 
higher in both neurosphere populations (Hesl by 3.3-fold in dorsal telencephalon 
cultures and 1.79-fold in spinal cord cultures; Hes5 by 3.87-fold in dorsal 
telencephalon cultures and 2.32-fold in spinal cord cultures). Hes5 was not identified 
as a potential candidate despite having a significant expression increase in the 
neurosphere populations, as the arbitrary intensity levels were lower than 1,000 units 
in 3 out of the 4 array conditions. These findings substantiate a potential correlation 
between HES proteins and an association with the proliferative NSC state, as enriched 
NSC populations express Hesl and Hes5 at higher levels, as they do St at3.
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Our group, through the use of conditional Stat3 mutant mice, is investigating the role 
of STAT3 in neural stem cells further. Mice deficient for St at3 in the CNS can be 
used to derive neurospheres from the telencephalon, demonstrating that Stat3 is not 
the sole factor required for neurosphere generation. However, we hypothesise that 
activated STAT3 does have a role in NSC proliferation and neurosphere generation in 
vitro, because dominant negative inhibition of St at3 in NSC cultures leads to a 
reduction in the number of secondary neurospheres, while transfection with a 
constitutive active form of St at3 leads to an increase. The effect of STAT3 may be 
masked by the expression of genes complementing its function. One likely candidate 
is Sox2. A reduction in neurosphere generation is seen following the introduction of a 
dominant negative form of Sox2 (section 6.2.1.1). If SOX2 can activate targets of 
STAT3 such as Id2, independent of Stat3 expression (which has not been 
demonstrated), then a reduction in the levels of SOX2 in the absence of STAT3 may 
lead to a more severe phenotype than the sole absence of STAT3. This can be 
achieved through the generation of mice null for St at3 in the CNS (targeted deletion 
of Stat3 leads to early embryonic lethality (Takeda et al. 1997)) and heterozygous for 
Sox2/3geo. This can be done through breeding Stat3ilox/f[ox animals (Alonzi et al. 2001) 
with Nestin::Cre mice (Nestin driving Cre expression. Nestin is expressed in the CNS 
from 11.5 dpc), and then breeding conditionally null St at3 mutants (Stat3ConA/ConA) 
with Sox2^geol+ animals. The prediction would be that the numbers of neurospheres 
that could be derived from these mice would be reduced compared to mice mutant for 
St at3 but wild type for Sox2. However, we have to consider functional redundancy 
between the SOXB1 subgroup genes, as this may mask the severity of any phenotype. 
We have the means to generate embryos conditionally null for St at3, heterozygous 
null for Sox2, homozygous null for Soxl and conditionally null for Sox3. The
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generation of these mice, however, has not been successful as mice heterozygous for 
Sox2 and conditionally null for Sox3 die during embryonic stages and exhibit a 
truncation of the anterior CNS (Rizzoti et al, unpublished data). Therefore, other 
strategies need to be employed to overcome this problem, such as the conditional 
deletion of Sox3 at later stages of development to overcome the lethality, in order to 
determine the roles of St at3 and Sox2 in NSCs.
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CHAPTER 6
Effects of lowering SOX2 levels in NSCs 
6.1 Background
The ideal way to investigate the role of SOX2 in neural stem cells would be to 
characterise the stem cell populations in its absence. Since Sox2 null mutants exhibit 
peri-implantation lethality, two further approaches are possible: 1) the generation of 
a conditional knockout, 2) lowering the levels of SOX2 through the in vitro post- 
transcriptional silencing of SOX2 by RNA interference (RNAi) or by dominant- 
negative strategies. In this study, the second, in vitro approach was chosen to 
investigate the role of SOX2 in cultures of embryonic neural stem cells and to 
identify candidate transcriptional targets of SOX2.
6.1.1 RNA interference
RNAi can be an effective means of achieving the down-regulation of protein 
products. It is the process by which epigenetic gene silencing effects occur, triggered 
by double-stranded RNA (dsRNA). ‘RNAi’ is the term used in animals, but a similar 
mechanism identified in plants is termed ‘posttranscriptional gene silencing’ (PTGS), 
and in the fungus Neurospora crassa, ‘quelling’. The stability of eukaryotic genomes 
is often under threat from random integration of transposable elements and 
transgenes, as well as by the infection of viruses. In such situations, the invaders 
frequently produce dsRNA, during viral replication or by aberrant transcription from 
promoters located near transgene insertion sites. RNAi is thought to have developed 
as a cellular defence mechanism, responding to dsRNA, to rapidly process it into 
small fragments that direct the sequence-specific degradation of the single-stranded
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mRNAs of the invading genes (Elbashir et al. 2001). The injection of antisense RNA 
in Caenorhabditis elegans embryos results in the extinction of homologous 
endogenous gene expression (Guo and Kemphues 1995). However, dsRNA 
molecules act as more potent inducers of interference than antisense single-stranded 
RNA (ssRNA) (Fire et al. 1998). This mechanism has been described amongst others 
in Paramecium (Ruiz et al. 1998), trypanosomes (Ngo et al. 1998), Drosophila 
(Kennerdell and Carthew 1998; Misquitta and Paterson 1999), and mammals 
(Wianny and Zemicka-Goetz 2000; Elbashir et al. 2001). The process of RNAi takes 
place predominantly in the cytoplasm, so pre-mRNA in the nucleus remains 
unaffected. Evidence suggests that either amplification of the signal or catalytic 
activity is involved, as very low levels of dsRNA are capable of triggering 
interference. In some species e.g. C. elegans and Artemia, it can act systemically- 
reaching every cell in the organism, and in some cases may even be transmitted to 
the offspring (Tabara et al. 1998). Critical characteristics of siRNA duplexes for the 
silencing function are 5’ phosphate and 3’ hydroxyl termini on each strand (Zamore 
et al. 2000) and 2-nucleotide 3’ overhangs (Elbashir et al. 2001). We know that it is 
RNA and not DNA that is targeted, as sequences designed against introns are not 
effective (Montgomery and Fire 1998). dsRNA structures are cleaved to ~21bp 
fragments directly through the action of an RNase type III nuclease termed Dicer 
(Bernstein et al. 2001). It is thought that the antisense siRNAs are incorporated in a 
larger RNase complex (the RNA-induced silencing complex (RISC)), which targets 
homologous mRNA leading to their degradation (Hammond et al. 2000). Such 
ribonucleotide fragments can be synthesised in vitro specific to a target gene 
sequence and introduced in mammalian cells. Their cleavage by Dicer or RNase III 
into small interfering RNAs (siRNAs) results in the post-transcriptional silencing of
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the target gene. siRNAs bind with target mRNA and interact with proteins to form 
the dsRNA-induced silencing complex (RISC).
6.1.2 Construct design and sequence selection
Several methods of delivery have been described to establish RNA-mediated 
silencing in mammalian cell culture. The most efficient system at the time that this 
study commenced was through vector delivery. The pSUPER vector was used, which 
contains a sequence that forms a hairpin, allowing Dicer to excise the dsRNA that 
forms the hairpin arm (Brummelkamp et al. 2002). Sequence selection had to be 
vigorous however, with the efficiency of finding a successful sequence being 1 in 4. 
Promoters typically used to drive the expression cassette are either U6 or HI, both 
members of the type III polymerase promoters (Medina and Joshi 1999). They are 
located upstream of the transcribed region, eliminating the need for promoter 
sequence to be included in the siRNA design. Inserts shorter than 400 nucleotides 
can be transcribed, which is ideal for the expression of siRNA hairpin cassettes. The 
delivery of siRNA sequences into a cell instead of long dsRNA is advantageous, as 
siRNA does not elicit a non-target dependent interferon response that is potentially 
cytotoxic. Long dsRNA activates the cellular enzymes Protein Kinase R and 2’- 
5’oligoadenylate synthetase related to the interferon system.
This section aims to demonstrate the effects of lowering the levels of SOX2 in NSCs 
as well as to identify likely downstream targets of SOX2 by identifying changes in 
the expression profiles in lowered SOX2 conditions.
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6.2 Results
6.2.1 Reducing the levels of SOX2 in NSCs
6.2.1.1 Electroporation o f dominant negative constructs
To determine the effects of lowering SOX2 levels on neurosphere formation, single 
cells from dissociated primary neurospheres that had previously been selected for 
Sox2 expression, were electroporated using dominant negative constructs of Sox2. As 
a control, the EGFP-N1 vector was used in parallel electroporations on an aliquot of 
the same cells. Two different dominant negative constructs were used: A truncated 
form of Sox2 lacking the HMG box sequence, cloned into the pCMV/myc/nuc vector 
(Dr Karine Rizotti) and a fusion of Sox2 with the engrailed repressor domain, cloned 
into the pCI-neo vector (Dr Ariel Avilion). Both of these constructs have been 
previously used to demonstrate a dominant negative effect on SOX2 in ES cells (Dr 
Robin Lovell-Badge, unpublished data). After electroporation of the Sojc2-engrailed 
repressor domain fusion construct, no effect in the reduction of neurosphere numbers 
was observed. However 36 hours after electroporation with the Sox2 HMG- 
truncation construct, a 6-fold reduction in neurosphere numbers was seen compared 
to the control electroporation (control EGFP-N 1 vector 188 neurospheres, where 
standard error from the mean is ± 4.25, Sox2 HMG-truncation construct 32 
neurospheres, where standard error from the mean is ± 4.84. Experiments were 
performed in triplicate). The surviving neurospheres looked like typical proliferating 
cultures, without exhibiting elevated adherence to the culture dish surface or signs of 
grossly differentiated cellular morphology.
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6.2.1.2 RNAi by delivery o f a hairpin vector
Sequences from the Sox2 and control LacZ genes were selected based on established 
methods as being good predicted targets for RNAi (Brummelkamp et al. 2002). Four 
sequences for each gene (two from the N-terminal region of each gene and two from 
the HMG box for Sox2 and C-terminal region for LacZ) were selected and each was 
cloned into the EcoRI/XhoI sites of the pSUPER vector. The post-transcriptional 
knockdown activity of each siRNA sequence was assessed in Sox2^geo,+ ES cells. 
Downregulation of Sox2 in the embryo by targeted deletion causes a failure to isolate 
ES cells from the ICM due to their rapid differentiation (Avilion et al. 2003). Hence, 
differentiation was chosen as an indicator that the Sox2 siRNA constructs were 
having an effect. After ampicilin selection, X-gal staining of Sox2^geol+ ES cells 
transfected with control LacZ siRNA constructs was used as an indicator of RNA 
interference. As expected, white colonies were observed in cells transfected with 
LacZ constructs (Figure 6.1 B), but in cells transfected with Sox2 constructs, which 
should remain blue, white colonies were also observed (Figure 6.1 A). High levels of 
differentiation into typical ES cell derivatives were seen under both conditions. To 
investigate the presence of white colonies in the ES cells transfected with the Sox2 
construct, as a control, non-transfected Sox2^geol+ ES cells were subjected to X-gal 
staining. This assay revealed that a proportion of white colonies were present in the 
stock ES Sox2^eol+ line. The latter results probably reflect a deletion of an enhancer 
sequence 3’ to the Sox2 open reading frame (ORF), which compromises early 
expression (Avilion et al. 2003). This result, together with high levels of 
differentiation using construct against both genes, prevented the validation of the 
selected sequences. Transfection of the same constructs in neural stem cells showed 
no significant change in neurosphere numbers.
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Figure 6.1 RNAi in Sox2^eol+ ES cells against S0X2 and p-galactosidase. 
siRNA sequences used for silencing of SOX2 and p-galactosidase at the 
post-transcriptional level were tested in ES cells prior to delivery in NSCs. 
No effects were seen using Sox2 siRNA sequences (A). White colonies 
were seen after transfection with Lac siRNA sequences against P- 
galactosidase and subsequent X-gal staining (white arrowheads B), but these 
were also present in ES cells transfected with Sox2 siRNA (white 
arrowheads A). The mechanisms underlying this experiment are illustrated 
in cartoon C.
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6.2.1.3 RNAi by delivery o f  siRNA sequences
To increase the likelihood of selecting a good target sequence leading to 
protein knockdown, siRNA sequences were generated in vitro, prior to 
delivery. A region of the Sox2 ORF exhibiting low homology with other B1 
group genes was transcribed and recombinant Dicer was used for cleavage 
of the sequence into random 19-21 bp fragments, the length of siRNAs. The 
entire Egfp sequence from the Egfp-N 1 vector (800bp) was used as a control 
to assess transfection efficiency by EGFP protein knockdown in Egfp- 
expressing cells. Determining EGFP intensity via fluorescence microscopy 
enabled quick progress assessment during the experiment, offering an 
advantage over using LacZ control sequences. Through regular monitoring 
of EGFP, the maximum effect of protein knockdown was determined at 48 
hours (Figure 6.2 E, F and Figure 6.3 C). The use of a non-vertebrate 
protein as a control minimized the risk of interference with vital processes 
and ensured that knockdown effects observed were not due to intrinsic 
mechanisms, which may be independent of the experiment. RNAi was 
carried out on neurosphere-generating cells isolated from the dorsal 
telencephalon of Sox2^geol+;B5EGFP/+ mice, which ubiquitously express 
EGFP. Through immunofluorescence staining, maximum knockdown of 
SOX2 was also observed 48 hours post transfection (Figure 6.2 K, L and 
Figure 6.3 E). Cells were initially cultured as neurospheres and dissociated 
24 hours prior to transfection. Their subsequent ability to form neurospheres 
after reduction in the levels of SOX2 was investigated. No significant 
decrease in neurosphere number or size was observed in cells that had 
undergone RNAi for SOX2 compared to the EGFP control.
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Figure 6.2 RNAi against SOX2 and EGFP in NSCs (1). After transfection 
with siRNA sequences against EGFP, NSC cultures derived from R26- 
EYFP fluorescent mice show very little EGFP fluorescence (E, F) compared 
to untransfected controls (B, C). RNAi against SOX2 reveals lower levels of 
the protein as seen by immunofluorescence staining 48h post-transfection 
(K, L) compared to untransfected controls (H, I). Scalebar is 100pm (applies 
to all panels).
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Figure 6.3 RNAi against SOX2 and EGFP in NSCs (2). Independent example of an 
RNAi experiment identical to the one in Figure 2.9. The quality of this image is poor 
(due to a failing confocal laser) but it is important to show that the levels of SOX2 
remain unaffected in cells treated for RNAi against EGFP (A to C) and the levels of 
EGFP remain unaffected in cells treated for RNAi against SOX2 (D to F). Control 
transfections without siRNA sequences show that the protein levels for both SOX2 
and EGFP do not change (G to I). Scalebars represent 100pm. Scalebar in A applies 
in panels A to F and scalebar in G applies in panels G to I.
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6.2.2 Microarray analysis on neurospheres that have been subjected to RNA 
interference against SOX2
6.2.2.1 Determining S0X2 target candidates through fold-change in expression levels 
The gene expression profiles of neurospheres that have undergone RNAi against 
S0X2 and neurospheres that have not been transfected with an RNAi sequence were 
compared through microarray analysis on the Mouse 430A GeneChip platform. The 
experimental outline is shown in Figure 6.4 and the parameters for the experiment are 
summarised in Table 6.1. The control used was a population treated in an identical 
fashion as the RNAi-treated sample except that no siRNA sequence was used. This 
control offers the following advantage over a control that employs a population 
treated with a non-specific sequence: a likely interferon response or other side effects 
in the RNAi treated population can be detected in the microarray comparisons.
Figure 6.4 Microarray Experiment Outline: microarray analysis after RNAi. 
Microarray analysis was performed on NSCs derived from the dorsal telencephalon of 
14.5 dpc Sox2^geol+ mice after they had undergone RNA interference against SOX2, 
and compared to untreated NSCs. Both populations had previously been selected for 
the expression of Sox2j3geo to provide NSC enrichment.
DT Neurospheres (+G418) DT N eurospheres (+G418)
siR N A  a g a in s t  
SOX2
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Table 6.1 Determining potential targets o: ' SOX2 through RNAi interference
Experiment
Design
Type Normal neurospheres v Treated 
neurospheres (RNAi)
Experimental
Factors
48h treatment with siRNA (against SOX2)
Number of 
Hybridisations
2
Reference Sample None
Hybridisation
Design
RNAi treated (SOX2)- Control (No 
siRNA), see diagram
Quality Control 2 replicates
Samples Origin 14.5 dpc murine dorsal telencephalon of 
Sox2^geol+ mice (MF1 outbred background)
Manipulation Mechanical tissue dissociation, culture in 
NPM as neurospheres. Selected with 
neomycin (G418) for 10 days, dissociated 
into single cells on day 10 and transfected 
on day 11. Lipid based transfection 
(sIMPORTER (Ambion)) with siRNA 
sequences (or no siRNA) for 48 hours
Sample
Preparation
Extraction of total RNA using RNeasy 
Midi kit (Qiagen). DNase treatment using 
DNA-free (Ambion)
Labeling Protocol Biotin labeling
Hybridisation
Procedures
Parameters Affymetrix ‘Eukaryotic Sample and Array 
Processing’ guide followed for all 
protocols (see Methods)
Measurement
Specifications
Hardware
Information
GenAmp PCR System 9700 (Applied 
Biosystems), GeneChip Hybridization 
Oven 640, GeneChip Fluidics Station 450 
and GeneChip Scanner (all Affymetrix). 
NanoDropND-1000 spectrophotometer 
(Labtek) and Bio Analyzer 2100 (Agilent 
Technologies) for RNA quality control and 
quantitation
Software
Information
GCOS (Affymetrix), GeneSpring 7.2 
(Silicon Genetics)
Measurements
used
Raw values after GC RMA Normalisation, 
per chip, per chip: normalise to 50 
parcentile, per gene: normalise to median 
and data transformation: set measurements 
less than 0.01 to 0.01 (GeneSpring)
Array Design Platform Affymetrix GeneChip
Type Mouse 430A
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A 1.5-fold or higher level of expression in the control slides compared to SOX2 RNAi 
treated cells (i.e. 1.5-fold lower levels in SOX2 RNAi treated cells) was imposed as a 
cut-off to determine potential targets of SOX2 whose expression would be 
downregulated when levels of the SOX2 protein are low (14 genes short-listed). 
Genes that were short-listed and did not exhibit the same pattern in all replicates were 
eliminated (6 genes eliminated, 8 genes remaining). The expression levels of the 
short-listed genes were compared to those of genes known to be absent from 
neurosphere populations as determined from previous array studies. Genes that had 
similar arbitrary levels of expression to these negative controls were eliminated as 
these where showing expression differences of over 1.5-fold due to their differences 
with the expression of background signal that can have high fold changes when the 
numbers are very low.. After elimination of these unreliable genes as, only one gene 
remained as having significantly downregulated expression in SOX2 RNAi treated 
cells and that gene is Sox2. This was also the only gene to display higher than a two­
fold difference in levels of expression between the two conditions (2.26-fold).
Figure 6.5 Scatter plot of microarray results comparing cells that have and have not 
undergone RNAi against SOX2. Raw values of data from the sample of cells 
undergone RNAi against SOX2 (y-axis) were plotted against raw data from the 
sample of cells that were transfected without any siRNA sequences (x-axis). The line 
of best fit intercepting zero indicates a relative expression value of 1 i.e. genes that 
remain unchanged between the two conditions are plotted along this line. Blue lines 
on either side indicate 2-fold significant changes in relative gene expression favouring 
either condition. Dots represent individual genes and are coloured by expression 
where yellow marks genes with similar expression levels between the two samples, 
green marks genes that are expressed higher in the SOX2 RNAi-treated sample (as is 
the case for interferon response-related genes) and orange/red marks genes that are 
expressed higher in the control sample. As indicated, only SOX2 expression is over 
the 2-fold significance cut-off in the control sample indicating lower numbers of 
mRNA transcripts with siRNA treatment. The strength of the colours is relative to the 
arbitrary expression levels of individual genes.
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6.2.2.2 Determining SOX2 target candidates through clustering analysis 
An alternative approach was applied to identify potential targets of SOX2 that have 
been affected in SOX2 RNAi treated cells. All genes with an expression difference 
higher that one-fold in the control slides (11,545 genes), i.e. have higher levels in the 
control than in the SOX2 RNAi-treated, were subject to 10-way X-means clustering 
analysis. The cluster set containing Sox2 was isolated (1217 genes) as it included 
genes that had the most similar expression pattern to Sox2 across all array chips used
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in this experiment. Genes with arbitrary expression levels under 100.00 were 
eliminated from the list to exclude potential false positives, as their signal levels were 
similar to background signal levels. The remaining genes were subject to further K- 
means clustering (5-way, as the gene set could only be subdivided further into 5 sets) 
and the cluster group containing Sox2 was again isolated (246 genes). The highest 
expressing genes from this group were short-listed as potential targets of SOX2 that 
show downregulation after SOX2 RNAi treatment compared to the control (16 genes, 
Table 6.2). To gain insight into the potential role of these genes, they were classified 
according to their molecular function as in Table 6.3.
Table 6.2 Candidate target genes for SOX2. List of genes expressed the highest from 
those that show downregulation trends after SOX2 siRNA treatment i.e. in the 
presence of low levels of SOX2 protein. Genes are listed in the order of their arbitrary 
expression levels Sox2 being the highest.
Gene Name Common Name Description
1416967 at Sox2 SRY-box containing gene 2
1426679 at 3110006P09Rik RIKEN cDNA 3110006P09 gene
1435176 a  at Idb2 inhibitor of DNA binding 2 (Id2)
1428080 at 2610528A17Rik RIKEN cDNA 2610528A17 gene
1418816 at 2810405111Rik RIKEN cDNA 2810405111 gene
1424586 at AF424697 DNA sequence AF424697
1424571 at Ddx46 DEAD (Asp-Glu-Ala-Asp) box polypeptide 46
1423921 at C77668 expressed sequence  C77668
1428612 at Apg7l autophagy 7-like (S. cerevisiae)
1448985 at Dusp22 dual specificity phosphatase  22
1418088 a  at Stx8 syntaxin 8
1421177 at 9030625G08Rik RIKEN cDNA 9030625G 08 gene
1425090_s_at Kcnc4 potassium voltage gated  channel, Shaw-related subfamily, 
m em ber 4
1426607 at 3110070M22Rik Transcribed seq u en ces
1450295 s  at D7Ertd458e DNA segm ent, Chr 7, ERATO Doi 458, expressed
1422647_at Ringl ring finger protein 1
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Table 6.3 Gene Ontology classifications of candidate target genes of SOX2. Genes, as 
listed in Table 2.3, are classified according to molecular function.
Common Name Gene Ontology Classification
Sox2 Cell fate specification: DNA binding, transcription factor activity
3110006P09Rik —
Idb2 Development
2610528A17Rik Metabolism: catalytic activity
2810405111 Rik —
AF424697 —
Ddx46 Helicase activity
C77668 —
Apg7l Ubiquitin activating enzyme activity
Dusp22 Phosphatase activity, positive regulation of JNK cascade
Stx8 Transporter activity
9030625G08Rik DNA binding, nucleic acid binding
Kcnc4 Potassium  ion transport: cation channel activity
3110070M22Rik —
D7Ertd458e R eceptor activity: cell-cell adhesion, cell migration; signal transducer
Ringl Chromatin modification, transcriptional repressor activity
6.2.2.3 Further analysis o f candidate target genes- Id2
From the list of candidate target genes of SOX2, Idb2 (Id2) was the most interesting 
gene for further study, as it is highly expressed in neurospheres and it has been 
previously implicated in the maintenance of the undifferentiated state and the 
suppression of neurogenesis (discussed in section 6.3.3). Analysis of the promoter 
sequence for Id2 did not reveal any putative binding sites of the SOX consensus 
binding motif (A/T)(A/T)CAA(A/T)G. Computational analysis 10Kb further 
upstream of this promoter exposed five potential binding sites for SOX2 (Table 6.4). 
These sites may be located within potential cw-regulatory element sequences. These 
sites however, are not clustered in one location, which would suggest that the region 
might be a potential enhancer with multiple binding sites. In the ld2 promoter 
sequence, there are two sites of sequence ACCAATG - ‘C’ in bold font differs from 
the SOX consensus binding sequence, but this sequence may also have the potential to 
act as SOX2 binding sites (Table 6.4). One of these two sites in the promoter region
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overlaps with a functional binding site for C/EBPp (Karaya et al. 2005). The location 
of these sites in the Id2 promoter encourages the hypothesis that Id2 may be a direct 
target of SOX2 involved in the maintenance of an undifferentiated state in neural stem 
cells.
Table 6.4 Potential binding sites for SOX2 upstream of the murine Id2 gene. 
Sequences in black are putative binding sites. Sequences in red indicate potential sites 
in the Id2 promoter sequence.
S equence Site location from  transcrip tiona l s ta r t
AACAATG -9941 to -9934
AACAATG -8858 to -8851
TACAAAG -8104 to -8097
TTCAAAG -3325 to -3315
AACAATG -5386 to -5379
ACCAATG -126 to -120
ACCAATG -82 to -76
6.3 Discussion
6.3.1 Dominant negative approaches in neurosphere cultures
RNAi interference against Sox2 in murine dissociated neurospheres via transfection 
siRNA sequences in pSUPER did not reveal an apparent phenotype in the cells during 
the 48-hour period post-transfection (section 6.2.1.2). When a dominant negative form 
of SOX2 was electroporated into dissociated primary neurosphere cells, a reduction in 
the number of secondary neurospheres generate was observed (section 6.2.1.1). In this 
dominant negative approach, the construct employed a truncation in the HMG box, 
which makes it likely not to be specific for SOX2 and to also work against SOX1 and 
SOX3. Electroporation using an engrailed repressor domain fusion to SOX2 acting as 
dominant negative did not reveal a reduction in neurosphere numbers. This construct 
did function to reduce neuropoiesis in a Xenopus embryo assay (Karine Rizzoti, 
personal communication) but perhaps it was too short-lived in the transfected
173
neurospheres or too specific against Sox2 (if functional redundancy is an issue) to 
give a noticeable reduction in secondary neurosphere generation. To assess this, 
subsequent detailed differentiation assays of the electroporated cells are required. It is 
likely that functional redundancy between the B1 subgroup genes reduces the severity 
of the phenotype seen through the engrailed repressor domain construct. There are 
data to suggest that SOX1 and SOX3 are not required for the neural stem cell state 
(unpublished data). This does not mean that they would not be able to function in the 
place of SOX2 when this is absent. To determine if functional redundancy is taking 
place, the engrailed repressor domain-SOX2 fusion construct can be introduced in 
Soxl null, Sox3 conditional null neurospheres. As discussed earlier, the transient 
nature of the siRNA transfections limits the effects that can be seen in the cells 
therefore alternate approaches where required.
6.3.2 RNA interference against SOX2
There is increasing evidence that SOX2 is important in the maintenance of the neural 
stem cell state (Zappone et al. 2000; Bylund et al. 2003; Graham et al. 2003; Kondo 
and Raff 2004). From experiments using rat neural stem cell and oligodendrocyte 
precursor-derived neural stem cells it was shown that it’s activation depends on the 
recruitment of Brcal and Brm (Brahma) to an enhancer in the Sox2 promoter region 
(Kondo and Raff 2004). However, other more specific transcription factors are also 
likely to be involved in Sox2 expression, perhaps including SOX2 itself in an 
autoregulatory loop. RNAi on Sox2 in rat neural stem cells induces neurogenesis 
(Kondo and Raff 2004). The microarray analysis presented here on RNAi treated 
murine neural stem cell cultures of the 14.5 dpc dorsal telencephalon does not indicate 
significant upregulation of genes associated with neuronal differentiation such as 
neurogenins, neurofilaments and specific markers characteristic of differentiating
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neurons (Figure 6.5). The analysis of the gene expression profiles in these cells took 
place 48 hours post transfection, where maximum levels of SOX2 protein knock­
down are seen through immunofluorescence (western blots were also performed but a 
low specificity of the antibodies used in this method made it difficult to quantify the 
reduction in protein levels)(Figures 6.2 and 6.3). However, this effect was only 
transient, with levels of SOX2 returning to normal after 4 days. Perhaps if a stable 
transfection system had been used, the indirect impact on neurogenesis and 
gliogenesis would have been observed. Post-RNAi differentiation assays were 
performed by Kondo and co-workers after 5 days under differentiation promoting 
conditions. A requirement for SOX2 to inhibit neurogenesis is supported by results 
described earlier, where reduced numbers of neurons differentiate from Sox2^geol+ 
selected neurospheres (Figure 4.2) and in the presence of G418 during differentiation 
culture (section 3.2.3.1). However, this is not absolute as some differentiated neurons 
in the adult brain maintain Sox2 expression.
6.3.3 Candidate transcriptional targets ofSOX2
As indicated from the genes significantly upregulated in the siRNA-transfected cells, 
there was an interferon response, most likely due to remaining dsRNA that was not 
cleaved by Dicer into siRNA fragments. This is likely, as no method to eliminate 
uncleaved dsRNA was employed prior to transfection of the sequences. This 
response, makes it difficult to determine which, if any, genes may be normally 
repressed by SOX2. To determine the genes normally positively regulated directly or 
indirectly by SOX2, higher transcript levels would be expected in the control non­
transfected population compared to the RNAi-treated sample. Apart from 
immunofluorescence analysis to determine the efficiency of transfections, microarray
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hybridisations of RNA from SOX2 siRNA-transfected cells against RNA from non­
transfected control cells revealed that the levels of Sox2 mRNA are significantly 
lower in the siRNA transfected cells (Figure 6.5). The levels of expression of other 
SOX B1 subgroup genes (Sox! and Sox3), as well as of other Sox genes, were 
unaffected, highlighting the specific nature of the siRNA, which was generated 
against a non-homologous region of the Sox2 ORF excluding the HMG box. It has 
been previously proposed that SOX2 acts as a transcriptional activator for its own 
regulation (Tomioka et al. 2002; Boyer et al. 2005). This remains a possibility 
although it cannot be determined if the lower expression levels are solely due to 
mRNA degradation or not. Although the in silico method of designing siRNA 
sequences was efficient, in that it elicited specific protein knock-down effects, the 
particular siRNA sequences responsible for this effect cannot be determined unless all 
of the potential short RNA sequences are individually designed and assayed in 
numerous combinations. Since only Sox2 showed significantly lower levels of 
expression after RNAi treatment, other bioinformatic methods were used to determine 
candidate target genes that may be positively regulated by SOX2. The highest 
expressing genes that showed similar expression to Sox2 across the arrays were short­
listed as described in the results section of this chapter. The highest expressing known 
gene in this list, apart from Sox2, is Idb2 (which from here on will be referred to as 
Id2). Id2 encodes a well-characterised inhibitory bHLH protein that has an inhibitory 
impact on neurogenesis. Unlike other bHLH proteins, Id family members are unable 
to bind DNA. They contain a dimerization domain and can therefore form non­
functional dimers with other bHLH proteins (Benezra et al. 1990). Proneural bHLH 
proteins (as are neurogenins), which normally bind DNA as heterodimers with the 
ubiquitously expressed E proteins, form non-functional dimers with Id proteins
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(Coppe et al. 2003). This results in the inhibition of proneural protein activity; the Id 
proteins negatively regulating the differentiation of neural precursors. The 
overexpression of Id2 is also known to inhibit the expression of neuron-specific genes 
and to promote the apoptosis of cortical progenitors (Toma et al. 2000). Subsequent 
inhibition or targeted deletion of Id2 protects neurons from apoptosis (Gleichmann et 
al. 2002). An involvement of Id proteins in the Notch signalling pathway (which is 
important in regulating neurogenesis) has been shown by Reynaud-Deonauth and co­
workers (Reynaud-Deonauth et al. 2002). Also, BMPs can lead to the induction of Id 
genes in neuroepithelial cells (Nakashima et al. 2001).
6.3.4 The possible relationship between Id2 and Sox2 in NSCs 
In the microarray pair-wise comparison experiments of non-selected Sox2^geol+ and 
neural stem cell-enriched populations selected for the expression of Sox2, Id2 levels 
are significantly higher in the former (2.7-fold difference) (section 4.2.1.4). Id2 is 
expressed in oligodendrocyte precursor cells (OPCs) prior to lineage commitment. At 
this early OPC stage, the expression of the bHLH factor Olig2 is inhibited by ID2 (as 
well as ID4), which localises in the nucleus (Gokhan et al. 2005). Its expression 
continues in oligodendrocytes undergoing lineage specification, where nuclear ID2 
and its inhibitory action is overcome through the synergistic expression of the bHLH 
factors Oligl, Mashl, the homeodomain protein-coding gene Nkx2.2 and SoxlO. 
These factors are all able to activate the myelin basic protein (MBP) promoter and 
those of other myelination genes (Gokhan et al. 2005). Through these microarray 
comparisons it became apparent that a high proportion of genes involved in 
myelination are also expressed at higher levels in the non-selected neurospheres. The 
increase in the expression of Id2 may be a result of a larger proportion of
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oligodendrocyte precursor cells undergoing commitment. To understand the 
relationship between Sox2 and Id2, the region lOkb upstream of the Id2 gene was 
analysed. In the promoter region, two sites were found that could act as SOX2 binding 
sites, although they differ in one nucleotide from the consensus binding motif (section 
62.23). Functional analysis of these sites needs to be performed to determine if 
SOX2 does indeed bind to regulate the transcription of Id2.
6.3.5 The relationship between Stat3 and Id2
There are several reports that suggest a direct activation of Id2 by STAT3 (Gu et al. 
2005; Sekkai et al. 2005). From the microarray analysis performed on SOX2 RNAi- 
treated cells, Id2 was identified as a potential target of SOX2. SOX2 and STAT3 may 
therefore both be involved in the activation of Id2. From the recent report mentioned 
which identifies STAT3 as a potential SOX2 target in human ES cells, the expression 
of Stat3 is expected to be lower in SOX2 RNAi-treated cells than in the control. 
Surprisingly, the expression of Stat3 is higher in these cells relative to the control. 
However, as discussed earlier, an interferon response is elicited in the RNAi-treated 
population. Extracellular interferons are known to activate Stat genes and this is likely 
to be happening in the RNAi treated cells. IFNa and IFNy have been shown to 
specifically induce St at3 activation in mouse retinal explants (Zhang et al. 2005). 
Supporting this hypothesis, Statl shows highly increased expression levels in the 
RNAi treated cells (10-fold increase), as do several known interferon-induced genes 
{Ifit3, I flt f  Ifltm, Ifi35, I f f  Isgf3g and Igtp). It is possible that the small increase in 
the levels of Stat3 (1.2-fold increase) is buffered by a potential reduction in Stat3 
expression by lower levels of SOX2, if this regulatory mechanism is also in place in 
NSCs. One way of establishing if endogenous Sox 2 activates St at3 in these cells is to
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perform an EGFP RNAi control transfection alongside SOX2 RNAi. If an interferon 
response is generated from the EGFP RNAi, then St at3 should be activated. If the 
levels of St at3 mRNA in the EGFP RNAi treated cells are significantly higher than in 
the SOX2 RNAi treated cells, this would suggest that SOX2 contributes to the 
activation of Stat3 in NSCs.
To determine if there is a STAT3-independent action of SOX2 on ld2 expression, the 
following can be performed: Stat3 conditional null embryos can be used to derive 
NSCs, which can undergo RNAi for SOX2 and subsequent microarray analysis 48 
hours post-transfection. We expect the levels of Id2 mRNA to be lower in St at3 null 
cells than in wild type cells. If in SOX2 RNAi treated, Stat3 null cells, the levels of 
Id2 mRNA are even lovter, then this would confirm that SOX2 can regulate Id2 in a 
STAT3-independent manner.
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CHAPTER 7 
Conclusions and Future Directions
The initial aims of this thesis were to examine differences between neural stem cells 
and lineage-restricted progenitors, and to determine if NSCs isolated from separate 
regions or stages during CNS development are essentially identical, but behave 
differently according to extrinsic cues, or if they are innately distinct. Through this 
work, novel candidate markers for NSCs have been identified, which should 
contribute to our understanding of their biology. During the time of this PhD 
research, the glial character of at least some NSCs has been confirmed in the 
literature by other researchers, and their plasticity in giving rise to each of the major 
CNS lineages, as well as to other cell types has been demonstrated. NSCs in the 
embryo have been characterised as radial glia, while those in the adult are a 
subpopulation of astrocytes derived from radial glia. Despite a lineage relationship 
and both having stem cell properties, these clearly correspond to distinct NSC 
populations. However, one aspect of neural stem cell identity that had not been 
examined was whether distinct NSC populations co-exist at the same developmental 
stage in different regions of the CNS. This thesis has highlighted some of the 
differences in the character of NSCs residing in the embryonic spinal cord and dorsal 
telencephalon. As highlighted from microarray analysis, neurosphere cultures from 
the embryonic spinal cord and dorsal telencephalon have veiy similar expression 
profiles and they share a large common subset of genes, which are preferentially 
expressed at high levels in NSC-enriched cultures. At the same time, they retain 
some of their spatial and temporal properties. It remains unclear, if these two NSC 
types are interchangeable in vivo, having the competence to respond correctly to
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local environmental cues. Assessment of this would be the next step towards 
determining the plasticity and intrinsic character of NSCs.
Selection for the expression of Sox2/3geo provided an initial enrichment for NSCs in 
vitro, but it is likely that the removal of differentiated subsets of cells has had an 
impact on the proportion of the NSCs themselves. This seems to include a change of 
long-term potential. These experiments support the notion that extrinsic cues 
provided by differentiated cells in vivo might play a role in the maintenance of the 
stem cell state. The altered environment within selected Sox2/3geo neurospheres may 
result in the loss of the ability of NSCs to respond to particular extrinsic cues, 
highlighting the importance of the microenvironment.
Amongst the short-list of candidate markers generated to aid in the process of 
deconstructing sternness, there are candidates already implicated in the maintenance 
of the stem cell state, such as St at3. The interactions between STAT3 and SOX2 are 
being investigated further and recently, SOX2 has been shown to regulate St at3. The 
expression of Sox2 was shown to be of importance for the generation of 
neurospheres. Its role appears to be essential for the maintenance of the stem cell 
state and for inhibition of neurogenesis. Candidate target genes for SOX2 were 
identified through RNAi against SOX2, followed by microarray analysis. One 
interesting candidate target gene is Id2, which inhibits neurogenesis through the 
formation of non-functional dimers with bHLH proteins. STAT3 has been shown to 
regulate Id2, but in these RNAi experiments, the levels of St at3 mRNA were raised, 
probably due to an interferon response. Nevertheless, this leads to the hypothesis that 
SOX2 may regulate Id2 in a STAT3-independent manner. Experiments following on
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from this thesis will aim to determine if SOX2 and STAT3 have unique and 
independent roles in NSCs or if their action to inhibit differentiation and promote 
their stem cell state is synergistic. A working model incorporating some of the 
factors involved in neurogenesis and gliogenesis is outlined below. This is almost 
certainly an over-simplification as it does not take into account Notch signalling or 
the role of regional fate determinants such as Pax6. However, it provides a few 
additional connections that can now be tested by experimentation.
Figure 7.1 Potential pathways leading to neurogenesis or gliogenesis. A glial 
character has been associated with neural stem cells. The interactions between the 
factors shown here have previously been proposed in the literature by others apart 
from the direct regulation of ID2 by SOX2. Data in this thesis has led to the proposal 
of this interaction.
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CHAPTER 8 
Materials and Methods
8.1 ANIMALS
8.1.1 Animal care
Animals were kept on a 12 hour light-dark cycle and food and water where provided 
ad libidum. The day of detection of a vaginal plug was taken as 0.5 days post coitum, 
assuming the time of conception was half way through the dark phase. All methods 
where carried out under Home Office approval.
8.1.2 Genotyping
8.1.2.1 Preparation o f DNA from murine tail biopsies
Tail pieces (25mm) were lysed overnight at 55°C in tail lysis buffer, with lOOpg/ml 
proteinase K. Phenol extraction was performed by adding an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1) and centrifuging on a desktop 
centrifuge (Heraeus) at 16,000g  for 15 minutes. The aqueous phase was used for 
PCR.
8.1.2.2 PCR genotyping for the Sox2^geo allele
The primers used for the Sox2 targeted allele were: sense (Sox2 5’UTR) 5’ CAC 
AGT CCT GGC CGG GCC GAG G 3’,antisense (pgeo) 5’ GTA GAT GGG CGC 
ATC GTA ACC GTG C 3’, generating a 336 base pair fragment, and for the Sox2 
wild type allele: sense 5’ GGC AGC TAC AGC ATG ATG CAG GAG C 3’, 
antisense 5’ CTG GTC ATG GAG TTG TAC TGC AGG 3’, generating a 130 base 
pair fragment. The PCR profile consisted of 94°C for 1 minute (1 cycle), 92°C for 1
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minute, 60°C for 1 minute, 72°C for 2 minutes 30 seconds (36 cycles) and 72°C for 5 
minutes (1 cycle). A Peltier Thermal Cycler (MJ Research) was used for all 
reactions.
8.1.2.3 PCR genotyping for the Stat3^ox/+ allele
The primers used for the Stat3 floxed allele were: sense (APRF_11_UP) 5’ CAC 
CAA CAC ATG CTA TTT GTA GG 3’, antisense (APRF_1 l_DOWN) 5’ CCT 
GTC TCT GAC AGG CCA TC 3’, generating a 400 base pair fragment, and for the 
Stat3 wild type allele: sense (APRF_11_UP) as before, antisense
(APRF14_DOWN) 5’ GCA GCA GAA TAC TCT ACA GCT C 3’, generating a 
250 base pair fragment. The PCR profile consisted of 94°C for 4 minutes (1 cycle), 
94 °C for 1 minute, 60°C for 2 minutes, 71°C for 3 minutes (35 cycles) and 72°C for 
5 minutes (1 cycle). A Peltier Thermal Cycler (MJ Research) was used for all 
reactions.
8.2 CELL CULTURE & TREATMENT
8.2.1 Neurosphere generation from the dorsal telencephalon of 14.5 dpc Sox2^ 
geo/+ mice
Sox2^geo/+ males were crossed with wild type MF1 females and checked for the 
presence of vaginal plugs. At day 14.5 of gestation, pregnant dames were killed 
using schedule 1 methods and the embryos were dissected free from their decidua in 
PBS-A. Complying with schedule 1 methods, the head of each embryo was severed 
from the body. Both eyes of each embryo was dissected out and stained for p- 
galactosidase activity to identify Sox2^geo/+ positive animals. The heads were
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transferred into DMEM F-12 media containing lOOU/ml penicillin G and lOOpg/ml 
streptomycin sulfate (both Gibco). Both lobes of the dorsal telencephalon were 
dissected out, and surrounding membranes were removed. Telencephalons from 
Sox2^geo/+ positive mice were placed on ice in neurosphere proliferation medium 
(NPM). Up to four lobes were combined and dissociated into one 6cm tissue culture 
dish. Tissue was mechanically triturated into a single-cell suspension using fire- 
polished Pasteur pipettes. The dissociated cells were passed through a 40pm cell 
strainer (Falcon). The cellular flow-through, a suspension culture, was incubated at 
37°C, 5% CO2. Cells were re-dissociated after 24 hours, and passed through a 70pm 
strainer (Falcon) without a medium change. 72 hours after initial culturing, the 
medium was replaced with fresh NPM. From the following day and for a minimum 
of 10 days, daily media changes were performed, using NPM with 250 pg/ml G418, 
in order to select for Sox2^geo/+ expressing cells for the duration of the culture. For 
the generation of non-selected Sox2^geo/+ neurospheres, G418 was not added in the 
medium. Wild type neurospheres were generated from wild type littermates of Sox2^ 
geo/+ mice.
8.2.2 Generation of neurospheres from the spinal cord of 14.5 dpc mice
Whole spinal cords from Sox2^geo/+ mice were dissected out and attached somites 
were removed. Neurospheres were generated as described above, in identical 
conditions to those used for generation of neurospheres from the dorsal 
telencephalon.
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8.2.3 Generation of neurospheres from the SVZ of adult mice
Eight Sox2^eo/+ adult males were killed using schedule 1 methods and cells from the 
subventricular zone (SVZ) were isolated in PIPES solution. The dissected tissue was 
pooled and the PIPES solution was replaced with activated Papain solution, filtered 
through a 22 pm syringe filter. After the addition of DNase I (20U), the tissue was 
incubated at 37°C for 1 hour with gentle agitation. The tissue was centrifuged at 
1200 rpm for 10 minutes at 4°C and the enzyme solution was replaced with 1ml 
DMEM-F12. The tissue was triturated into a single cell suspension using a fire- 
polished Pasteur pipette. A further 7 ml DMEM F-12 were added and the cells were 
centrifuged at 1200 rpm for 10 minutes at 4°C. The DMEM F-12 was replaced with 
NPM plated on a 6 cm culture dish. To select for Sox2pgeo/+ expressing cells, G418 
was added in the medium at a concentration of 250 pg/ml, 72 hours after initial 
culturing.
8.2.4 Differentiation of neurospheres
18 day old neurospheres were placed onto Matrigel-coated Sonic Seals and allowed 
to settle and adhere overnight in neurosphere differentiation media (NDM) at 37°C in 
5% CO2. Differentiating neurospheres were cultured for five days, the medium being 
replaced daily with fresh NDM. On the fifth day they were fixed under appropriate 
conditions for subsequent immunofluorescence/p-galactosidase activity staining.
8.2.5 Embryonic Carcinoma (EC) cell culture
PI9.6 EC cells (passage 12) were stored in liquid nitrogen in 0.5ml aliquots in 10% 
DMSO in foetal calf serum (FCS). Cells were thawed following standard protocols 
and resuspended at a density of 3x106 cells per 10ml PI9 cell medium. Cells were
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cultured on gelatin-coated 10cm culture dishes at 37°C, 5% CO2 and passaged 
following trypsinisation at a 1:9 ratio every 48 hours.
8.2.6 Embryonic Stem (ES) cell culture
Feeder-independent, LIF-dependent Sox2^geo ES cells (passage 24) were stored in 
liquid nitrogen in 0.5ml aliquots in 10% DMSO in FCS. Cells were thawed following 
standard protocols and resuspended at a density of 3x106 cells per 10ml ES cell 
medium. Cells were cultured on gelatin-coated 10 cm culture dishes at 37°C, 5% 
CO2 and passaged following trypsinisation at a 1:3 ratio every 48 hours.
8.2.7 Fluorescent Activated Cell Sorter Analysis
For Fluorescent Activated Cell Sorter (FACS) analysis on Sox2^eol+ cells, 1-2 x 107 
cells were dissociated into a single cell suspension, washed in PBS-CMF and 
resuspended in 200pl NPM with 10% FCS. The CMFDG LacZ staining kit 
(Invitrogen) was used as follows: 1% of the total volume CMFDG reagent and 0.1% 
verapamil (to reduce the efflux of the product) were added and cells were incubated 
at 37°C for 45 minutes. To stop the reaction, cells were diluted to 1 ml in ice-cold 
serum-containing medium and 2% of total volume PETG (competitive inhibitor of P- 
galactosidase) was added. Cells were strained through a 40pm cell strainer (Falcon) 
and sorted into positives and negatives with a FlowJo in the FL1 channel.
For FACS analysis using specific antibodies, single cells were washed in PFN and 
fixed in 2% PFA for 20 minutes on ice, washed briefly in PBS-0.5% saponin 
(Sigma), then incubated in PBS-0.5% saponin for 20 minutes on ice. The wash was 
replaced with the appropriate dilution of primary antibody in PBS-0.1% saponin, and
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the cells were incubated for 30 minutes on ice. Cells were washed briefly three times 
in PBS-0.1% saponin and incubated in an appropriate dilution of secondary antibody 
(anti-mouse or anti-rabbit Alexa Fluor 488 (Molecular Probes)) in PBS-0.1% saponin 
for 30 minutes at room temperature. The secondary antibody solution was rinsed 
three times in PBS-0.1% saponin and cells were resuspended in PFN. Cells were 
analysed using a BD FACSCalibur in the FL1 channel.
For both methods, compensation was performed using the Beckton-Dickinson 
CELLQuest software using either a wild type cell sample (i.e. non-pgeo) stained in 
the same way or a negative control incubated only in secondary and not in primary 
antibody solution. Data was further analysed using the FlowJo 5.5 software.
8.2.8 Bromodeoxyuridine (BrdU) assay on neurospheres
Neurospheres were incubated for 4 hours in NPM containing 10pM BrdU in PBS 
(lOmg/ml stock). After washing briefly in PBS Neurospheres were dissociated and 
single cells were plated on poly-D-lysine coated slides before treatment and 
subsequent BrdU antibody staining.
8.2.9 BrdU assay on cortical cells- in vivo labeling
lOOpg of BrdU in PBS-A per gram of mouse weight were administered by intra- 
peritoneal injection to pregnant dames. After 30 minutes, pregnant dames were killed 
using schedule 1 methods and embryos were harvested and fixed for subsequent 
sectioning.
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8.2.10 BrdU assay on cortical cells- in vitro labeling
Cells were pulsed with DMEM-F12 medium containing IOjjM BrdU in PBS-A for 
45 minutes at 37°C, 5% CO2.
8.2.11 Electroporation of neural stem cells to introduce plasmid vectors
Neural stem cells were mechanically dissociated into a single-cell suspension using 
fire-polished Pasteur pipettes. Cells were centrifuged for 5 minutes at lOOOrpm and 
resuspended in 800pl ice-cold PBS-CMF at a density of 1.5 x 106 cells per ml. The 
cell suspension was mixed with 20 pg of appropriate circular plasmid in 0.4 cm 
electroporation cuvettes (Bio-Rad) and electroporated at 300V, 500pF using a Bio- 
Rad Gene Pulser, then allowed to recover on ice for 30 minutes before plating in pre­
warmed NPM.
8.3 HISTOLOGY
8.3.1 Preparation of embryos for paraffin sections
Sox2^geo/+ embryos stained for P-galactosidase activity and stored in 50% glycerol 
were placed in 80% ethanol in for 20 minutes and then in 70% ethanol overnight. 
They were then progressively dehydrated for 20 minutes in washes of 80%, 90% and 
three washes in 100% ethanol at room temperature. To clear, embryos were passed 
once through 50%/50% ethanol/xylene and twice in 100% xylene for 20 minutes. 
The embryos were equilibrated in a mixture of 1:1 xylene :fibrowax (BDH) for 20 
minutes at 60°C. The solution was replaced with pure molten fibrowax three times 
for 20 minutes at 60°C, using a Blockmaster Embedding Centre (Reynard-Lamb). 
The embryos were transferred to fresh wax in dispomoulds (CellPath), which were 
then allowed to cool for the wax to set.
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8.3.2 Sectioning and counterstaining of paraffin-embedded embryos
14.5 dpc Sox2^geo/+ embryos were sectioned at 6pm thickness, using a Leica RM 
2165 microtome. Wax sections were floated on a 50°C section-mounting water bath 
(Electrothermal) and then mounted on Superfrost+ slides (BDH) and allowed to dry. 
Slides were de-waxed by twice immersing in Histoclear for 10 minutes at room 
temperature. The slides were rehydrated through a decreasing ethanol series (3 x 
100%, 1 x 90%, 1 x 80%, 1 x 70%, 1 x 50% 1 x 20%), then washed in distilled 
water. Eosin counterstaining was performed followed by an ethanol dehydration 
series (briefly through 1 x 20%, 1 x 50%, 1 x 70%, 1 x 80%, 1 x 90%, 3 x 100%). 
Slides were rinsed in Histoclear two times for 5 minutes and mounted with DPX 
mounting medium (Raymond Lamb) under glass coverslips.
8.3.3 Preparation and sectioning of paraffin-embedded neurospheres
Fixed neurospheres were set in 4% low melting point agarose in PBS and cut in 
0.3cm diameter blocks. The neurosphere-containing blocks were then treated as 
described above (Preparation of embryos for paraffin sectioning). Blocks were 
sectioned at 3pm thickness, using a Leica RM2165 microtome as described above 
(Sectioning and counterstaining of paraffin-embedded embryos).
8.3.4 Preparation and Cryosectioning of 14.5 dpc embryos
Embryos were fixed in 4% PFA (30 minutes for neurospheres, 2 hours for 14.5 dpc 
embryos) and washed in PBS-A. They were placed in 20% sucrose in PBS for 4 
hours (until fully sunk). Embryos were transferred into OCT Compound which was 
replaced after 10 minutes. Samples were then transferred into fresh OCT compound
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in Dispomoulds and frozen on dry ice. They were stored at -80°C until required for 
cryosectioning. 10-15pm (12pm) sections were cut using a Cryostat (Leica).
8.4 PROTEIN METHODS
8.4.1 Fixation of cells/neurospheres
Samples were washed with PBS-CMF. They were fixed in either: 4% PFA for 20 
minutes on ice, or in MEMFA for 15 minutes on ice, or in ice cold 100% methanol 
for 15 or 30 minutes on ice or in ethanol/acetic acid for 15 minutes at room 
temperature, then briefly washed with PBS containing 0.1% Triton-X.
8.4.2 Staining for p-galactosidase activity
14.5 dpc embryos were fixed with Glutaraldehyde/Formaldehyde fixative for 15 
minutes on ice. Neurospheres and embryonic stem (ES) cells were fixed under the 
same conditions for 10 minutes. After fixation, all samples where washed in buffer 
Lo. LacZ Staining Solution was added, through a 0.22pm syringe filter to cover the 
samples and the enzymatic reaction allowed to proceed in the dark at 37°C overnight. 
Embryos were stored in 50% glycerol. Stained neurospheres and ES cells were post­
fixed in 4% paraformaldehyde (PFA) and stored in PBS-A at 4°C. Images of 
neurospheres were captured using a Leica MZ75 dissection microscope at 5x 
magnification and of embryos at 0.8x magnification, using the Leica IM50 Software.
8.4.3 Immunofluorescence antibody staining on cells/neurospheres
Fixed samples were washed briefly in Blocking Buffer. The primary antibody, 
diluted in blocking buffer containing 1% sheep serum was added to the sample and 
incubated overnight with gentle rocking at 4°C. The excess primary antibody
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solution was removed and the sample washed three times with Blocking Buffer. The 
secondary antibody diluted in Blocking Buffer containing 1% sheep serum, was 
added and incubated for 30 minutes at room temperature, on a shaker, in the dark (for 
fluorescent secondary antibodies). The excess secondary antibody solution was 
removed and the sample rinsed three times with Blocking Buffer. One drop of 
Vectashield with 4’,6-Diamidino-2-phenylindole (DAPI) (Vector Laboratories) was 
added on Superffost slides and the samples were mounted. All immunofluorescence 
images were obtained with a Leica TCS SP confocal using a UV 10x/0.4 or 40x/0.5 
NA dry HC-PLAPO lens (Leica) and were composed of 16 sections of 4 accumulates 
per section unless otherwise specified. Images were processed using the ImageJ 
1.30v (National Institutes of Health) and Adobe Photoshop CS v8.0 (Adobe Systems) 
software packages.
8.4.4 Immunofluorescence antibody staining on cryosections
Slides were air-dried and washed for 2 minutes in PBS-CMF. They were blocked for 
1 hour in PBS-CMF containing 0.1% Triton and 10% heat-inactivated sheep serum. 
Primary antibody was added and incubated overnight at 4°C, in Blocking Buffer 
containing 1% sheep serum. Slides were washed 3 times for 5minutes in PBS-T 
(PBS + 0.1% Triton X-100). The appropriate secondary antibody was added and 
incubated for 30 minutes in the dark at room temperature in Blocking Buffer 
containing 1% sheep serum. Slides were washed twice for 5 minutes. Excess solution 
was removed and 22x64 mm coverslips (BDH) were mounted using Vectashield with 
DAPI (Vector laboratories).
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8.4.5 TUNEL assay on neurosphere sections
Wax sections were air-dried for 24 hours, heated to 60°C for 15 minutes then cooled 
to ambient temperature. They were passed twice through Histoclear for 10 minutes, 
once through 50% Histoclear/50% Ethanol for 5 minutes, then through a progressive 
ethanol series (twice in 100%, 90%, 70%, 50% for 5 minutes in each) before rinsing 
in 0.1% Triton-X in 0.1% sodium citrate. They were permeabilized on ice for 8 
minutes in 0.1% Triton-X in 0.1% sodium citrate ad finally rinsed in PBS-A. Slides 
were incubated in TUNEL Labeling solution (terminal deoxynucleotidyl transferase 
in reaction buffer containing labeled nucleotide mix (both Roche)) for 1 hour at 30°C 
in the dark then rinsed in PBS-A, air-dried and mounted. Fluorescence detection was 
performed using standard settings for fluorescein.
8.4.6 Pre-treatment of sections/slides for BrdU antibody staining
After immunofluorescence labeling using appropriate primary and secondary 
antibodies, slides were washed 3 times for 5 minutes each in Blocking Buffer and 
post-fixed in 4% PFA for 5 minutes. Sections or cells were rinsed in PBS and treated 
with 0.05% pepsin (Sigma) in 0.01 M HC1 for 1 minute at 37°C. They were incubated 
in 20M HC1 for 30 minutes at 37°C and rinsed in borate buffer (0.1M boric acid 
pH8.5), then PBS. Anti-BrdU antibody was added at an appropriate dilution in 
Blocking Buffer and staining was performed following protocols described 
(Immunofluorescence Antibody Staining on Cells/Neurospheres or Cryosections).
8.4.7 Western blotting
Samples were lysed in RIPA buffer, vortexed for 20 seconds and placed on ice for 10 
minutes. They were loaded onto QIAshredders (Qiagen) and centrifuged for 5
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minutes at 16,000g to homogenise. Dilutions of 20pg, 10pg and 5 jag of each sample 
were loaded onto a NuPage 10% or 4%-12% Bis-Tris gel (Invitrogen) alongside 
SeeBlue Plus2 protein standard (Invitrogen) in NuPage MOPS SDS running buffer 
(Invitrogen). Gels were run at 200V for 1 hour and transferred at 30V for 2 hours 
using an Xcell SureLock Mini-Cell tank with a PowerEase 500 power pack (both 
Invitrogen). Membranes were washed in PBS-T (PBS-0.1% tween) and blocked for 1 
hour in PBS-T with 10% skimmed milk powder (Nestle). Membranes were incubated 
overnight at 4°C in primary antibody solution at the appropriate dilution in PBS-T 
containing 5% milk powder. Membranes were washed four times for 10 minutes 
each, in PBS-T and incubated for 1 hour at room temperature with either anti-rabbit 
IgG or anti-mouse IgG peroxidase conjugate secondary antibodies (both Sigma). 
After four 5 minufe washes in PBS-T membranes were incubated for 1 minute with 
Detection Reagent (Pierce) according to manufacturers protocols and visualized after 
1, 3 and 15 minute exposures with Kodak X-OMAT AR film in a dark room and 
developing using standard protocols.
8.5 DNA METHODS
8.5.1 Transformation of DH5a cells
Luria-Bertani (LB) agar plates containing ampicillin (lOOpg/ml) were warmed in a 
37°C oven. DH5a E.coli competent cells (Stratagene), stored at -80°C were thawed 
on ice and divided into two cooled eppendorf tubes- each to be transformed by a 
different plasmid. Plasmids pSUPER and PKO PURO (both lpg/jal) were diluted to 
lng/pl in water. Cells and plasmids were mixed for 30 minutes on ice, and then heat 
shocked at 42°C on a dry heat block, for 90 seconds and then cooled on ice for 2 
minutes. LB broth was added to the cells, which were then allowed to recover for 30
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minutes in a shaker at 37°C. 200pl of cells were plated onto ampicillin plates using 
glass beads. Plates were incubated in a 37°C oven overnight.
8.5.2 Picking of single colonies and inoculation of starter culture
Individual bacterial colonies were picked from the ampicillin resistant plates, using 
sterile P200 pipette tips, and inoculated in 2 ml of LB broth containing 50pg/ml 
ampicillin. They were incubated at 37°C in a Brunswick Scientific Incubator Shaker 
for 8 hours at 200 rpm.
8.5.3 Expansion of starter culture
The starter culture was diluted in 90ml LB containing 50 pg/ml ampicillin and 
incubated at 37°C in a Brunswick Scientific Incubator Shaker for 16 hours at 250 
rpm.
8.6 RNA METHODS
8.6.1 RNA extraction
Fresh samples were lysed in lysis buffer RLT (Qiagen) and homogenized either by 
loading on QIAshredders (Qiagen) and centrifuging for 5 minutes at 16,000g (for 
neurospheres) or through the Ultra Turrax T25 IKA-Labortechnik tissuemiser (Janke 
& Kunkel GMBH & Co) at 24,000 vibrations per minute for 5 minutes (for tissue). 
Total RNA was extracted from samples according to the Qiagen RNease Midi 
protocol for animal cells/animal tissues. RNA was eluted in nuclease-free H2O and 
treated with DNase I at 37°C for 30 minutes using the DNA-free kit (Ambion) 
according to the manufacturer’s instructions. The RNA was quantified using a
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NanoDrop ND-1000 spectrophotometer (Labtek) and/or a Bio Analyzer 2100 
(Agilent Technologies). RNA was precipitated by ethanol precipitation and 
resuspended in nuclease-free H2O at a concentration of 2pg/pl.
8.6.2 Microarray methods for spotted arrays
8.6.2.1 SMART cDNA Synthesis
The SMART PCR cDNA Synthesis Kit (Clontech) was used according to 
manufacturer’s instructions, lpg of starting RNA was used for each reaction. The 
first strand was synthesized using a modified oligo(dT) primer to selectively prime 
mRNA. A specialized SMART oligonucleotide (provided) was used to extend the 
template creating a synthetic adaptor. Second strand synthesis took place, using 
primers specific tb the synthetic adaptor sequences generated by the SMART 
oligonucleotide, ensuring that full-length cDNA species were produced. Each 1st 
strand reaction was amplified through PCR and the appropriate optimal number of 
cycles for each sample was determined (ranging from 25 to 32).
8.6.2.2 Roche cDNA Synthesis
The Transcriptor First Strand cDNA Synthesis kit (Roche) was used according to 
manufacturer’s instructions. 20 pg of starting RNA was used for each reaction. The 
first strand was synthesized using a 5’ modified oligo(dT) primer to selectively prime 
mRNA and second strand synthesis using DNA polymerase I with E.coli ligases and 
RNase H.
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8.6.2.3 Klenow labeling
An appropriate amount of target cDNA (one single 50pl cDNA reaction per 
hybridisation) was incubated at 100°C with Random Octamers (Invitrogen) in 
Reaction Buffer (Invitrogen), according to manufacturer’s protocols, for 5 minutes, 
then rapidly cooled on ice. Low dCTP dNTP mix (lOOpM dCTP final, 200pM 
dATP, dTTP, dGTP final) and 60U Klenow fragment [Large Fragment of DNA 
Polymerase I] (Invitrogen) were added to the mix together with either Cy3-dCTP or 
Cy5-dCTP. Samples were incubated in the dark at 37°C for 4 hours. The reaction 
was stopped by adding EDTA pH8.0 to a final concentration of 50pM. Each 
labeling mix was loaded onto a sephadex G50 Probequant column (Codelink) and 
centrifuged for 2 minutes at 4000g. Each labeling mix pair to be hybridised on the 
same slide was combined and Mouse Cofi DNA (Invitrogen) was added at a final 
concentration of 0.3pg/pl to block non-specific hybridisation. Samples were 
desiccated using a SpeedVac Concentrator SPD131DDA (Thermo) and resuspended 
in 12.5 pi ddFLO. Microarray Hybridisation Buffer was added to 50pl and each 
hybridisation mix was incubated at 85°C for 5 minutes.
8.6.2.4 Hybridisation
The Mouse Known Oligo Array (provided by the MRC-HGMP, now RFCGR) on 
CodeLink Activated Slides (Amersham Biosciences) (Serial numbers 0807038078- 
85 and 0803048028-48) were placed in hybridisation chambers (Qiagen) with a small 
amount of water and pre-warmed at 42°C for 1 hour. Each hybridisation mix was 
pre-warmed by incubating at 42°C for 1 hour with dry heat and centrifuged for 2 
minutes at 16,000g. Hybridisation mix was loaded onto array slides and cover slips 
were mounted avoiding air bubbles. Arrays were hybridised overnight in a 48°C
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water bath. Slides were washed in Wash solution A until the cover slips came off. 
They were transferred rapidly into Wash solution B with vigorous shaking for 5 
minutes, then Wash solution C for 2 minutes. During washing, slides were not 
allowed to dry or exposed to air and the arrays were not touched on any surface or 
with forceps. Slides were centrifuged for 5 minutes or until dry at 75 x g and scanned 
using a two-colour 428 scanner (Affymetrix).
8.6.3 Microarray methods for Affymetrix arrays
Total RNA was extracted and quantified from tissue or cell culture samples, as 
described previsouly. All the reactions for the preparation of samples and array 
processing were performed according to the Affymetrix ‘Eukaryotic Sample and 
Array Processing’ *guide. One-cycle cDNA synthesis was performed on 8pg total 
RNA starting material and a GenAmp PCR System 9700 (Applied Biosystems) was 
used for all reactions. Synthesis of biotin-labeled cRNA was carried out for 18 hours 
at 37°C and labeled cRNA was quantified using a NanoDrop ND-1000 
spectrophotometer (Labtek). 20pg of labeled cRNA were used for fragmentation and 
quantified on a Bio Analyzer 2100 (Agilent Technologies). Overnight hybridisation 
to the Mouse 430A GeneChips (Affymetrix) took place in a GeneChip Hybridisation 
Oven 640 (Affymetrix). Post-hybridisation washes of GeneChips took place in a 
GeneChip Fluidics Station 450 (Affymetrix) and GeneChips were scanned using a 
GeneChip Scanner (Affymetrix) and the GCOS Software. GeneSpring 7.2 was used 
for downstream analysis.
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8.6.4 Reverse-Transcription PCR
Total RNA samples were treated with DNase I (Promega) for 30 minutes at 37°C and 
reverse transcribed for 1 hour at 37°C using Omniscript RT (Qiagen) with Random 
Decamers (Ambion). 2pg of starting cDNA were used for each PCR reaction, 
employing gene-specific primers. The PCR profile consisted of 94°C for 15 minutes 
(1 cycle), 95°C for 30 seconds, 55°C for 30 seconds, 72°C for 1 minute (30 cycles) 
and 72°C for 8 minutes (1 cycle). A Peltier Thermal Cycler (MJ Research) was used 
for all reactions.
8.6.5 Real-time Reverse-Transcription PCR
For all samples, cDNA templates were prepared as described (see Reverse 
Transcription PCR) and used at a concentration of up to 30ng per 25 pi reaction. All 
reactions were repeated in triplicate using gene-specific primers. A no primer control 
and non-reverse transcribed sample control were performed for each reaction set. 
Primers were designed using the ABI Prism Primer Express version 2.0.0 software 
(Applied Biosystems) and their efficiency was determined through absolute 
quantification reactions of a dilution series of template. A standard curve of Cj 
(threshold cycle) value against logarithm of template concentration and the slope of 
each standard curve was determined. Ct values of primers that were efficient (slope 
between -3.3 to -3.8) were used to determine if they had comparable amplification 
efficiencies to the endogenous control. The difference in Ct values (CjTarget -  
CxControl) was plotted against the logarithm of the template amount and primers that 
generated slope values of less that 0.1 were deemed comparable to primers against 
the endogenous control. Efficient primers for target genes were used to perform 
relative quantification across samples against glyceraldehyde-3-phosphate
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dehydrogenase (Gapdh) amplification acting as the endogenous control. The 
fluorescent dye ROX was used as a passive reference calibrator to correct well-to- 
well variation. The PCR profile consisted of 50°C for 2 minutes (1 cycle), 95°C for 
15 minutes (1 cycle), 95°C for 15 seconds and 60°C for 1 minute (40 cycles). The 
ABI 7000 and ABI 7500 Real Time PCR Machines (Applied Biosystems) were used 
for all reactions. The normalized target gene expression levels between samples were 
relatively quantified, as described in the Appendix.
8.7 RNA INTERFERENCE
8.7.1 Selection of siRNA sequences for inclusion in the pSUPER vector
Sequences were selected following guidelines provided by Brummelkamp et al 
(2002) against the target LacZ gene (Lacl and Lac2), the N-terminal of the target 
Sox2 sequence (Sox2nt) and the Sox2 HMG box (Sox2HMG) as follows:
Lacl
Lac2
Sox2nt
Sox2HMG
5’-GATCCCCTTATCGATGAGCGTGGTGGTTCAAGAGACCACCACG 
CTCATCGATAATTTTTGG AAA-3 ’
5’-GATCCCCCGGGCGCTGGGTCGGTTACTTCAAGAGAGTAACCGA 
CCC AGCGCCCGTTTTTGGAAA-3 ’
5’-GATCCCCGAGGCCCATGAACGCCTTCTTCAAGAGACTCCGGGT 
ACTTGGGG A AGTTTTTGGAAA-3 ’
5 ’-GATCCCCGT AC ACGCTTCCCGG AGGCTTC AAGAGAC ATGTGCG 
A AGGGCCTCCGTTTTTGGAAA-3 ’
Where: 5’[spacer]-[19bp target sense]-[spacer]-[19bp target asense]-
[spacer]3’
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Only sense construct sequences are shown. Each construct is designed to form a 
hairpin structure upon excision from the vector for cleavage by Dicer in vivo to 
generate small interfering RNA (siRNA).
8.7.2 Construction of vectors for siRNA delivery
The pSUPER vector was digested with restriction enzymes Bglll and Hindlll 
(Promega). The digested DNA was dephosphorylated using shrimp alkaline 
phosphatase (SAP) (Roche) in a 37°C water bath for 1 hour. The forward and reverse 
pairs of oligonucleotides Sox2HMG, Sox2nt, Lacl and Lac2 (custom synthesized by 
Oswell) were annealed in annealing buffer for 4 minutes at 95°C, 10 minutes at 
70°C, using a Biometra Personal Cycler, then cooled gradually to room temperature 
overnight. Annealed oligonucleotides were phosphorylated using IX T4 PNK, ImM 
ATP in IX T4 PNK buffer (New England Biolabs), for 30 minutes at 37°C, 10 
minutes at 70°C, then cooled to 4°C using a Biometra Personal Cycler. Each set of 
annealed, phosphorylated oligonucleotides (Sox2HMG, Sox2nt, Lacl, Lac2) was 
ligated into linearised, dephosphorylated pSUPER vector using T4 DNA ligase (New 
England Biolabs) for 1 hour at 16°C using a Biometra Personal Cycler. DH5a 
bacteria were transformed with each resulting plasmid and starter cultures were 
inoculated. Maxi-preps were performed for each plasmid (following protocols from 
the Qiagen Plasmid Purification Handbook). A 1:100 dilution of each Maxi-prep 
DNA plasmid product in TE pH 8.0 was used to quantify the amount of DNA in each 
sample using a NanoDrop ND-1000 spectrophotometer (Labtek).
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8.7.3 Transfection of ES cells
ES Sox2^geo cells were cultured to 90% confluency in 6-well plates. Each well was 
transfected with the appropriate pSUPER plasmid which was previously linearised 
with Xhol. The PKO PURO plasmid was co-transfected at 1/10th of the concentration 
of each pSUPER plasmid to allow further puromycin selection. The plasmid 
combinations transfected were: Lacl, Lac2, Lacl+Lac2 (mixed 1:1), Sox2HMG, 
Sox2nt, Sox2HMG + Sox2nt (mixed 1:1), no plasmid (control). Transfections were 
carried out using the cationic lipid transfection reagent Lipofectamine 2000 
(Invitrogen), according to the manufacturers protocols.
8.7.4 Culture of transfected cells
The day following*transfection, each well of a 6-well dish was transferred onto a 10 
cm culture dish. The ES medium was replaced with ES medium containing 5pg/ml 
puromycin (Sigma). Cells underwent selection for 48 hours (at which point the 
control cells had not survived), after which 50 colonies were picked from each plate 
into 96-well culture dishes and cultured in the absence of selection. Each colony was 
expanded to 4 x 96-well wells to be further used for DNA isolation and subsequent 
PCR, immunofluorescence and p-galactosidase activity staining and for freezing.
8.7.5 PCR analysis of transfected ES cells
Primers for the ampicillin resistance sequence of the pSUPER vector were designed 
using the DNA STAR PrimerSelect programme and synthesised by Sigma-Genosys: 
forward 5’GGG CCG AGC GCA GAA GTG G3’, reverse 5’ TGA CGC CGG GCA 
AGA GCA 3’, generating a 422 base pair fragment. The PCR profile consisted of 3 
minutes at 94°C (1 cycle), 1 minute at 94°C, 1 minute at 58 °C, 1 minute at 72°C (30
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cycles), and 3 minutes at 72°C (1 cycle). A Peltier Thermal Cycler (MJ Research) 
was used for the reactions.
8.7.6 Selection of sequences for generation of short double-stranded RNA
Following guidelines accompanying the siRNA generation kit (GTS), sequences 
between 600 and 800bp in length were selected for transcription from each template. 
Gene specific primers to amplify 770bp of the Sox2 sequence (nucleotides 1287- 
2057 of the Sox2 1015 vector (RLB lab), 524 bp downstream of the HMG box) and 
700bp of the Egfp sequence (nucleotides 681-1381 of the pEGFP-Nl vector (BD 
Biosciences Clontech), which includes the entire Egfp sequence) were designed to 
add T7 promoter flanking sequences to both ends of each DNA template as follows:
SOX2_fw
5 ’-GCGTAATACGACTCACTATAGGGAGAGTTTGCCTTAAACAAGACCA-3’
SOX2_rv
5’-GCGTAATACGACTCACTATAGGGAGACACATGGCCCAGCACTACCA-3 ’ 
E G F P -N lJw
5 ’ -GCGTAATACGACTCACTATAGGGAGAGGTGAGCAAGGGCGAGGAGC-3 ’ 
EG FP-N 1RV
5’-GCGTAATACGACTCACTATAGGGAGACTTGTACAGCTCGTCCATGCCGAG-3 ’
Where: 5 ’-rLeaderMT7 promoter sequence! [AGA]-[gene specific sequence]-3’ and G = +1 
o f  transcription
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8.7.7 Generation of short double-stranded RNA
50ng of DNA template were used in each PCR reaction designed to add T7 promoter 
flanking sequences to both ends of each template using the gene-specific primers 
outlined above. The PCR profile consisted of 94°C for 3 minutes (1 cycle), 94°C for 
30 seconds, 58°C for 30 seconds, 68°C for 1 minute (35 cycles) and 68°C for 5 
minutes (1 cycle). An MJ Research Peltier Thermal Cycler was used. PCR products 
were purified by ethanol precipitation using standard protocols and the DNA was 
resuspended in 20pl nuclease-free H2O. lpg of template DNA was used for 
transcription using Turboscript T7 Enzyme Mix (GTS) and transcribed for 4 hours at 
37°C. The dsRNA generated was treated with DNase I (Promega) for 15 minutes at 
37°C. dsRNA was digested into 22bp fragments using 1 unit of Recombinant Dicer 
Enzyme (GTS) per lpg dsRNA for 15 hours at 37°C.
8.7.8 Delivery of siRNA into neural stem cell cultures
Neurospheres were dissociated into a single cell suspension the night prior to siRNA 
delivery and 5 x 105 cells were plated per well in 24-well plates (Coming). On the 
day of transfection, proliferation medium was replaced with 500pl OptiMEM 
(Gibco). For each transfection, 3.5pi of slmporter (Ambion) (or RiboJuice 
transfection reagent (Novagen) or GeneSilencer reagent (GTS) both of which have a 
lower transfection efficiency) were mixed with 25 pi OptiMEM to form the 
Transfection solution. 500ng of appropriate diced siRNA was diluted in water to 
lOpl and mixed with 15pl OptiMEM for 5 minutes to form the d-siRNA solution. 
The Transfection and d-siRNA solutions were mixed together and incubated at room 
temperature for 5 minutes to allow RNA/lipid complexes to form, then applied drop-
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wise onto the cells. After 4 hours, 1 ml of NPM was added and the following day 
replaced completely with fresh NPM.
8.7.9 Assessment of protein knock-down through RNAi
48 hours post transfection, transfected and control cells were fixed for 15 minutes in 
4% PFA and used for immunofluorescent antibody staining. Anti-SOX2 primary 
antibody using Alexa-594 secondary antibody, was used to assess the knock-down of 
Sox2. EGFP control knock-down was assessed based on EGFP intensity, viewed with 
a Leica TCS SP confocal.
8.7.10 Assessment of RNAi through microarray analysis
Cells were harvested 48 hours post transfection and washed in PBS-CMF. RNA was 
extracted and treated with DNase I as described previously.
205
CHAPTER 9 
Appendices and Bibliography
9.1 APPENDIX I
9.1.1 GENOTYPING
9.1.1.1 Tail Lysis Buffer 
Tris-HCl pH 8.5 
EDTA
SDS
Sodium chloride 
In ddH20
lOOmM
5mM
0.2%
200mM
9.1.1.2 PCR reaction mix
Taq DNA polymerase 1.25U
Buffer IV (10X) . IX
Magnesium chloride 1.5mM
dNTP mix (4N) 0.2mM
Primer (each) 125ng/pl
DMSO 20%
DNA (upper phase of phenol extraction) 2pl 
Total volume of 25pi in ddH20
9.1.2 CELL CULTURE
9.1.2.1 NSC hormone mix
Putrascine 9.6pg/ml
Progesterone 6.3ng/ml
Sodium selenite 5.2mg/ml
Insulin 25pg/ml
Transferrin 1 OOpg/ml
9.1.2.2 Neurosphere proliferation medium (NPM)
N2 (5X)* IX
B27 (10X) IX
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Glucose 0.6% (w/v)
Penicillin G lOOU/ml
Streptomycin sulfate 100jng/ml
L-glutamine 2mM
Human recombinant bFGF 20ng/ml
Human recombinant EGF 20 ng/ml
In Dulbecco’s Modified Eagle’s Medium (DMEM) F-12 NUT (nutrient)
MIX (All from Gibco, glucose from Sigma)
*N2 components include insulin, human transferrin, putrascine,
progesterone
9.I.2.3. Neurosphere differentiation medium (NDM)
N2 (5X) IX
B27 (10X) IX
Glucose 0.6%
Penicillin G lOOU/ml
Streptomycin sulfate lOOpg/ml
L-glutamine 2mM
In DMEM F-12 NUT (nutrient) MIX (All from Gibco, glucose from Sigma)
9.1.2.4. Preparation of Matrigel-coated Sonic Seals
Matrigel (BD Biosciences) was diluted 10-fold in DMEM-F12 (Gibco), 
using pipettes cooled at -20°C and stored in aliquots at -20°C. Prior to use, 
aliquots were thawed at 4°C and diluted 5-fold in DMEM-F12. 4-chamber 
Sonic Seals were coated with 200 pi per chamber of diluted Matrigel, and 
incubated for 1 hour at 37°C until set. The excess liquid was aspirated off
9.1.2.5. Preparation of gelatin-coated cell culture dishes
PBS Medium with gelatin (GIBCO) [0.1 (w/v) gelatin solution] was used to 
cover the surface of tissue culture dishes. The medium was left on for 30 
minutes at room temperature, after which, the excess was aspirated.
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9.1.2.6 PIPES Solution
PIPES (Sigma) 0.1M
In PBS
pH to 6.8 using 1M Na-pyruvate
9.1.2.7 Papain Solution
75U papain in 1 ml DMEM F-12 containing 4.3 mg L-cysteine
Activated for 30 minutes at 37°C
4ml PIPES Solution added after activation
9.1.2.8 PFN
PBS-A
Fetal calf serum (Gibco)
Sodium azide (Sigma)
9.1.2.9 P19 cell medium
Penicillin G (Gibco)
Streptomycin sulfate (Gibco)
L-glutamine (Gibco) 
p-mercaptoethanol (Sigma)
Fetal calf serum (Gibco)
In DMEM (Sigma)
9.1.2.10 ES cell medium
Penicillin G (Gibco)
Streptomycin sulfate (Gibco)
L-glutamine (Gibco) 
p-mercaptoethanol (Sigma)
Leukaemia Inhibitory Factor (Chemicon) lOOOU/ml 
ES qualified fetal calf serum (ESQ) (Gibco) 15%
In DMEM (Sigma)
9.1.2.11 Picking ES colonies
IX
2%
0 .1%
lOOU/ml 
100 pg/ml 
2mM 
90 pM 
15%
lOOU/ml 
100 pg/ml 
2mM 
90 pM
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Individual colonies were picked under a microscope using sterile P200 
pipette tips. They were transferred in gelatin-coated 96-well plates 
containing 25 pi trypsin and incubated at 37°C for 5 minutes. 200 pi ES cell 
medium was added to each well and the colonies were mechanically 
dissociated using a multipipettor. They were cultured at 37°C, 5% CO2, the 
medium being replaced daily.
9.1.3 FIXATIVES
9.1.3.1 Paraformaldehyde (PFA) fixative
4%
Freshly prepared 4% (w/v) paraformaldehyde was dissolved in PBS-A in a 
67°C water bath. Aliquots were stored at -20°C for up to 2 months.
2%
4% paraformaldehyde 50% (v/v)
PBS-A 50% (v/v)
9.1.3.2 Ethanol/Acetic Acid fixative
Ethanol 100% 95%
Acetic acid 5%
9.1.3.3 MEMFA fixative
10X MEM stock was prepared as follows:
MOPS pH7.4 (filtered) 1M
EGTA (autoclaved) 20mM
Magnesium sulfate (autoclaved) lOmM
In ddH20
Aliquots were stored at 4°C. Prior to use, one part 10X MEM stock and one 
part formaldehyde 37% were added to 8 parts ddH20.
9.1.3.5 Glutaraldehyde/Formaldehyde fixative
Glutaraldehyde 0.2%
Formaldehyde 2% In Buffer L0
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9.1.4 X-GAL STAINING
9.1.4.1 PB
Sodium phosphate pH 7.2 (filtered)
9.1.4.2 PBS-T
Tween-20 
in PBS-A
9.1.4.3 Buffer L
PB pH7.2
Magnesium chloride
EGTA
NP40
Na-Deoxycholate
9.1.4.4 Buffer Lo
PB pH7.2
Magnesium chloride 
EGTA
9.1.4.5 Staining Solution
K3Fe(CN)6 
K4Fe(CN)6.3H20 
In Buffer L
9.1.4.6 X-gal Stock
X-gal 
in DMF
9.1.4.7 LacZ Staining Solution
X-gal
In Staining Solution
0.1M
0 . 1%
lOOmM
2mM
5mM
0.2% (0.02% for cells) 
0.1 % (0.01 % for cells)
lOOmM
2mM
5mM
lOmM
lOmM
50mg/ml
1 mg/ml
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9.1.5 PROTEIN METHODS
9.1.5.1 Blocking buffer
Triton-X 
Glycine 
BSA 
In PBS-A
9.1.5.2 TUNEL Labeling solution
4p l enzyme, 36jLtl buffer for each sample
9.1.5.3 RIPA Buffer
Sodium chloride
SDS
NP40
Sodium deoxycholate 
Tris pH7.5-8.0 
Sodium fluoride 
Sodium orthovanadate
0 .1%
0.15%
2 mg/ml
150mM
0.1%
1%
0.5%
50mM
2mM
lmM
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Table 9.1.A Primary antibodies used for immunofluorescence
Primary
Antibody
Host
spp
Poly-/
Mono­
clonal
Dilution Antigen Recognized Source
Sox2
(Purified)
Ra P 1:2500 SOX2 Lovell-Badge
lab
Nestin Rat 
401
Mo M 1:75 Intermediate Filament 
(I-F-)
D.S.H.B.
GFAP Mo M 1:100 Glial Fibrillary Acid (I.F.) Chemicon
GFAP-Cy3 Ra P 1:100 Glial Fibrillary Acid (I.F.) Sigma
GFAP Mo M 1:100 Glial Fibrillary Acid (I.F.) Sigma
TuJl Mo M 1:1000 P-III Tubulin (I.F.) Covance
GalC ascites Ra P. 1:100 Galactocerebroside Sigma
04 Mo M Oligodendrocyte marker 
04
Chemicon
CNPase
ascites
Mo M 1:100 2’,3’-cyclic nucleotide-3’- 
phosphodiesterase
Santa Cruz
Ssea-1 Mo M 1:75 Surface carbohydrate 3-
fucosyl-N-
acetyllactosamine
Santa Cruz
Oct4 Mo M 1:250 OCT3/4 protein Santa Cruz
Stat3 (K-15) Ra P 1:500 STAT3 p92 and STAT3b Santa Cruz
Sox9 Ra P 1:500 SOX9 Gift from 
Silvana Guioli
Sox 10 Ra P 1:200 SOXIO Gift from 
Matin Cheung
Sox2 Ra P 1:200 SOX2 Chemicon
RC2 Mo M 1:100 RC2 D.S.H.B.
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Table 9.1.B Secondary antibodies used for immunofluorescence
(All from Moecular Probes)
Secondary Antibody Dilution Primary Antibody Recognized
Goat Anti-Mouse Alexa 594 IgG 1:350 Mouse Monoclonal
Goat Anti-Mouse Alexa 488 IgG 1:350 Mouse Monoclonal
Goat Anti-Mouse Alexa 488 IgM 1:350 Mouse Monoclonal
Goat Anti-Rabbit Alexa 594 IgG 1:350 Rabbit Polyclonal
Goat Anti-Rabbit Alexa 488 IgG 1:350 Rabbit Polyclonal
9.1.6 DNA METHODS
9.1.6.1 Annealing buffer
Potassium acetate 
HEPES-KOH pH 7.4 
Magnesium acetate
9.1.6.2 PI
Tris-Cl (pH 8.0)
EDTA 
in ddHiO
9.1.6.3 Solution I (TEG)
Glucose
Tris-Cl (pH 8.0)
EDTA 
in ddH20
9.1.6.4 P2/Solution II
Sodium hydroxide 0.2N
SDS 1%
in ddH20
50mM
25mM
lOmM
50mM
lOmM
100 mM 
30 mM 
2 mM
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9.1.6.5 P3/Solution III
Porassium acetate (pH5.5) 3M
Glacial acetic acid 2M
in ddH20
9.1.6.7 QBT
MOPS (pH 7.0) 
Sodium chloride 
Isopropanol 
Triton X-100 
in ddH20
50mM
750mM
15%
0.15%
9.1.6.8 QC
MOPS (pH 7.0) 50 mM
Sodium chloride . 1M
Isopropanol 15%
in ddH20
9.1.6.9 QF
Tris-Cl (pH 8.5) 50mM
Sodium chloride 1.25M
Isopropanol 15%
in ddH20
9.1.6.10 Isolation of DNA from ES colonies
Cells were washed twice in PBS-CMF and 50 pi lysis buffer (lOmM Tris 
pH7.5, lOmM EDTA pH8.0, lOmM NaCl, 0.5% Sarcosyl , lmg/ml 
proteinase K) was added per well. The plates were wrapped in parafilm and 
incubated overnight at 60°C in a humid box. lOOpl of fresh 75mM NaCl in 
100% ethanol was added to each well for 30 minutes at room temperature. 
The solution was discarded and the DNA (stuck onto the plate) washed 5 
times in 70% ethanol. Wells were air-dried and DNA resuspended in 20pl 
TE pH8.0
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9.1.6.11 Freezing 96-well plates
Wells were washed twice in PBS-CMF and 25pl of trypsin added to each 
well. Cells were incubated for 5 minutes at 37°C after which the plates were 
gently tapped to dislodge the cells and then returned to 37°C for another 5 
minutes. 75pl ES cell medium was added to each well and a single cell 
suspension generated by pipetting up and down. lOOpl of 20% DMSO in 
FCS was mixed into each well. 50pl filter-sterilized mineral oil was added 
to cover each well and the lid sealed with parafilm. Each plate was placed in 
a polystyrene box and frozen at -80°C.
9.1.7 RNA METHODS
9.1.7.1 DEPC treatment of ddH20
0.1% DEPC added to ddFhO and allowed to evaporate overnight in a loose- 
capped bottle.
The treated solution was autoclaved for 15 minutes per liter.
(This treatment is not appropriate for solutions containing Tris, MOPS, 
HEPES or PBS).
9.1.7.2 Spotted Array Solutions
9.1.7.2.1 Microarray Hybridisation Bujfer 
Formamide 42%
SSC 5X
SDS 0.1%
Filtered through a 0.22pm sterile syringe filter
9.1.7.2.2 Wash solution A 
SSC 2X
Filtered through a 0.2pm sterile filter
9.1.7.2.3 Wash solution B
SSC
SDS 0.1%
Filtered through a 0.2pm sterile filter
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9.1.7.2.4 Wash solution C
SSC 0.1X
Filtered through a 0.2pm sterile filter
9.1.7.3 Reverse Transcription PCR mix
Buffer RT 1 OX (Qiagen) 1X
dNTP mix (Qiagen) 4pl
Random decamers (Ambion) 8jli1
Rnase inhibitor (Ambion) 0.5 pi
DTT (Promega) 0 .4 4 jll1
Omniscript RT (Qiagen) 2.0 pi
RNA template 2pg
In ddHiO to 40 pi
9.1.7.4 Real time PCR mix
SYBR Green ROX mix(2X) (ABgene) IX 
DNA 7-3 Ong
Primer forward (1 OpM stock) 150nM
Primer reverse (10 pM stock) 150 nM
In ddH20  to 25pl
9.1.7.5 Relative quantification of amplification of target genes
Out of each group of samples that were compared, one sample acted as the
calibrator (in this example B). The following equations were followed in 
order:
ACx(sample A) = Cj target gene -  Ct endogenous reference gene 
ACr(sample B)= Ct target gene -  Ct endogenous reference gene 
AACT(sample A)= ACt(A) -  ACt(B)
AACT(calibrator B)= ACt(B) -  ACt(B) = 0
Normalised target gene expression level = 2'AACt, where for calibrator = 1
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Table 9.1.C List of Primers used for RT-PCR
Target Direction Sequence
Product
length
Casr-
rs5
Forward 5 ’ - ATTC AAGGCCACTGTTCC AG-3 ’ 209bp
Reverse 5’-TGTGGAAGGCAACTGTTGAA-3’
Dcx Forward 5 ’ -T CCCC AAC ACCT C AAAAGAC-3 ’ 236bp
Reverse 5’-ATGGAATCGCCAAGTGAATC-3’
Foxgl Forward 5 ’ -GAACGGC AAGTACGAGAAGC-3 ’ 197bp
Reverse 5 ’ -T CACGAAGC ACTT GTT GAGG-3 ’
Nsg2 Forward 5 ’ -TT GGCTT GACT CT GCTCT GA-3 ’ 178bp
Reverse 5’-CAGCCAGCTGCAAATGATTA-3 ’
Gfap Forward 5’-AGAAAACCGCATCACCATTC-3 ’ 184bp
Reverse 5,-TCACATCACCACGTCCTTGT-3’
Mela Forward 5 ’ - ACTGT GTCCT GGT CG AGCTT-3 ’ 184bp
Reverse* 5 ’ -ACTAGGGCGGT AGTCCCT GT-3 ’
Sacs Forward 5 ’ - AGGG ACT GCCCCT ACT C ATT-3 ’ 195bp
Reverse 5 ’ -C AGC AAAGCT GG AAAT GT C A-3 ’
Lag Forward 5’-CGGGAGAATGTCTGGACCTA-3 ’ 217bp
Reverse 5 ’ - AGC AGAC AGCT GT GGT GAT G-3 ’
Ttr Forward 5 ’ -ITT C AC AGCC AACGACTCT G-3 ’ 153bp
Reverse 5 ’ - AT GGGAT GCTACT GCTTT GG-3 ’
Olfr65 Forward 5 ’ -GAGC AAAGGCT CT C AAC ACC-3 ’ 195bp
Reverse 5 ’ -ITT GCTT GGT CTT GAT GCT G-3 ’
Pip Forward S’-GGCGACTACAAGACCACCAT^’ 154bp
Reverse 5’-CAAACTTGTCGGGATGTCCT-3’
Pten Forward 5’-ACACCGCCAAATTTAACTGC-3’ 170bp
Reverse 5 ’ -T AC ACCAGTCCGT CCCTTT C-3 ’
mFatl Forward 5 ’ -T C AGG AG AC AGCGAAAACCT-3 ’ 152bp
Reverse 5 ’-GCTTTCTCC ACTGCCTTG AC-3 ’
Aprf
(Stat3)
Forward 5 ’ -GACCCGCC AAC AAATTAAGA-3 ’ 215bp
Reverse 5 ’ -TCGT GGT AAACT GG AC ACC A-3 ’
Oda8 Forward 5 ’ - AT GTAC AGCGGT GT GCT GAG-3 ’ 183bp
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Reverse 5 ’ -T GACT CT GGT GT GCCT CTT G-3 ’
Pdgfa Forward 5 ’-GAGATACCCCGGGAGTTGAT-3 ’ 238bp
Reverse 5 ’ - AAAT G ACCGT CCT GGT CTT G-3 ’
Actb Forward 5’-
TCATGCCATCCTGCGTCTGGACCT-
3’
600bp
Reverse 5’-
CCGG ACT CAT CGT ACTCCT GCTT G- 
3’
Table 9.1.D List of Primers for qRT-PCR
Target Direction Sequence
Sox2 Forward 5 ’ -CT GTTTTTT C ATCCC AATT GC A-3 ’
Reverse 5 ’-CGGAGATCTGGCGGAGAATA-3 ’
StatS Forward 5’-GGGCCAGGCCAACCA-3 ’
Reverse 5 ’ -CCGGAC ATCCT GAAGAT GCT-3 ’
Gfap Forward S’-CGTTTCTCCTTGTCTCGAATGA-S’
Reverse 5 ’-CCCGGCCAGGGAGAAGT-3 ’
Tnc Forward 5 ’ -CCTT GCCCCTT CT GG AAAA-3 ’
Reverse 5 ’ -GCCGTCC AGGAAACT GT GA-3 ’
Ptn Forward 5’-CCTGTGGCAAGCTCAGGAA-3’
Reverse 5 ’ -TT CTT GCCTT CCTTTTT CTT CTT C-3 ’
Actb Forward 5’-TGACCGAGCGTGGCTACA-3’
Reverse 5 ’ -TCTCTTT GAT GT C ACGC ACGAT-3 ’
Gapdh Forward 5 ’ -GGGAAGCCC AT C ACC ATCTT -3 ’
Reverse 5 ’ -GCCTT CTCC AT GGT GGT GAA-3 ’
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9.1.8 RNA INTERFERENCE
9.1.8.1 Master mix for amplification of DNA template (RNAi)
Buffer IV (10X) IX
Magnesium chloride 2.0pM
dNTPs 100 pM
DNA (circular) lpg
F orward primer 1 Ong/pl
Reverse primer 1 Ong/pl
Taq DNA polymerase 5U
In nuclease-free ddH20, to lOOpl
9.1.8.2 Master mix for transcription of template for dsRNA generation
ddH20 lpl
NTP mix 8pl
T7 Reaction buffer 2pl
PCR template 7pl
T7 Enzyme mix 2 pi
Reaction was assembled in the above order at room temperature.
9.1.8.3 Recombinant Dicer Enzyme Digestion mix
dsRNA lpg
ATP ImM
MgCl2 2.5mM
Dicer Reaction Buffer (2.5X) IX
Recombinant Dicer Enzyme 1U
in nuclease-free ddH20
Reaction buffer kept at room temperature prior to assembly to avoid 
precipitation
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9.1.9 STATISTICS
9.1.9.1 Standard Deviation 9.9.1.2 Standard Error
< « r - »
i t *a .  s_ci—
" r
9.9.1.3 Chi Square Test 9.9.1.4 ANOVA
z : = S ^ - ‘ SSt = X x 4 £ * i )2.V
ss,=yii^>2.f e ) :
L-* n N
Where: SSvr- SSx - SSb
dfv =  {number of groups - i)s = series number *>
i = point number in series 5 dfx = (number of subjects - 1)
m = number of series for point y  in chart df = df df
n = number of points in each series * T b
yls = data value of series s and the 7th point _  SSb
Ny = total number of data values in all series * dft
M  = arithmetic mean SSv.
I  = sum of M S r= d f 7
X = Chi T7 _  MSt
O = observed
E = expected
SS = sum of squares
df = degrees of freedom
T = total
b = between groups
w = within groups
MS = mean squares
F = F-statistics
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9.9.10 PLASMID VECTORS
Figure 9.1.10.A pSUPER vector (Brummelkamp et al, 2002)
Ampicilin
pSUPER
«1Wbp)
H l-R N A
promoter
Figure 9.1.10.B Sox2 dominant negative (engrailed repressor domain 
fusion) in pCI-neo vector [kind gift from Dr. Ariel Avilion]:
AA14 
1492bp
CMVI.E.
Enhancer/Promoter
M yctag
Intron
Sox2/Engrailed 
(AA14) in pCI-neo 
~7000bp
SV40 Lat 
poly(A)
Engrailed 
(947bp)
Synthetic
poly(A)
BamH II
Sox2 HMG (545bp)
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Figure 9.1.10.C Sox2 dominant negative (truncated HMG box) in 
pCMW/wyc/nuc vector [kind gift from Dr. Karine Rizzotti]:
Sox2BD'(HMG box-less) 
in pCMV/myc/nuc
•7400bp
Figure 9.1.10.D Sox2 4C #1015 in pBluescript SK- used as template for 
Sox2 siRNA generation
T7 promoter 
Kpnl 
Apal 
Drall 
Xhol 
AccI
Mouse Sox2 4C subclone
-  3700 bp
fragment
PstI
Xbal 
Nod 
EagI 
SacII 
BstXI 
Sacl 
T3 promoter
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Figure 9.1.10.E pEGFP-Nl vector (Clontech)- used as template for Egfp 
siRNA generation:
A so I
£co0109 I
Figure 9.1.10.F £ta£?-DN plasmid. Stat3 dominant negative (Y705F) in 
pMY-IRES-GFP [Kind gift from Professor Shizuo Akira] :
ATG
— | LTR
Cloning sites
> V ,IRES- GFP -  LTR —
Selection: Amp
Insert: DN-STAT3 (Y705F) 
-2300 bp
N-tagging: FLAG C-tagging:
pMY-IRES-GFP
-6000 bp
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Figure 9.1.10.G pKO SelectPuro vector- used as transfection control to 
introduce puromycin selection:
AscI 3291
pKO SelectPuro
3297 bp
)a 1355
Xmn 1474
AscI 1800-
Figure 9.1.10.H pRC/CMV vector containing either STAT3-C (a 
constitutive active form of Stat3) or STAT3wt-FLAG (wild type Stat3 
with FLAG tag). [Kind gifts from Dr. T.Kondo] :
* There is an ATG 
upstream of the 
Xba I site.
224
9.2 APPENDIX II
Table 9.2.A Potential candidate NSC markers, not shortlisted. List of genes 
not included in the candidate NSC marker list generated from the Affymtrix 
GeneChip platform approach. It is likely that several genes in this list should 
be considered NSC candidates.
A2m Aldol
Aaas Aldo3
Aard Alg1
Aars Alg12
Abca2 Alg3
Abca3 Alg5
Abccl Amph
Abcd3 Angptl2
Abhdl ank
Abhd3 Antxrl
Abhd4 Anxal
Abhd5 Anxa2
Acaa2 Anxa4
Acadm Anxa6
Acads Aox1
Acadvl Ap3m2
Acas2 Apba3
Acas2l Apegl
Aco2 Apln
Acoxl Aplp2
Acsl5 Apoalbp
Actcl Apobecl
Adam 12 Apobec3
Adam 15 Araf
Adam 17 Arc
Adam 19 Areg
Adamtsl Arhgap18
Adamts4 Arhgdia
Adamts5 ArllOc
Adcy3 Arl4
Add3 Arl6ip2
Adk Armet
Adoral Arpdb
Adora2a Arpc4
Adrbl Artsl
Adsl Asahl
Aebpl Asah2
Aes Asb13
Afg3l1 AscH
Afg3l2 Asns
Agl Asph
Agpat3 AsrgH
Agpt2 Ass1
Ahcyll Atad3a
Ak1 Atf5
Ak2 Atf6
Ak3l Atp1a1
Ak5 Atp1a2
Akap12 Atp1b1
Akap2 Atp2a2
B2m Capn5
Bag2 Capnsl
Bag3 Carl 2
Baiap2 Carl 3
Bak1 Car3
Bbc3 Car8
Bcap29 Cask
Bcap31 Caspl
Bcap37 Casp7
Bcar3 Catns
Bche Cav
Bckdha Cbfb
Bckdhb Cbl
Bcl10 Cbln3
Bcl3 Ccnbl
Bcl6 Ccnb2
Bcl7c Ccndl
Bdnf Ccnd2
Bet1 Ccnd3
Bet 11 Ccnf
Bicd Ccs
Bicd2 Cd151
Blvra Cd164
Blvrb Cd38
Bmp1 Cd44
Bmp4 Cd81
Bmp7 Cdc20
Bre Cdc42
Brp17 Cdc42ep1
Bsg Cdgap
Btbd14a Cdh13
Btebl Cdh22
Btg2 Cdh4
Btrc Cdk5rap2
Bzrp CdkaM
C1ql1 Cdv3
C1qr1 Cebpb
C1qtnf5 Cecr5
C1qtnf6 Centg3
Cabd Cerk
Cacng5 Cflar
Cad Chchd3
Calca Chd1
Calcri Chdll
Caldl Chl1
Calmbpl Chm
Calml4 Chn2
Calr ChrdU
Calu Chrna4
Camkl Chst2
CklfsfS Cspg2
Clcn3 Cspg3
CldnlO Cspg5
Cldn11 Csrpl
Clid Cst3
Cln2 Ctbs
Cln3 Ctdspl
Cln5 Ctdsp2
Cln6 Cte1
Cml1 Ctsb
Cnnm2 Ctsc
Cntnl Ctsd
Cntn3 Ctsh
Coasy Ctsl
Col11a1 Ctsz
Col16a1 Cx3cl1
Col18a1 Cxxc5
Col19a1 Cycs
Col4a5 Cyfipl
Col9a1 Cyp4f15
Col9a3 Cyp4f16
Commdl Cyp4v3
Commd6 Cyp51
Commd9 Cyp7b1
Comt Cyr61
Copeb Dab2
Cops7a Dad1
Coq3 Dag1
Cotll Dap
Cox15 Dbi
Cox6a1 Dbp
Cox8a Dbt
Cp DcamkH
Cpd Dck
Cplx2 Dcxr
Cpne2 Ddit3
Cpne3 Ddit4
Cpox Ddit4l
Cptla Ddost
Cpt2 Ddr1
Cpxml Ddt
Crat Ddx41
Creg Ddx54
Creldl Deb1
Criml Decrl
Crkl Dedd2
Crtap Defcr3
Cryz Degs
Cs Dep1
Csad Depdd
Dhrs8 Elovl5
Dial Elovl6
Diap3 Emb
Dio2 Emid2
Dip3b Emp1
Dlat Endog
Dleu2 End
Dlg7 Eno2
Dlst Enpp2
Dmd Enpp5
Dmrtbl Entpd5
Dnahc8 Epb4.1l2
Dnaja3 Epb4.1l4a
Dnajbl 1 Epb7.2
Dnajb12 Epn2
Dnajc3 Epn2
Dnase2a Erall
Dnmll Ercc4
Dnm2 Erf
Dockl Erp29
Dorzl Ethel
Dph2l1 Ets2
Dr1 Etv4
Drpla Evi5
Dsc2 Ext2
Dscam Extl3
Dtna Eya1
Dtr Eya2
Dullard F8a
Dusp14 Fadsl
Dusp16 Fads2
Dusp6 Fancc
Dusp7 Fasn
DXImx39e Fastk
Ece1 Fbn1
Ecgfl Fbn2
Echdd Fbp1
Edeml Fbxl3a
Edil3 Fbxo32
Eefld Fbxo33
Eef2k Fbxo36
Efcbp2 Fbxw4
Efempl Fgd6
Efemp2 Fgf11
Efs Fgfrl
Egfr Fgfrl
Eglnl Fgfr3
Egln3 Fgfr3
Egr2 Fhit
Ehd2 Fip111
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Akr1b3 Atp4a Camk2b Cib1 Csda Dgka Ehd4 Fjx1
Akr7a5 Atp5g2 Camk2d Cited 1 Csf1 Dgkz Eif2s1 FkbpIO
Aldh6a1 Atp6v0a2 Camkk2 Ckap4 Csnk1g2 Dhcr7 Elf1 Fkbp11
Aldh7a1 Avpil Camta2 Ckb Csnk2a1 Dhh Elk3 Fkbp2
Aldh9a1 Axl Canx Cklfsf3 Csnk2a2 Dhrs7 Elovll Fkbp7
Fkbp9 Gla Gtpbp3 Idb1 Kif20a Ltbr Mrpl39 Ndufs8
Fliih Glee Gtsel Idb3 Kif2c Luzpl Mrpl4 Ndufvl
Flot2 Glg1 Gus Ide Kifc3 Lxn MrpWO Nek7
Fnbpl Glo1 Gypc Idh3a Kifc5a Lyl1 Mrpl48 Nek8
Fnbp2 Glrxl Gys3 Idh3g Kitl Lyn Mrpl51 Nek9
Fndc4 Gltp H2-Ab1 Idi1 Klf13 Lynxl Mrpl9 Nes
Fntb Glud H2-DMa Ier2 Klf3 Lysall Mrps16 Netol
Fosl2 Glut H2-K1 Ifi1 Klf5 Lztrl Mrps18a Neu1
Foxcl Gm2a H2-Ke6 Ifitm2 Kns2 Mad1l1 Mrps18b Nfatd
Foxml Gmfb H2-T10 Ifnar2 Kntc2 Mad2l2 Mrps25 Nfia
Fth Gmpr2 Hadha Igfbp2 Kpnbl Mad4 Mrps28 Nfic
Fthfd Gna12 Hadhb Igfbp3 Krtcap2 Mag Mrps36 Nfkb2
Fuca Gna13 Hadhsc Igfbp4 Kua Man2b1 Mrps6 Nfkbia
Fut8 Gnai2 Has2 Igfbp5 L259 Manba Mrps7 Nfs1
Fxc1 Gnb1 Hbp1 IHOrb Lama5 Maoa Mrsb Ninjl
Fxrlh Gne Hccs 1111 ra1 Lamcl Map2k1 Mrvldcl Nmi
Fycol Gng12 Hdgf 1118 Lamp2 Map3k1 Msn Nmnat
Fyn Gng5 Hes1 111 rl 11 Laptm4b Map4k4 Mt3 Nol3
Fzd1 Gnpdal Hexa Il6st Lass2 Mapk12 Mtap Nola2
Fzd4 Gns Hexb Impdh2 Lbh Mastl Mtap4 Nold
G2an Golph2 Hey1 Incenp Lcat Matn2 Mthfdl Notch 1
G6pc3 Golph3 Hfe Inhbb Ldh1 Mbd2 Mthfd2 Notch3
Gaa Gorasp2 Hibadh Inpp5a Ldlr Mbd3l1 Mthfs Npd
Gab1 Got1 Hibch lpo4 Lfng Mbtpsl Mtm1 Npc2
Gadd45a Got2 Hifla Iqgapl Lgalsl Mcee Mtmr2 Npl
Gadd45b Gpc6 Hig1 Iraki Lgals3bp Mcm5 Mtmr6 Npn3
Gal3st1 Gpd1 Hip1 Irf2 Lgals8 Mecp2 Mut Npnt
Gale Gpd2 Hipk2 Irx3 Lgmn Meigl Mvd Nptxl
Galkl Gphn Hipk3 Irx5 Lifr Mela Mybph Nqo1
Gains Gpi1 Hist1h2bc Itga6 Limdl Mertk Myc Nqo2
Galntl Gpm6b Hist1h3d Itgav Limsl MettH Myd116 Nr1i3
GalntIO Gpr23 Hk1 Itgbl Lin7c Mfhasl Myd88 Nr2f6
Galntl 1 Gpr56 Hlf Itgb1bp1 Lip1 Mfn1 Myh9 Nr4a1
Galnt2 Gprc5b Hlx Itgb5 Litaf Mgll Mynn Nrbfl
Galnt7 Gpx3 Hmg20b Itm2b Lmanl Mina Myo10 Nrm
Gamt Gpx7 Hmgcsl Itm2c Lmna Mint Nab1 Nt5c
Gart Grb14 Hmmr Itpr5 Lmo1 Mkks Nab2 Ntn1
Gas1 Grcc3f Hnrpl Jaridlc Lnx1 Mlf2 Naglu Ntn4
Gas7 Grhpr Hnt Jun Lor Mlycd Nap1l5 Ntrk2
Gba Gria3 Hod Junb Loxl3 Mmab Nbl1 Ntrk3
Gca Gria4 Hoxal Jundm2 Lpinl Mmp15 Nbn Nubpl
Gcat Grid2 Hoxa7 Jup Lpo Moxdl Ncald Nucb
Gclm Grim19 Hoxc6 Kail Lpp Mpdul Ncaml Nudt9
Gcn5l2 Grina Hrasls3 Kcna2 Lpxn Mpp1 Ncam2 Nup210
Gcs1 Grn Hrsp12 Kcncl Lrp1 Mpp5 Ncl Nuprl
Gdf1 Grp58 Hs2st1 Kcnd2 Lrp10 Mpp6 Ncor2 Nxphl
Gdf15 Gsn Hsd17bl2 Kcnell Lrp4 Mpra Ncstn Odf2
Gdpd2 Gsr Hsd17b4 Kcnmb4 Lrrc4 Mpv17 Ndell Ogdh
Gem Gstkl Hsd3b7 Kctd4 Lrrc8 Mras Ndst2 Oggl
Gfer Gstml Hspala Kdelr2 Lrrfipl MrpHO Ndufabl Omg
Gfpt2 Gstm5 Hspalb Kdelr3 Lrrnl Mrpl12 Ndufafl Oprsl
Ggh Gstpl Hspa9a Keapl Lss Mrpl17 Ndufb2 Orc2l
Ggtal Gstzl Hspbl Kif13a Ltb4dh Mrpl27 Ndufs2 OsbpHO
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Ghitm Gtf2h4 Hspb8 Kif18a Ltbpl Mrpl35 Ndufs5 OsbpHa
Gja1 Gtl3 Htatip2 Kiflc Ltbp3 Mrpl36 Ndufs7 Osbpl6
Ostfl Pgd Polr3c Purb Rgs7 Sdc2 Slc1a3 Socs5
Otubl Pgkl Polr3g Pus1 Rhbdfl Sdc3 Slc1a4 Sod2
Oxr1 Pgls Pop5 Pvrl2 Rhoa Sdc4 Slc20a2 Sorcsl
P2rx4 Pgm2 Ppap2b Pvrl3 Rhoc Sdf2l1 Slc22a17 Sorcs2
P4ha2 Pgrmc2 Ppargcla Pxmp2 Rhog Sdf4 Slc24a3 Sortl
P4hb Phgdh Ppargclb Pxmp4 Rhoj Sdfr2 Slc25a10 Sox10
Pa2g4 Phkal Ppat Pxn Rhoq Sdh1 Slc25a25 Sox3
Pacrg Phkb Ppfibp2 Pygb Rnaset2 Sdha Slc25a5 Sox6
Pacsin2 Phldal Ppgb Pygl Rnf128 Sdhc Slc27a3 Sox9
Paid Phlda3 Ppib Qdpr Rnf13 Sdhd Slc29a1 Sp1
Papssl Phosphol Ppic Qk Rnf141 Sec14l1 Slc2a1 Spag5
Pard3 Phxr4 Ppp1r14b Qscn6 Rnf26 Sec14l2 Slc2a3 Sparc
Parva Phyhipl Ppp2r4 Rab10 RnpepH Sec61a1 Slc2a8 Sparcll
Pax6 Pigk Ppp2r5a Rab13 Rod1 Sec8l1 Slc2a9 Spata6
Pcbp2 Pigm Ppp2r5c Rab14 Rorb Sellh Slc31a1 S p ed
Pcca Pigq Ppp3cc Rab34 Rp2h Sema4b Slc35a2 Spg20
PcdhIO Pigs Ppp5c Rab3b Rpl36al Sema6a Slc35a4 Spg7
Pcdh7 Pigt Ppt1 Rab5c Rpl37 Sep-15 Slc35b1 Sponl
PcdhblO Pik3r1 Pqlc2 Rab6 Rpn1 Sepm Slc35f5 Spp1
Pcdhb11 Pim2 Prdxl Rab7l1 Rpn2 Sepnl Slc37a4 Spr
Pcdhb21 Pip5k2a Prdx3 Rab9 Rpo1-3 Seppl Slc38a3 Spredl
Pcdhb9 Pkd1 Prdx4 Rabl3 Rps20 Sep-02 Slc39a1 Spred2
Pcdhga12 Pkm2 Prelp Rad 18 Rps27l Sep-08 Slc39a7 Spryl
Pcnx Pkn1 Prep Rad23a Rps6ka4 Sep-09 Slc3a2 Spry2
Pcolce Pla2g12a Prkaca Rad51ap1 Rras Serhl Slc41a1 Spry4
Pcolce2 Pla2g6 Prkca Rad51c Rrbpl Serpine2 Slc4a4 Sqrdl
Pcp4l1 Plat Prkcb Rad51l3 Rrm2 Serpinhl Slc6a1 Srcasm
Pctkl Plcb3 Prkcb Raetla Rsu1 Sertadl Slc6a8 Srd5a2l
Pcx Pled Prkcdbp Ralb Rtkn Sesn2 Slc6a9 Srebfl
Pcytla Pld2 Prkcm Ramp2 Rtn4ip1 Sesn3 Slc7a5 Srebf2
Pdcd6ip P led Prkcn Ranbp9 Runx2 Sf3a2 Slc9a1 Sri
Pde4b Plekha3 Prkwnkl Rangnrf Ryk Sfrs9 Slc9a3r1 Srm
Pdgfa Plekha4 Pmp Rap 1a S100a1 Sfxnl Slc9a3r2 Srprb
Pdgfra Plekhel Prps2 Raplb S100a10 Sgce Slitl2 Srr
Pdhal Plekhkl Prss15 Rap1ga1 S100a11 Sgpll Slmap Ssb4
Pdir Plk1 Psa Rap1gds1 S100a13 Sgppl Smfn Ssbp4
Pdk2 Plodl Psap Rap2b S100a6 Sh3bp4 Smo Sspn
Pdk3 Plod2 PsmblO Rap2c Sall2 Sh3d19 Smox Ssr3
Pdk4 Plod3 Pstpip2 Rapgef3 Sall3 Sh3glb1 Smpdl Ssr4
Pdlim3 Pip Ptdsr Rarb Sardh Shc3 Smpd2 StardIO
Pdlim4 Plscrl Ptdsr Rasgrfl Sas Shmtl Smpdl3a Stard5
Pdxk Plvap Ptdss2 Rassf3 Sat1 Shmt2 Smpdl3b Statl
Pdxk Plxdc2 Ren Rbms2 Sc4mol Siah2 Smtn Stat3
Pea 15 Pmaipl Rer Rbpms Scamp2 SiatIO Smyd2 Stat5b
Peer Pmf1 Rgds Rdh11 Scamp4 Siat6 Snagl S td
Pelo Pmm1 Rk7 Rdh5 Scamp5 Siat7d Snap23 Steap
Perl Pmp22 Rn Rec8L1 Scap Sirt2 Snapc2 Stk11 ip
Per2 Pnkp Rp4a3 R eed Scarbl Skp2 Sncaip Stk17b
Perp Pnn Ptpla Relb Scd1 Slc12a4 Sntg2 Stk3
Pes1 Pnp Rpn13 r Renbp Schipl Slc12a9 Snx3 Stoml2
Pfdnl Pold2 Rpnsl Repinl Sen 1b Slc13a3 Snx5 Stx4a
Pfkfb3 Pold4 Ptpra Rerg Scotin Slc16a2 Snx5 Stxbp3
Pfkl Pole2 Rprzl Rest Scpepl Slc16a3 Snx6 Sulf2
Pfkp Polg Pttglip Rga Scube2 Slc19a2 Snx9 Suox
Pgaml Polr2a Pura Rgl1 Sdbcag84 Slc1a1 Soatl Surf4
Svil Tm4sf7 Tspyl Ysg2 B930041F14Rik D15Ertd405e
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Swap70 Tm4sf9 Tst Ywhab BC003281 D15Ertd747e
Synel Tm7sf1 Ttyh2 Zc3hdc1 BC003331 D15Wsu75e
Syngrl Tm7sf2 Tulp3 Zdhhc2 BC003479 D16Bwg1494e
Syngr2 Tm7sf3 Twsgl Zdhhc6 BC005662 D16Wsu65e
Synj2 Tm9sf2 Txn1 Zfhxla BC008103 D16Wsu65e
Sypl Tm9sf4 Txndc4 Zfp119 BC008155 D17Wsu104e
Syt11 Tmc6 Txndc5 Zfp146 BC009118 D17Wsu92e
Sytl2 Tmem14c Txnip Zfp191 BC010304 D17Wsu94e
T2bp Tmem19 Tyro3 Zfp277 BC013529 D19Ertd678e
Taf10 Tmem5 Ube2r2 Zfp294 BC014795 D19Ertd721e
Taf7 Tmem9 Ubl3 Zfj354 BC017158 D19Wsu12e
Tagln2 Tmlhe Ugp2 Zfp64 BC020025 D1Bwg1363e
Tap2 Tmlhe Ugt1a2 Zf|367 BC022146 D1Ucla4
Tapbp Tnfaipl Ugt8 Zfyve21 BC022224 D2Ertd217e
Tbc1d1 T nfaip2 Upp1 Zmpste24 BC023151 D2Ertd750e
Tbc1d15 Tnfaip8 Uqcr Zyx BC023179 D430028G21Rik
Tbc1d8 Tnfrsf12a Uqcrc2 A030012M09Rik BC023488 D530020C15Rik
Tbl2 Tnfrsf13c Usp2 A130072J07 BC023957 D530030D03Rik
Tbrg4 Tnfrsf19 Usp31 A230035L05Rik BC026370 D630048P19Rik
Tceb3 Tnfrsfla Vamp3 A230050P20Rik BC026432 D6Wsu176e
Tcf4 Tnfrsf21 Vangll A330066M24Rik BC027342 D730049H07Rik
Tcf7l2 TnfrsfB Vapb A430091022Rik BC031407 D7Ertd156e
Tcfcp2l1 Tnfsf13 Vav3 A630072M18Rik BC034204 D7Ertd458e
Tcfl5 Tnip2 Vcaml A730019l05Rik BC048841 D830019K17Rik
Tcirgl Tnk2 Vcl A830037N07Rik BC051244 D8Ertd325e
Tcn2 Tnrc15 Vdacl A830059l20Rik BC056474 D8Ertd354e
Tdrd7 Tom1 Vdac2 A830073021 Rik C230080l20Rik D930010J01Rik
Tegt Tomm40 Vegfa A930011 F22Rik C230093N12Rik E030024M05Rik
T end Tor2a Vegfb AA408451 C330006A16Rik E130016l23Rik
Tesc Tpcnl Vim AA415817 C330007P06Rik E130107N23Rik
Tex15 Tpd52 Vkord AA536743 C330008l15Rik E130112L23Rik
Tex264 Tpi Vldlr AA881470 C530025K05Rik E130209G04Rik
Tgfb2 Tpk1 . Vps52 AA959742 C530044N13Rik E130307C13
Tgolnl Tpm1 Vrk2 AF155546 C530046K17Rik E430007K15Rik
Thap7 Tpm3 Wasf2 AI181996 C630011I23 E430019H13Rik
Thrsp Tpmt Wasl AI429613 C730025P13Rik E430021N18Rik
Tie9 1 Tpr Waspip AI463102 C730036B01Rik E430036l04Rik
Timm44 Tra1 Wbp2 AI604832 C76683 LOC14433
Timm8a Tradd Wdr1 AU04095 C87777 LOC215866
Timpl Traf3 Wdr10 AV216087 C920006C10Rik MGC18837
Timp3 Traf4 Wfs1 AW049604 D0HXS9928E
Tiparp Traml Wig1 AW049900 D10Bur2e
Tjp2 Trdn Wnt4 AW050020 D10Bwg0940e
Tkt Tribl Wnt5a AW061234 D10Ertd214e
Tle2 Trib3 Wwox AW123240 D10Ucla1
Tle6 Trim21 Xist AW125391 D11Ertd498e
Tin Trim47 Xrcc5 B230118H07Rik D11Ertd730e
Tlr3 Trim8 Yaf2 B230208H17Rik D11Ertd99e
Tm4sf11 Trp53 Yes B230339H12Rik D11Wsu68e
Tm4sf12 Trpsl Yif1 B830009D23Rik D130038B21Rik
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Figure 9.2.1 qRT-PCR validation of all microarray experiments. Relative 
expression changes are shown for the selected representative genes Tnc, 
StatS and Sox2, which largely reflect changes from the microarray analysis. 
Target hybridisations (x-axis) have been grouped together based on the 
experiment and the relative expression from the microarray analysis is 
shown next to the relative expression from the qRT-PCR analysis. The 
values are relative between all conditions for each gene investigated.
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